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Estradiol sensitization of sexual behaviors in the ovariectomized rat:  
Mechanisms and applications 
 
Sherri Lee Jones, Ph.D. 
Concordia University, 2015 
 
Estradiol sensitization refers to a phenomenon whereby each subsequent injection of 
estradiol benzoate (EB), when administered to the ovariectomized (OVX) rat to induce sexual 
behavior, potentiates the occurrence of those behaviors. The goals of the current thesis were to 
characterize the pattern of estradiol sensitization by varying the EB dose and injection interval, 
to examine some behavioral, hormonal, and neural factors involved in its induction and 
maintenance, and to apply it as a diagnostic tool in models that have been shown in the literature 
to produce sexual inhibition. It was first determined that estradiol sensitization is robustly 
induced by 10µg EB administered SC every 4 days, and that the effect is further potentiated if 
EB is administered in the absence of the opportunity to copulate. Furthermore, although adrenal 
progesterone (P) did not play a role, chronic administration of systemic injections of the P 
receptor antagonist RU486 revealed that P receptors are important in the maintenance of the 
sensitization. The next set of experiments determined that vaginocervical stimulation (VCS) 
received on repeated tests attenuates the sensitization of appetitive sexual behaviors (hops, darts, 
solicitations), and that inhibitory mechanisms related to estrous termination may be involved, 
since the attenuation was mimicked by repeated infusions of the glutamate receptor agonist 
AMPA to the ventrolateral division of the ventromedial hypothalamus in place of copulation. 
Moreover, the onset of estrous termination was accelerated in estradiol-sensitized animals that 
were not given the opportunity to copulate. This suggests that estradiol sensitizes mechanisms of 
sexual excitation and inhibition. The final experimental chapter determined that prenatally 
androgenized females are not permanently desensitized to the activational effects of EB, since 
repeated hormone treatments in combination with sexual experience generally restored sexual 
behaviors and those females also displayed estradiol sensitization. Finally, the inhibitory effect 
	  	  
iv 
of corncob bedding, as reported recently in the literature, did not prevent estradiol sensitization. 
In conclusion, the extent of estradiol sensitization, and the duration of behavioral estrus in 
estradiol-sensitized animals, interacts with sexual experience, particularly VCS. The data 
presented herein have implications for all research areas investigating the role of estradiol on 
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Imagine this happened in your laboratory. You are running a preclinical double-blind 
study to test whether a compound increases sexual behaviors in female rats. The females are 
ovariectomized, which abolishes the expression of sexual behavior, treated with the appropriate 
hormones to reinstate sexual behavior, and given sexual training followed by a hormone washout 
period. When you test the acute effect of the drug given in combination with estradiol, which is 
required to prime the circuits that permit the expression of sexual behavior, there is a rock solid 
facilitation by the drug. However, the company you work with has been made aware that this 
drug, bremelanotide, has a blood pressure marker issue and aggressive screening is requested. A 
new set of animals is ordered, ovariectomized, trained, and given a hormone washout, and now 
the animals are treated repeatedly every four days (mimicking the natural ovarian cycle) for 
long-term screening of its effects. Once the behavior is scored and the double-blind code is 
broken, you are astonished to find that the baseline has risen, making it impossible to find any 
facilitation by the drug. But how could this be? How is it that your female rats that were treated 
with estradiol alone are displaying greater levels of sexual behavior with repeated 
administration? Is the female brain responding differently to estradiol when it is repeatedly 
administered? Has her brain become increasingly sensitive to its effects? 





CHAPTER 1: GENERAL INTRODUCTION 
Ovariectomized (OVX) rats are commonly used in the development of models to study 
underlying neuroendocrine and neurochemical mechanisms of female sexual behavior, 
reproductive function, and physiology. Establishing those models relies on strong methodologies 
and can be hampered if baseline responding is unstable. Such instability occurs with repeated, 
but not acute, administration of 17-β-estradiol (E2), an ovarian steroid hormone required to 
prime the neural circuits involved in the display of sexual behavior in the female rat. During the 
course of a particularly aggressive preclinical screening of pharmaceutical agents that could be 
useful in the treatment of female sexual arousal and desire/interest disorders, the rising baseline 
of both appetitive and consummatory sexual behaviors induced by estradiol benzoate (EB), 
administered every four days to mimic the normal estrous cycle of the female rat, became an 
obstacle. Although several studies had previously reported enhanced behavioral responding to 
chronic EB, the dosing and treatment regimens were in no way consistent across studies. 
Moreover, virtually nothing concrete was known about the mechanisms of this augmentation, nor 
was it possible to determine a dose or treatment regimen that would delay or prevent it.   
The experiments in this thesis first describe the rising baseline that occurs in the OVX rat 
with repeated administration of EB every four days, such that sexual behaviors become 
potentiated over time. This behavioral phenomenon is referred to as estradiol sensitization. Next, 
a description of the necessary and sufficient conditions that elicit behavioral sensitization to EB 
is provided, followed by an examination of important hormonal and behavioral mechanisms that 
contribute to the effect. The behavioral and neural mechanisms that contribute to an attenuation 
of estradiol sensitization when the female receives vaginocervical stimulation (VCS) are then 
investigated. In the final chapter, the estradiol sensitization paradigm is used to examine whether 
sexual inhibition (by endocrine disruption in adulthood or by prenatal androgen administration) 
can be overcome. These experiments establish the appropriate dosing regimens that should be 
used in preclinical models depending on the desired baseline, examine behavioral and 
neuroendocrine mechanisms that contribute to estradiol sensitization and its attenuation, and 
illustrate how this phenomenon can be used to assess models of sexual inhibition. The estradiol 
sensitization data are important for all studies that examine the effects of E2 on physiology, brain, 
and behavior (e.g., sexual behavior, hypothalamic-ovarian feedback mechanisms; and studies 
examining the role of E2 in memory and cognition, or in sex differences associated with 
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psychiatric disorders and drug- taking behaviors). The results of these studies are considered in 
the global context of the flexibility of female sexual response strategies and neuroendocrine 
regulatory mechanisms. 
 
Female rat sexual behavior in an historical context 
A traditional view of rat sexual behavior describes the male making active copulatory 
advances toward sexually receptive females that passively receive his mounts, intromissions, and 
ejaculations (Caggiula et al., 1979; Hardy & Debold, 1973). This receptivity posture, called 
lordosis, is a concave arching of the back that raises the rump and allows males to mount with 
intromission. In order to study male sexual behavior and to prevent pregnancy and control testing 
schedules and conditions, females were typically OVX, abolishing the expression of female 
sexual behavior since ovarian steroid hormones are required for its expression. Early work 
established systemic (e.g., subcutaneous) dosing regimens that could maximally induce lordosis 
behavior, and also restore precopulatory or appetitive behaviors such as hops, darts, ear wiggling 
(Boling & Blandau, 1939). Optimal timing for the full induction of appetitive sexual behaviors 
and lordosis was also established, with EB administered 48 hours and progesterone (P) 
administered 4 hours prior to testing, respectively (Boling & Blandau, 1939; Hardy & Debold, 
1972; Whalen, 1974). Tests could then be conducted once every four days with exogenous 
ovarian steroid administration mimicking the rises in plasma hormone levels normally seen with 
natural ovarian output (Albert et al., 1991), which in turn approximated a normal 4-5 day estrous 
cycle (Blandau, Boling, & Young, 1941). Thus, most of the early literature relied on priming 
OVX rats fully with EB and P to ensure that they were maximally receptive for the male.  
Sexual behavior tests were also traditionally conducted in small testing chambers which 
permitted the male easy access to receptive females, and which appeared to maximize her 
display of lordosis at the expense of other sexual behaviors. In part, this focused attention on 
lordosis as a reliable and consistent sexual response in females, and made it arguably the most 
thoroughly-studied sexual response after male erection. In fact, Pfaff (1980; 1999) has argued 
that lordosis represents the first vertebrate behavior for which a complete neural circuit has been 
identified. However, it became clear thanks to the work of Beach (1976), Madlafousek and 
Hliňák (1977a), McClintock (1984) and Erskine (1989) that female rats were anything but 
passive recipients of male sexual behaviors, and in fact females controlled the initiation and rate 
	  	  
4 
of copulation in the wild, or appropriate laboratory situations, using solicitations and runaways to 
pace or regulate the timing of the sexual stimulation they received from the male. In particular, it 
became apparent that females controlled the rate and number of vaginocervical stimulations 
(VCSs) that were induced by penile intromission, which in turn bring about a faster termination 
of estrus behavior (Lodder & Zeilmaker, 1976), and activate neuroendocrine reflexes that 
maximize the likelihood of successful pregnancy (Adler, 1969). Indeed, the ability of the female 
to control sexual stimulation and to display appetitive sexual responses was limited in the small 
testing chambers used traditionally in the study of male sexual behavior. Such testing 
environments in fact stimulated the display of defensive responses that many females would use 
to enforce a longer interval between successive bouts of mounts with intromission. Such 
behaviors were used to infer decreased sexual motivation in females or that female rats did not 
“like” the feeling of intromission (Bermant & Westbrook, 1966; Hardy & Debold, 1972; Peirce 
& Nuttall, 1961). Given the existence of penile spines on a fully erect male rat penis (Sachs, 
Glater, & O'Hanlon, 1984), such interpretations were often taken at face value.  
Female control of the initiation and rate of copulation can be viewed more easily in large 
open fields (Coria-Avila, Ouimet, Pacheco, Manzo, & Pfaus, 2005; Kippin, Talianakis, 
Schattmann, Bartholomew, & Pfaus, 1998; McClintock, 1984), or in bilevel or unilevel pacing 
chambers that allow females to enforce her preferred temporal intervals by running from level to 
level, side to side, or crossing a Plexiglas barrier through holes that the male on one side cannot 
get through (Erskine, 1989; Paredes & Alonso, 1997; Pfaus, Smith, & Coopersmith, 1999). In 
addition to its effects on estrus duration and pregnancy, pacing is rewarding to the female and 
induces both conditioned place (Arzate, Portillo, Rodríguez, Corona, & Paredes, 2011; Paredes 
& Vazquez, 1999) and partner preferences (Coria-Avila et al., 2005; 2006) for contextual or 
partner-related cues that have been associated with the ability to pace.  
 
Hormonal influences on sexual behavior in the female rat 
As mentioned above, in the rat ovulation occurs every 4-5 days and coincides with 
behavioral estrus, a period whereby she displays stereotypical sexual behavior patterns that allow 
a male to successfully copulate and impregnate her. It is only during this periovulatory period 
when she is fertile that sexual behavior is displayed. If a female is not in behavioral estrus, 
attempted mounts from a male will result in antagonistic escape-related behaviors from the 
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female. Female sexual behavior is primarily dependent on fluctuating levels of ovarian E2 as 
well as P. Estradiol begins to rise during the diestrous phase of her cycle as the maturing ovarian 
follicles that contain the egg (or oocyte) grow under the influence of follicle stimulating hormone 
(FSH) released from the pituitary in response to hypothalamic gonadotropin releasing hormone 
(GnRH). During the proestrous phase a sharp rise in E2 from the mature follicles feeds back on 
the hypothalamus and under a positive feedback mechanism, which involves the stimulation of 
neuroprogesterone synthesis (nP) (Kuo & Micevych, 2012; Micevych, Soma, & Sinchak, 2008), 
stimulates a sharp rise in FSH and luteinizing hormone (LH) from the pituitary. This LH surge 
sets the stage for the final maturation of the follicles. Ovulation occurs when the follicles rupture 
and release the oocytes, and the follicles (now called the corpora lutea) release large amounts of 
P and other hormones, preparing the uterus for implantation should the eggs become fertilized.  
The gradual rise in E2 primes the hypothalamic circuits necessary for the display of 
sexual behavior that will occur approximately two days later, and its effects are potentiated by 
the subsequent rise in P. Sexual behavior begins to appear during late proestrus and carries over 
into the estrous phase, lasting approximately 12-20 hours depending on whether or not she 
copulates (Erskine, 1985; Erskine, Kornberg, & Cherry, 1989). In the absence of mating, steroid 
hormone levels will fall following absorption of the corpora lutea, and sexual behavior becomes 
inhibited until E2 and subsequently P rise again to induce the LH surge and ovulation four days 
later. Thus, as with exogenous administration of ovarian hormones, E2 and P act synergistically 
to activate appetitive and consummatory sexual behaviors. Those behaviors in turn, serve to 
entice the male to chase and mount her, and to allow successful intromissions, respectively, at 
optimal time intervals to facilitate fertilization of the ovum following the receipt of ejaculation 
(McClintock, 1984). Importantly, VCS received from penile stimulation during copulation plays 
a role in the duration of behavioral estrus, and the activation of neuroendocrine events that are 
necessary to prepare for and maintain pregnancy. 
 
Sequence of onset and offset of female sexual behavior 
As the female transitions into behavioral estrus, lordosis postures are the first to emerge, 
followed by appetitive behaviors (sometimes referred to as precopulatory (Erskine, 1989), 
proceptive (Beach, 1976), or paracopulatory (Blaustein & Erskine, 2002) behaviors) which also 
emerge in a sequential order. When sexually vigorous male and female rats are placed in a 
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pacing chamber, they begin anogenital investigation (initiated by either the female or the male), 
followed shortly thereafter by a full solicitation (headwise orientation to the male and a quick 
runaway) or partial solicitation (hop over and or dart by the male) made by the female (Pfaus, 
1996; Pfaus, Jones, Flanagan-Cato, & Blaustein, 2014). This causes the male to chase her. As the 
female comes to a stop, she initiates a pre-lordosis presentation posture, facilitating the ability of 
the male to mount her flanks when he arrives, which engages a full lordosis. As mentioned above, 
lordosis is necessary for penile intromission, and occurs in response to flank stimulation by the 
male. Its intensity can be measured on a three-point scale primarily according to the magnitude 
of the concave curvature of the back and elevation of the head and rump (Hardy & Debold, 
1972). 
The first appetitive behaviors to appear are presenting postures, followed by hops away 
from the male and then darting fly-bys (Madlafousek & Hlinak, 1977). Hops and darts typically 
co-occur when the female is fully primed and in a bilevel chamber are displayed when the female 
is on the same level as the male. In contrast, full solicitations in the bilevel chamber are observed 
when she runs away from one level to another (Pfaus et al., 1999), or in a unilevel “racetrack” 
chamber when she runs from side to side (Kippin et al., 1998; Kippin & Pfaus, 2001a; 2001b; 
Pfaus et al., 2009). Although the expression of full or partial solicitations is somewhat dependent 
on the amount of space the animals have, if the chambers are large enough (McClintock & Adler, 
1978), or constructed in a way that otherwise allows them to be expressed, full solicitations are 
indicative of greater sexual motivation than hops/darts, since they are more often observed in 
females fully primed with EB and P than with EB alone (Pfaus et al., 1999). Traditionally it is 
believed that higher levels of appetitive behaviors are indicative of a female manifesting more 
intense sexual motivation or desire (Hardy & Debold, 1971b; Madlafousek & Hlinak, 1977; 
Pfaus et al., 1999). Moreover, it has been proposed that appetitive behaviors in the female rat are 
used as a means of communication with the male (Madlafousek & Hlinak, 1977), and play an 
important role in the attractivity of the female (Beach, 1976), since inexperienced male rats will 
more readily copulate with females displaying greater intensities of those behaviors. For example, 
approximately 30% of inexperienced males will begin copulating with a female showing present 
postures, and the proportions increase to 60% and 90% if females are displaying hopping and 
darting, respectively (Madlafousek & Hlinak, 1977). Solicitations (and the increase in 
locomotion induced by E2) spread her estrous odors in a wider space, signaling the male that she 
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is sexually receptive and also enticing the male to search for her and, at least early in the male’s 
sexual experience, to chase her (Erskine, 1989; McClintock & Adler, 1978; Pfaus et al., 2012). 
Solicitational behaviors are reproductively relevant since they are more likely to elicit 
intromissions from the male (Erskine, 1989; McClintock & Adler, 1978). For example, 
McClintock and Adler (1978) reported that 90% of intromissions occurred when the female 
displayed a full solicitation and 84% of full solicitations were followed by an intromission. 
Following the receipt of a mount or intromission in a unilevel pacing chamber, a female may run 
away from the male and return to “her side” of the chamber for a brief time. However, following 
an ejaculation, the female returns to her side 100% of the time and for a longer time relative to 
intromissions or mounts (Erskine et al., 1989; Zipse, Brandling-Bennett, & Clark, 2000). In 
bilevel or racetrack chambers, the female typically responds to an ejaculation by moving 
immediately to the other level or side from the male (Pfaus et al., 1999; 2009). The receipt of an 
ejaculation from the male produces a large and sustained amount of VCS, as the ejaculate 
congeals into a “vaginal plug” acting as a cervical cap to protect and promote sperm transport 
(Toner, Attas, & Adler, 1987). After a brief period (ranging in minutes) of apparent sexual 
inhibition, the female returns to the male and shows increasing interest by sniffing his anogenital 
region or soliciting him to begin a new ejaculatory series initiated by the resumption of mounts 
with intromission. Sexual exhaustion in the male sets in by approximately 7 to 10 ejaculatory 
series, and the exhaustion alleviates within four days, coinciding with the females’ next bout of 
sexual receptivity (Beach & Jordan, 1956; Boling & Blandau, 1939; Larsson, 1956).  
As the period of sexual receptivity gradually terminates, the behaviors also dissipate in a 
sequential fashion. First, appetitive behaviors decline, coinciding with an increase in defensive 
behaviors, before the decrease in lordosis intensity and frequency is observed (Pfaus, Smith, 
Byrne, & Stephens, 2000). This behavioral pattern defines the transition into “estrous 
termination”. Hence, the period of sexual behavior in the female rat begins and ends with the 
lordosis posture, and the presence of appetitive solicitations is indicative of a more sexually 
motivated female. 
 
Factors influencing the activation and termination of sexual behavior 
Although E2 is crucial for priming the circuits required for the expression of sexual 
behavior, their expression per se is influenced by the presence of a male and the sexual 
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stimulation received. Sexual behavior (lordosis in particular) can be enhanced within an episode 
of heat by merely exposing the EB-primed OVX rat to a sexually vigorous male without the 
receipt of intromission (Auger, Moffatt, & Blaustein, 1997; Blaustein, Farrell, Ghavami, Laroche, 
& Mohan, 2009; Foreman & Moss, 1977; Hardy & Debold, 1973; Rajendren & Moss, 1993; 
Rajendren, Dudley, & Moss, 1990). This mating-induced enhancement of lordosis is also 
potentiated by application of crystalline E2 directly to the ventromedial hypothalamus (VMH) of 
OVX rats (Rajendren, Dudley, & Moss, 1991), is completely prevented by lesions to the VMH 
(Rajendren et al., 1991), and strongly attenuated by lesions to medial amygdala (MeA) 
(Rajendren & Moss, 1993). The mating-induced enhancement of lordosis also occurs as a result 
of experimenter handling (Hardy & Debold, 1973). Although this suggested at first that stress-
induced secretion of adrenal P may play a role, the enhancement is not prevented by removal of 
the adrenal glands (Auger et al., 1997; Blaustein et al., 2009) suggesting that peripheral P is not 
involved. 
VCS itself can induce low levels of lordosis in the OVX rat with or without prior E2 
administration if applied manually by an experimenter with a glass rod in combination with 
manual palpation of the flanks and perineum (Komisaruk, 1972; Komisaruk & Diakow, 1973; 
Rodriguez-Sierra & Komisaruk, 1983). However E2 administration potentiates lordosis in 
response to manual VCS with concomitant palpation of the flanks and perineum, even at 
subthreshold doses (Komisaruk & Diakow, 1973), and induces a faster recovery of lordosis 
compared to untreated animals, after exhaustion induced by successive stimulations (Rodriguez-
Sierra & Komisaruk, 1983). Interestingly, in the study of Komisaruk (1973), lordosis was never 
observed following initial application of flank-perineal palpation; however after applying manual 
stimulation that included VCS, lordosis was induced in EB-treated rats by later application of 
flank-perineal stimuli, and this effect did not occur in untreated rats, suggesting that EB 
permitted a behavioral facilitation by VCS. By the end of the test procedures, OVX oil-treated 
rats no longer displayed lordosis in response to manual VCS in combination with palpation of 
the flanks and perineum, whereas that inhibitory effect did not occur in EB-treated rats. This 
latter observation was an early indication that EB opposes the inhibitory effect of VCS on the 
display of lordosis, as proposed later by Pfaus (Pfaus et al., 2000). It was also shown that this 
mating or VCS-induced enhancement of lordosis (Hardy & Debold, 1972; Komisaruk, 1972; 
Komisaruk & Diakow, 1973) occurs via progesterone receptor (PR) activation (Auger et al., 
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1997). More recently it has been shown that appetitive behaviors are also enhanced within a 
mating session in OVX rats that were adrenalectomized (ADX) and primed with EB (5µg) 
(Blaustein et al., 2009); however the exact mechanism of this effect is not known. 
Although VCS can facilitate lordosis, it clearly activates mechanisms that are inhibitory 
to sexual behavior since it increases the probability that the female will withdraw from the male, 
increases the latency to return to the male, decreases solicitations and increases defensive 
responses, and accelerates the onset of estrous termination (Lodder & Zeilmaker, 1976; Pfaus et 
al., 2000). In turn, estrous termination permits the endocrine transition to pseudopregnancy or 
pregnancy (Erskine, 1985; Pfaus et al., 2000). Experimenter-applied VCS using a glass rod also 
shortens the period of behavioral estrus (Pfaus et al., 2000), and activates the same 
neuroendocrine events involved in the maintenance of pregnancy (Lehmann & Erskine, 2004), 
that occur with repeated mating. The onset of estrous termination by VCS, and the induction of 
pseudopregnancy is further accelerated if females are given the opportunity to pace the sexual 
stimulation (Coopersmith, Candurra, & Erskine, 1996; Erskine, 1985; 1989; Erskine et al., 1989). 
As little as 10-15 paced intromissions are sufficient to induce pseudopregnancy and activate 
mechanisms that are inhibitory to sexual behavior by accelerating the onset of estrous 
termination (Erskine et al., 1989), yet females display conditioned place preference for even high 
levels (approximately 25) of VCS if they are given the opportunity to pace those stimulations 
(Arzate et al., 2011). 
In summary, under the appropriate testing conditions, it has become clear that female rats, 
and indeed females of a number of disparate species, exert a great deal of control over the sexual 
stimulation received, which is driven at least in part by the expression of appetitive sexual 
behaviors, and that she actively controls the rate at which the stimulation is received from the 
male. Sexual solicitations help signal the male to assume mounting, increase the probability of 
the receipt of intromissions and ejaculation, which when coupled with lordosis and the ability to 
pace, increase the probability of successful fertilization. Although mating stimulation can 
enhance the expression of sexual behaviors, sufficient VCS in particular, especially when paced 
by the female, activates mechanisms that are inhibitory to sexual behavior (albeit without 
removing the positive affective state induced by that stimulation (Arzate et al., 2011; Meerts & 




Neural regions implicated in the activation and termination of sexual behavior 
The neural circuitry involved in the activation of lordosis by E2 has been carefully 
studied and described (McGinnis & Pfaff, 2012; Pfaff, 1980; 1999). The circuitry is typically 
broken down into four modules as shown in Figure 1, although the model has since been 
expanded upon by numerous research groups, and it is now well known that additional sites are 
also important in the regulation and facilitation of lordosis (Micevych & Sinchak, 2007). 
Lordosis requires appropriate hormone priming conditions acting on neurons within the VMH, 
and occurs in response to flank and perineal stimulation. The spinal cord module receives the 
majority of the somatosensory information following stimulation of the flanks and pressure 
placed on the rump, tail base, and perineum, which are necessary and sufficient for lordosis to 
occur (Pfaff, 1999). That stimulation activates neurons within the dorsal horn of the spinal cord, 
and those fibers that are relevant for lordosis travel up to the medullary reticular formation and 
lateral vestibular nucleus in the lower brainstem, and a small number of those fibers also ascend 
to the midbrain central gray (or periaqueductal gray, PAG). The lower brainstem module 
integrates the animal’s posture across spinal cord segments, including inputs from the vestibular 
organs to sense head position and movement, and proprioceptors that sense skeletal and muscle 
movement. The integration of the signals within the spinal cord segment occurs within the 
midbrain module. However, those ascending signals do not directly control the motor outputs for 
lordosis to occur, rather they require descending inputs from hypothalamic and surrounding 
regions which themselves must be primed with E2. 
The neurons in and around the ventrolateral region of the VMH (vlVMH) are required for 
lordosis to occur. Lordosis is abolished by lesioning or pharmacologically blocking those cells, 
and electrically stimulating those cells facilitates lordosis (Pfaff & Sakuma, 1979b; 1979a). More 
recently additional hypothalamic and extrahypothalamic circuits have also been extensively 
studied in relation to their importance in the activation of the lordosis circuit (Micevych & 
Sinchak, 2007; Mills, Sohn, & Micevych, 2004). Estradiol also binds to membrane-bound 
estrogen receptors (mER) which form a complex with membrane glutamate receptors (mGluR) 
within neurons of the arcuate nucleus (ARC) that result in the release of opioids through 
efferents to the medial preoptic area (mPOA), a subset of which project to the VMH. This effect 
is initially inhibitory to lordosis, yet the later rise in P deactivates this inhibitory circuit to 




Figure 1.1. Neurocircuitry of lordosis. Lordosis expression is dependent on estradiol binding 
(black dots) within hypothalamic and extrahypothalamic sites. Olfactory stimulation arriving 
from the accessory olfactory system and somatosensory cues from perineal and flank stimulation 
converge their signals in the VMH, which sends descending information to permit the expression 
of lordosis. The pdMeA, BNST and arcuate signal to the mPOA, which relays information to the 
VMH. Reproductively relevant olfactory and hormonal information occur in the MeApd, BNST, 
and PAG (midbrain module) which itself receives ascending somatosensory stimulation from the 
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spinal module and descending information from the VMH. That descending information signals 
within the lower brainstem module (via the lateral vestibular nuclei and medullary reticular 
formation), sending facilitative signals to motor neurons in the spinal module to contract, 
resulting in a concave arching of the back, called lordosis. The circuitry underlying solicitational 
behaviors is less understood, but overlap with systems that activate lordosis (such as the VMH, 
mPOA and pdMeA, see text for details), and are also initiated by estradiol binding. BNST: Bed 
nucleus of stria terminalis. pdMeA: posterodorsal division of the medial amygdala. mPOA: 
medial preoptic area. PAG: periaqueductal gray. VMH: ventromedial hypothalamus. (Hardy & 
Debold, 1972; McGinnis & Pfaff, 2012; Micevych & Sinchak, 2007; Pfaff, 1980; Pfaff, 1999). 




Estradiol also acts within the MeA, particularly the posterodorsal division (pdMeA) and bed 
nucleus of the stria terminalis (BNST) which among other things, are involved in the pathway 
which receives olfactory signals that facilitate the expression of sexual behaviors (Micevych & 
Sinchak, 2007). The synergistic actions of E2 and P in the VMH and surrounding hypothalamic 
regions, through genomic events and electrophysiological effects, send descending efferents to 
the midbrain central gray to “permit” the lordosis reflex in response to relevant somatosensory 
inputs. Thus, the hypothalamic module is the primary endocrine control center that is required 
for lordosis to occur (Kow & Pfaff, 1998; Pfaff, 1999).  
The neurons in the midbrain central gray (or PAG), in combination with a small number 
of neurons within the mesencephalic reticular formation, send descending facilitative signals to 
the medullary reticular formation in the lower brainstem (Pfaff, 1980; 1999). Thus the midbrain 
receives incoming hypothalamic peptides and proteins, and translates those signals that are 
relatively slow to faster-changing electrophysiological signals. Finally, signaling within the 
lower brainstem module (via the lateral vestibulospinal and reticulospinal tracts) send facilitative 
signals to motor neurons in the lumbar region that control the deep back muscles. Those motor 
neurons are attached dorsally to the back muscles such that when the muscles contract in 
response to stimulation from the motor neurons, they elicit the concave arching of the back, 
called lordosis. 
In the female rat, the potential for sexual behavior depends primarily on the priming 
actions of E2 within the hypothalamus through classic genomic mechanisms. Estradiol is 
primarily synthesized in the ovary from its precursor cholesterol, and freely crosses the bi-lipid 
cell membrane in target tissue due to its lipophilic property, where it binds its receptor, dimerizes 
and activates hormone response elements on DNA to initiate gene transcription and the 
upregulation of numerous neurotransmitter, neurosteroid, and receptor systems (Micevych, 
Eckersell, Holland, & Smith, 1996; Pfaff, 1999; Sinchak & Micevych, 2001). Among its effects 
is the transcription and synthesis of PR in hypothalamic areas such as the VMH and mPOA 
which occurs within 48 hours of EB administration (MacLusky & McEwen, 1980). Subsequent P 
binding to its receptor elicits behavioral effects within four hours of a subcutaneous injection in 
the OVX rat. Activation of PR in the VMH amplifies the lordosis response whereas PR 
activation in the mPOA appears to be important in the display of appetitive behaviors (Beyer, 
Gonzalez-Flores, & González-Mariscal, 1997; Glaser, Rubin, & Barfield, 1983; Hoshina, Takeo, 
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Nakano, Sato, & Sakuma, 1994; Mani, Blaustein, Allen, Law, O’Malley, & Clark, 1994; Rubin 
& Barfield, 1983; Sakuma, 1994; 2008).  
There is a tight interplay between the mPOA and VMH in the control of appetitive and 
consummatory measures of sexual behavior, which are mutually exclusive. The mPOA is 
primarily involved in the display of solicitational behaviors which require heightened locomotor 
activity, and locomotion must be halted in order for the immobile lordosis stance, which itself is 
dependent on the vlVMH, to occur.  Estradiol applied in or around the vlVMH induces lordosis 
(Davis, Krieger, Barfield, McEwen, & Pfaff, 1982; Davis, McEwen, & Pfaff, 1979; Rubin & 
Barfield, 1980), whereas its application to the mPOA increases locomotor activity (Fahrbach, 
Meisel, & Pfaff, 1985; Wade & Zucker, 1970). Neural firing during proestrus, which coincides 
with the display of sexual behavior, increases in the VMH and the nearby arcuate nucleus of the 
hypothalamus (Dyer, 1973; Dyer, Pritchett, & Cross, 1972; Moss & Law, 1971). Similarly, 
neuronal firing rates in the VMH are higher in OVX rats treated with E2, but lower in the mPOA, 
compared to controls (Bueno & Pfaff, 1976; Hasegawa & Sakuma, 1990; 1993). Moreover, 
whereas electrical stimulation of the VMH enhances lordosis, stimulation of the mPOA inhibits 
lordosis, in E2 treated rats (Pfaff & Sakuma, 1979b). Lordosis is abolished following lesions of 
the vlVMH (Pfaff & Sakuma, 1979a), but facilitated by excitotoxic lesions specific to cell bodies 
within the mPOA (sparing fibers of passage), yet those mPOA lesions decrease appetitive sexual 
behaviors (and facilitate defensive behaviors) (Hoshina et al., 1994). Thus, solicitational 
behaviors and lordosis are mutually exclusive components of the full array of sexual behavior, 
and would therefore require rapid inhibitory and excitatory bi-directional signals between the 
vlVMH and mPOA during a copulatory bout. 
Ample evidence suggests that glutamate transmission within the VMH is inhibitory to 
sexual behavior, and that hormone priming opposes this process. Although the application of 
crystalline E2 to the VMH elicits lordosis (Dörner, Docke, & Moustafa, 1968), infusions of 
glutamate (an excitatory neurotransmitter) or its ionotrophic receptor agonists, as well as GABA-
A receptor antagonists to this region inhibit lordosis (Georgescu & Pfaus, 2006b; Kow, Harlan, 
Shivers, & Pfaff, 1985; McCarthy, Curran, & Feder, 1991). Conversely, infusions of glutamate 
receptor antagonists (Georgescu & Pfaus, 2006a) or GABA (an inhibitory neurotransmitter) 
receptor agonists stimulate lordosis (McCarthy et al., 1991; McCarthy, Kaufman, Brooks, Pfaff, 
& Schwartz-Giblin, 1995; McCarthy, Malik, & Feder, 1990). Presenting an OVX rat with a 
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sexually vigorous male elicits the release of glutamate within the VMH, but its release is blunted 
if females are treated with EB (10µg) 48 hours earlier (Georgescu, Afonso, Graham, & Pfaus, 
2014). Moreover, large amounts of VCS that are known to induce estrous termination activate 
glutamate neurons within the vlVMH but fewer of those neurons are activated if females are 
pretreated with EB (Georgescu, Sabongui, Del Corpo, Marsan, & Pfaus, 2009). Furthermore, 
frequent hormone priming with EB and P (for example every 4 days as opposed to every 21 
days) reduces the ability of VCS to induce estrous termination (Pfaus et al., 2000). Thus, EB 
appears to disinhibit neural mechanisms of sexual behavior residing in the vlVMH, and its 
effects appear to be more robust with frequent administration. 
As mentioned above, the amount and pattern of VCS is important in triggering the 
neuroendocrine events necessary for fertilization and to maintain pregnancy, and the MeA is a 
critical brain region involved in this process. The MeA has a large number of estrogen receptors 
(ER) (Pfaff & Keiner, 1973), the application of crystalline E2 to this region induces lordosis, as 
it does in the VMH (Lisk & Barfield, 1975), and long-term treatment with EB increases the 
firing rate of its neurons (Schiess, Joëls, & Shinnick-Gallagher, 1988), suggesting that neurons 
within the MeA sensitize to EB over time (Pfaus, Marcangione, Smith, Manitt, & Abillamaa, 
1996). In addition to the activation of glutamatergic cells in the vlVMH that appear to be 
inhibitory to sexual behavior, the receipt of VCS induces twice daily prolactin surges which is 
required for the maintenance of pregnancy (or the induction of pseudopregnancy if the egg is not 
fertilized), and that mechanism occurs, at least in part, via NMDA (N-methyl-D-aspartate) and 
AMPA (alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid) receptor activation within 
the pdMeA (Lehmann & Erskine, 2005; Lehmann, McKellar, & Erskine, 2005; Oberlander, Lin, 
Man, & Erskine, 2009; Polston & Erskine, 2001). Thus, the activation of sexual behavior in the 
female rat requires priming actions of E2 acting on hypothalamic tissue (see Figure 1), and its 
duration is partly dependent on VCS received during mating. That stimulation in turn activates 
reproductively relevant neural regions (i.e., such as the pdMeA) that are necessary for the 
neuroendocrine events required in the maintenance of pregnancy/pseudopregnancy.   
 
What is a physiological dose of estradiol? 
Across the ovarian cycle of the rat, plasma E2 levels begin to rise during diestrus, peak in 
the afternoon of proestrus followed by a sharp decline, resulting in the lowest levels during estrus 
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and metestrus (Belanger, Cusan, Caron, Barden, & Dupont, 1981; Henderson, Baker, & Fink, 
1977). Although the estimates of the precise circulating levels of E2 vary somewhat within the 
literature (which may due to a variety of factors such as the type of assay used, the age and strain 
of animal, diet, or the method of blood collection, for example cardiac puncture, jugular or tail 
vein), plasma levels measured by radioimmunoassay generally range from approximately 6-
10pg/mL during estrus into metestrus, begin to rise during diestrus, ranging from approximately 
10-50pg/mL, and peak in the afternoon of proestrus reaching approximately 50-70pg/mL (values 
extracted from (Belanger et al., 1981; Henderson et al., 1977)).  
Henderson, Baker and Fink (1977) proposed that physiological doses of EB, when 
administered acutely in oil to the OVX rat, range from 2.5-10µg. Female rats were OVX on the 
day of Diestrus and immediately treated with 2.5 or 10µg EB and blood was collected at various 
times after injection. Following an acute injection of 2.5µg EB, plasma E2 rose slowly, reached a 
peak of approximately 30pg/mL 24 hours later, and gradually returned to baseline levels 
approximately 12 hours thereafter. Following the administration of 10µg EB, plasma E2 
increased sharply, reached a peak (∿115pg/mL) approximately 24-30 hours later, followed by a 
sharp decline approaching pretreatment levels approximately 36 hours following the injection. 
Others have shown that OVX rats receiving doses lower than 10µg EB result in lower, and doses 
greater than 10-20µg EB resulted in higher, uterine weights compared to controls (Tapper, Greig, 
& Brown-Grant, 1974). Thus, although a 10µg EB dose may initially induce supraphysiological 
plasma levels of E2, it is physiological with respect to its actions on target tissue, whereas lower 
doses (e.g., 2.5µg EB) that do induce physiological plasma levels may not be sufficient to restore 
normal physiological function in target tissue.  
From a behavioral standpoint, a “physiological” dose of EB in the OVX rat should 
coincide with a reinstatement of the behavior in question. For example, although Silastic© 
capsule implants may induce plasma E2 levels within the physiological range (15pg/mL) they 
produce an abnormal pattern of sexual behavior such that females are constantly receptive 
(despite being approximately a third of the peak plasma E2 level achieved during the estrous 
cycle) (Albert et al., 1991). The co-administration of 10µg EB with 500µg P, administered 48 
and 4 hours prior to testing respectively, fully reinstates sexual behavior in the OVX rat to levels 
equivalent to that seen in an intact animal (Boling & Blandau, 1939). Thus, as proposed by 
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Henderson et al., (1977) subcutaneous injections ranging from 2.5 to 10µg EB appear to be both 
physiologically and behaviorally relevant. 
 
Increased behavioral sensitivity to estradiol 
The induction of sexual behavior in the OVX rat is most commonly induced by 
subcutaneous administration of EB (varying between 2µg to 10µg) followed 18-48 hours later by 
P, and the behavioral facilitation is seen within four hours of P administration (Boling & Blandau, 
1939; Edwards, Whalen, & Nadler, 1968). Sexual behavior is typically tested every four days, 
mimicking the pattern of fluctuating hormone levels in females, and allowing a four day rest 
period which is required for alleviation of sexual exhaustion in male rats which takes 
approximately 72 hours to recover (Romano-Torres, Phillips-Farfan, Chavira, Rodriguez-Manzo, 
& Fernandez-Guasti, 2007). This four-day behavioral testing pattern has been reliably used in 
Pavlovian conditioning paradigms to study sexual motivation (Pfaus et al., 1999), place and 
partner preferences (Coria-Avila et al., 2005; e.g., 2006; Holley, Shalev, Bellevue, & Pfaus, 
2014; Ismail, Gelez, Lachapelle, & Pfaus, 2009; Ismail, Jones, Graham, Sylvester, & Pfaus, 
2011; Kippin, 2000; Kippin, Samaha, Sotiropoulos, & Pfaus, 2001; Meerts, Schairer, Farry-
Thorn, Johnson, & Strnad, 2014; Parada, Abdul-Ahad, Censi, Sparks, & Pfaus, 2011; Parada, 
Vargas, Kyres, Burnside, & Pfaus, 2012; Paredes & Vazquez, 1999; Pfaus et al., 1999; Pfaus, 
Erickson, & Talianakis, 2013; Pfaus et al., 2010), as well as in preclinical studies examining both 
short- and long-term effects of pharmacological agents on sexual behavior (e.g., Pfaus, Shadiack, 
Van Soest, Tse, & Molinoff, 2004; Rössler et al., 2006). In the case where an inhibition of sexual 
behavior is predicted by a given manipulation, females are fully-primed with EB and P, yet when 
a facilitation is expected females are typically primed with EB only, which induces only low 
levels of lordosis, and (when administered acutely) prevents ceiling effects that occur with 
subsequent P administration (e.g., Georgescu & Pfaus, 2006a; Graham & Pfaus, 2010; Pfaus, 
Giuliano, Gelez, 2007; Snoeren et al., 2011).  
Another method of E2 administration that has been frequently employed in the literature 
is called the two-pulse (or discontinuous) paradigm, originally used in the study of uterine cell 
division (Harris & Górski, 1978), in which free E2 is used to induce sexual behavior. When free 
estradiol is administered in a single dose, a larger dose dose is required to induce sexual 
receptivity (between 10-100µg) because free E2 rapidly produces an increase in plasma and brain 
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levels of E2 which only lasts a brief period (Clark & Roy, 1983; Green, Luttge, & Whalen, 1970; 
McEwen, Pfaff, Chaptal, & Luine, 1975; Södersten, Eneroth, & Hansen, 1981; Tapper et al., 
1974). Such studies have found that P’s ability to induce sexual behavior is facilitated following 
at least two injections of free E2 compared to an equivalent dose given in single injection (Clark 
& Roy, 1983; Södersten et al., 1981), whereas when E2 was administered in a single injection, 
the dose had to be at least 10 times higher (Clark & Roy, 1983). These early studies suggested 
that the first dose of E2 primes subsequent E2 actions to facilitate P’s ability to induce sexual 
behavior.  
This increased behavioral sensitivity to subsequent treatment of E2 has also been reported 
in paradigms that repeatedly administer E2 alone. EB administered acutely, even in very high 
concentrations, elicits only partial expression of female sexual behaviors, such that lordosis 
occurs approximately 20-50% of the time that she is mounted by the male, very few appetitive 
behaviors are displayed, and she will often show aggression or rejection of the male in response 
to an attempted mount (Boling & Blandau, 1939; Davidson, Rodgers, Smith, & Bloch, 1968a; 
Davidson, Smith, Rodgers, & Bloch, 1968b; Edwards et al., 1968; Hardy & Debold, 1971b; 
Meyerson, 1964; Whalen, 1974). However, early studies reported that OVX rats treated 
repeatedly with EB are behaviorally more sensitive to subsequent treatments (Babcock, Bloch, & 
Micevych, 1988; Beach & Orndoff, 1974; Blaustein, Finkbohner, & Delville, 1987; Clark & Roy, 
1983; Kow & Pfaff, 1975; Parsons, MacLusky, Krieger, McEwen, & Pfaff, 1979; Whalen & 
Nakayama, 1965). Because those studies used EB dissolved in oil, resulting in a slow release 
(and more accurately reflecting the gradual rise in E2 that occurs across the ovarian cycle), it was 
suggested that residual E2 remained in the circulation and as such the concentration of 
subsequent administrations was additive, resulting in a potentiation of sexual behavior following 
each treatment (Parsons et al., 1979). One such study reported that following a 
(supraphysiological) subcutaneous injection of 50µg EB dissolved in 0.1mL sesame oil, E2 
plasma concentrations peaked at 1800pg/mL within 10 hours, and remained elevated (100pg/mL) 
four days later (Legan, Coon, & Karsch, 1975). However Parsons and colleagues (1979) have 
shown that OVX animals pre-treated with crystalline E2 through a subcutaneous capsule (5mm) 
for 1 week (which induced relatively constant plasma E2 levels of 40-45pg/mL) were also 
behaviorally more sensitive to subsequent E2 exposure following a 5-day washout, compared to 
animals that were not pre-treated with E2. Furthermore, following removal of the capsules, 
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plasma E2 had returned to control levels within 12 hours. Together those data show that E2 
induces long-term changes in how neural tissue responds to subsequent exposure.  
Estradiol-induced and estradiol-facilitated paradigms. The enhanced behavioral 
sensitivity of OVX rats to repeated E2 administration in the absence of P has been studied in two 
ways, one referred to as E2-induced and the other as E2-facilitated sexual behavior (Blaustein et 
al., 1987). In the E2-induced paradigm, females are given daily injections of EB (e.g.,, (Blaustein 
et al., 1987; Davidson et al., 1968a; Tennent, Smith, & Davidson, 1980) or a subcutaneous E2 
implant (Gorzalka & Moe, 1994; Parsons et al., 1979), whereas in the E2-facilitated paradigm a 
bolus injection of free E2 is given in place of P, following a priming injection of EB (Blaustein 
et al., 1987; Kow & Pfaff, 1975; Parsons, Rainbow, Snyder, & McEwen, 1984). In both 
paradigms the facilitation of lordosis has been shown to be independent of peripheral sources of 
P, since ADX does not prevent the increase (Davidson et al., 1968a; Gorzalka & Moe, 1994; 
Kow & Pfaff, 1975; Tennent et al., 1980); in fact ADX can increase lordosis following E2 
administration (Eriksson & Södersten, 1973; Gray & Gorzalka, 1980). In contrast, ADX has 
been shown to reduce the number of hops, darts and ear wiggles in an E2-induced paradigm that 
induces constant physiological levels of circulating E2 in OVX animals (15pg/mL) (Tennent et 
al., 1980). This dose is reportedly lower than the average serum E2 concentration present during 
the estrous cycle, at about a third of the peak concentration that is reached in the ovulatory cycle. 
This dose has also been shown to maintain normal body weight and is the minimal effective dose 
for maintaining lordosis in OVX rats (Albert et al., 1991).    
To further examine whether P plays a role in the induction of sexual behaviors by E2 
administered alone, PRs themselves were blocked using the competitive antagonist RU486 
(mifepristone). It had been shown that E2 has the ability to bind PR, albeit with low binding 
affinity (approximately 1% that of P) (MacLusky & McEwen, 1980; Parsons et al., 1984), as 
such Blaustein (1987) asked whether blocking PR would block the facilitation of sexual 
behaviors in both the E2-induced and E2-facilitated paradigms. Blocking PR with RU486 just 
prior to P administration in OVX rats primed with EB effectively inhibited the display of 
sexually appetitive behaviors and attenuated lordosis (Blaustein et al., 1987). Next, OVX rats 
were implanted with a subcutaneous capsule containing crystalline E2 followed one week later 
by an injection of RU486 or vehicle and behavioral tests were carried out between 4 and 38 
hours later, revealing no effect of PR blockade on E2-induced lordosis. Similarly, OVX rats were 
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treated with 2µg EB and 44 hours later with a bolus injection of free E2 in place of P (E2-
facilitated paradigm) but injected with RU486 or vehicle one hour prior to the second injection 
of E2, and again no effect was seen on lordosis. Unfortunately, appetitive sexual behaviors were 
not reported in that study. More recently, the mechanism underlying the increase in lordosis 
using a two-pulse paradigm has been shown to involve the activation of membrane-bound E2 
receptors, following the initial E2-priming effects that occur through classic genomic 
mechanisms (Kow & Pfaff, 2004). 
The effect of PR blockade on appetitive sexual behaviors was more recently evaluated 
using a modified E2-facilitation paradigm. This paradigm is used to study the mechanisms 
underlying estrogen-positive feedback on the induction of the LH surge, following the 
stimulation of nP synthesis by E2 in hypothalamic tissue (Kuo & Micevych, 2012; Micevych et 
al., 2008). OVX or OVX/ADX rats were treated with 10µg EB every 4 days followed by a bolus 
injection of free E2 in place of P on the third and fourth injections days, which resulted in an 
increase in lordosis as previously reported in the literature (and discussed above) as well as 
appetitive sexual behaviors (hops, darts, ear wiggles) (Micevych et al., 2008). Although blocking 
PR with RU486 just prior to the bolus injection of free E2 did not inhibit the facilitative effects 
of E2 on lordosis, in concert with Blaustein et al. (1987), RU486 attenuated the facilitation of 
sexually appetitive behaviors. Moreover blocking P synthesis (by blocking either P450 side-
chain cleavage, or the conversion of pregnenalone to P) mimicked the effect of RU486 in this 
paradigm. Those results suggest that at least in an E2-facilitation paradigm, nP synthesis within 
the hypothalamus (particularly the preoptic area (Micevych et al., 2003)) and binding to its 
receptor, is part of the mechanism that induces the heightened behavioral sensitivity of appetitive 
sexual behaviors to repeated injections of E2.  
In summary, sexual behavior in the OVX rat is dependent on the priming actions of E2 
acting on hypothalamic tissue. Although the literature has shown that the OVX rat is 
behaviorally more sensitive to E2 when treated daily with E2, or with a priming dose of EB 
following a bolus injection of free E2 in place of P, this phenomenon has never been reported if 




Outline of the current thesis 
Following initial observations from a number of researchers in our laboratory that sexual 
behavior in the OVX rat sensitized with repeated injections of 10µg EB every four days, the goal 
of the next chapter was to systematically characterize appetitive and consummatory patterns of 
sexual behavior using three doses of EB commonly used in the literature. EB was administered 
every 4 or 8 days, which established the behavioral pattern of estradiol sensitization by EB and 
the appropriate baseline dosing regimen for inducing low, steady levels of sexual behavior in the 
OVX Long-Evans rat (Chapter 2.1). It was found that administration of 10µg EB every four days 
induced the most robust sensitization, and thus this dose was selected for further examination of 
the phenomenon. Next, some hormonal and behavioral factors that may contribute to the effect 
were assessed. The next studies examined whether peripheral P plays a role by examining the 
phenomenon in ADX/OVX animals (Chapter 2.1, Experiment 2) and whether chronic PR 
blockade interfered with the induction of estradiol sensitization (Chapter 2.2). The conditions 
necessary and sufficient for the induction of estradiol sensitization with 10µg EB were examined 
next, and it was found that repeated copulation attenuated the effect (Chapter 2.3). The 
experiments of the third chapter discovered that VCS attenuated estradiol sensitization (Chapter 
3.1), and addressed whether mechanisms of estrous termination are involved in that attenuation 
(Chapter 3.2). In Chapter 4 the phenomenon of estradiol sensitization was applied to two 
paradigms of sexual inhibition to examine whether those inhibitory effects can be overcome. A 


















2.1. Sensitization of sexual behavior in ovariectomized rats by chronic estradiol treatment 
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The ovariectomized (OVX) rat treated with estradiol benzoate (EB) is used to elucidate 
neuroendocrine mechanisms of sexual behavior. Chronic behavioral and pharmacological 
manipulations can be confounded by rising baselines, since females are behaviorally more 
sensitive to repeated EB injections. The literature lacks a systematic examination of chronic 
effects of EB administered alone to the sexually experienced OVX rat. Long-Evans rats were 
repeatedly treated (8 tests) with SC injections of 2, 5, or 10µg EB at different time intervals (4 or 
8 days). Female sexual behaviors as well as receipt of mounts, intromissions and ejaculations 
from the male were observed in the unilevel 4-hole pacing chamber. The effects of 
adrenalectomy (ADX) and strain (Long-Evans vs. Wistar) were also assessed. Long-Evans OVX 
rats treated with 5µg EB every 8 days showed persistently low levels of sexual behavior. 
Sensitization was most robust following 10µg EB at 4-day intervals. Very few sexual behaviors 
were ever induced by 2µg EB. ADX did not affect the development of behavioral sensitization 
by 10µg EB. Therefore, to achieve a low steady state of sexual behaviors in sexually experienced 
Long-Evans OVX rats 5µg of EB administered every 8 days is optimal, whereas a persistently 
high level of sexual behaviors is induced with 10µg EB administered every 4 days. OVX Wistar 
rats are behaviorally more sensitive to EB. Behavioral sensitization to EB may serve as a 




The ovariectomized (OVX) rat treated with estradiol benzoate (EB) is used to examine 
neuroendocrine mechanisms underlying sexual behavior, and how pharmacological 
manipulations might alter these behaviors (e.g., Gelez, Greggain-Mohr, Pfaus, Allers, & 
Giuliano, 2013; Graham & Pfaus, 2010; Pfaus et al., 2000; Pfaus, Giuliano, & Gelez, 2007; 
Snoeren et al., 2011). In studies designed to investigate facilitative effects, females are typically 
primed with EB alone to elicit a low baseline of sexual responding. However, with repeated 
testing, OVX rats become more responsive to EB (Babcock et al., 1988; Beach & Orndoff, 1974; 
Blaustein et al., 1987; Clark & Roy, 1983; Gerall & Dunlap, 1973; Kow & Pfaff, 1975; Parsons 
et al., 1979; Whalen & Nakayama, 1965). This behavioral sensitization to EB confounds and 
complicates the interpretation of data, especially in studies where the manipulation facilitates 
sexual behaviors on an acute EB baseline, but appears to lose that effect following repeated 
testing. The establishment of stable behavioral baselines would be particularly useful in the 
development of preclinical research models of female sexual function and dysfunction (e.g., 
Gelez et al., 2013). Ideally, to study excitatory mechanisms, females should express a low but 
steady rate of sexual behavior at baseline. On the other hand, mechanisms involved in sexual 
inhibition should be studied in females presenting persistently high levels of sexual behavior. A 
thorough examination of the development of the sensitization of sexual behaviors following 
repeated EB can help elucidate underlying mechanisms of this poorly understood phenomenon.  
The restoration of sexual behaviors in the OVX rat requires adequate priming with 
estradiol (E2), since E2-bound to its receptor is necessary for the expression of sexual behavior 
(Blaustein & Feder, 1979; Blaustein & Wade, 1977; Walker & Feder, 1979). The acute 
administration of EB to the OVX rat induces, approximately 48 hours later, the partial expression 
of lordosis, a concave arching of the back that allows the male to intromit and ejaculate during a 
mount (Hardy & Debold, 1971b; Meyerson, 1964; Whalen, 1974). To maximally induce lordosis 
and activate sexually appetitive behaviors (such as hops, darts, solicitations, and ear wiggles), 
additional treatment with progesterone (P) is required 36-48 hours later, and its potentiating 
effects occur within four hours of treatment (Beach, Etkin, & Rasquin, 1942; Boling & Blandau, 
1939; Whalen, 1974). Although the fully-primed OVX rat is useful for testing manipulations that 
suppress sexual behavior, ceiling effects prevent the examination of dose-responses. Comparing 
manipulations between fully-primed and partially-primed females can be further complicated by 
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their different hormonal backgrounds. These issues can be overcome by characterizing 
behavioral responses to EB administered alone, following varying dosing regimens. Low doses 
of EB (< 3µg) fail to induce sexual behavior when administered alone, and do not result in 
behavioral sensitization (Kow & Pfaff, 1975; Micevych et al., 2008); thus, it should be possible 
to establish a low steady baseline of sexual behavior to allow facilitation of behavior, as well as a 
higher level of responding to allow for its attenuation.  
Although behavioral sensitization to EB is a well-recognized phenomenon, its underlying 
mechanisms are not well understood. The question is twofold: how does repeated EB-priming 
alone potentiate lordosis, as well as appetitive sexual behaviors (i.e., independent of subsequent 
P priming)? In the EB-primed OVX rat, lordosis is dependent on EB dose, yet appetitive sexual 
behaviors are dose-dependently increased by administration of P, not EB (Whalen, 1974). 
Moreover, large doses of acute EB administered alone to OVX and adrenalectomized-OVX 
(ADX/OVX) rats induce hops, darts, and ear wiggles, but those effects are not dose-dependent 
on EB (Erskine, 1989; Hlinak & Madlafousek, 1983; Zemlan & Adler, 1977), which suggests 
that EB does not directly mediate those behaviors. Given that P potentiates the priming effects of 
EB, the sensitization may be a result of adrenal overcompensation (e.g., increased production of 
P), since adrenal hypertrophy occurs following OVX (Andersen & Kennedy, 1933), and 
appetitive sexual behaviors are observed more frequently in EB-primed Long-Evans rats that are 
OVX compared to ADX/OVX (Erskine, 1985; Tennent et al., 1980). ADX has also been 
reported to decrease the sensitivity of OVX rats to priming with EB and EB+P (Ring, 1945), and 
it was suggested that although ADX does not prevent the facilitation of sexual behaviors by EB 
alone, greater doses or extended priming with EB are required to facilitate sexual receptivity 
(Kow & Pfaff, 1975). However, others have found a facilitation of receptive behaviors by EB 
following ADX (Davidson et al., 1968a; Eriksson & Södersten, 1973; Gorzalka & Moe, 1994), 
and have suggested that this effect is dose-dependent, with the facilitation occurring with low 
doses of EB (Gorzalka & Moe, 1994; Gray & Gorzalka, 1980). It has also been argued that the 
behavioral facilitation by repeated EB-alone is not dependent on the activation of P receptors 
(PR), suggesting differential pathways in the activation of sexual behavior by EB+P compared to 
EB-alone (Blaustein et al., 1987). Some of those studies used pigmented (Long-Evans) whereas 
others used albino (e.g., Sprague-Dawley or Wistar) rat strains, and both are commonly used 
throughout the neuroendocrinology literature. However important strain differences have been 
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reported in sexual behavior, endocrinology, and brain morphology (Garcia-Falgueras et al., 
2005; Hurwitz & Riley, 2011; Sachs, 1996; Tohei, Mogi, Kon, Hokao, & Shinoda, 2003; 
Uphouse et al., 2002), which should be considered in the assessment of the underlying 
mechanisms. 
The primary goals of this study were to establish appropriate dosing regimens of EB to 
achieve a desired baseline of female sexual behavior, as well as to characterize the development 
of behavioral sensitization to EB in the sexually-experienced OVX rat. We defined behavioral 
sensitization as the potentiation of sexual behaviors induced by the same dose of EB 
administered prior to repeated tests at delayed or intermittent intervals.  This is similar to the 
definition of sensitization that occurs with intermittent administration of psychomotor stimulants, 
opioids, and stressors (e.g., Kalivas & Stewart, 1991). Accordingly, we examined the effects of 
acute and repeated treatment with varying doses of EB (8 tests) in sexually-experienced OVX 
Long-Evans and Wistar rats.  The first experiment examined the dose-response and time course 
effects of repeated EB (2, 5, or 10µg) administered by subcutaneous injections at two dosing 
intervals (4 or 8 days) in OVX Long-Evans rats. Given that the adrenal gland is an important 
peripheral source of steroid hormones, the second experiment examined whether ADX would 
alter the sensitization. The third experiment characterized the sexual behaviors of Wistar OVX 
rats receiving 2, 5, or 10µg EB every 4 days.  
 
Materials and methods 
Animals 
 Animals were purchased from Charles River Canada (St-Constant, QC), and allowed one 
week to acclimate to the facilities prior to surgery (females) or sexual training (males). Females 
(150-200g) were pair-housed, and males (200-250g) were group-housed (4/cage) in Plexiglass 
cages lined with betachip, with standard laboratory chow (Charles River #5075) and tap water 
freely available.  Colony rooms were maintained at 21°C, on a 12-hour reverse day-night cycle 
(lights off at 8AM). Males were given at least four sexual training sessions in unilevel 4-hole 
pacing chambers with stimulus OVX females primed with 10µg EB and 500µg P (48hrs and 4hrs 
before training respectively), prior to the start of each experiment.  
Care was taken to minimize pain and discomfort to all animals throughout the duration of 
the experiments, which were conducted in accordance with the guidelines of the Canadian 
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 Ovariectomy. Bilateral OVX was performed under a 4:3 mixture of ketamine 
hydrochloride (50 mg/mL; Ketaset©, Wyeth Canada) and xylazine hydrochloride (4 mg/mL; 
Rompum©, Bayer Healthcare) injected IP (1mL/kg body weight). Animals were identified by 
ear-punch and post-operative care was given with SC injections of Flunixin meglumine 2.5 
mg/kg/mL (Banamine©) and 5 mg/kg/mL Enrofloxacin (Baytril©), and rehydrated with 2 mL of 
saline administered SC. Animals were given one-week post-operative recovery prior to sexual 
behavior training.  
Ovariectomy and adrenalectomy. Immediately following OVX as described above, the 
adrenals were located and removed (ADX/OVX group), or were located and left intact 
(SHAM/OVX). ADX animals were administered corticosterone (4-pregnen-11β,21-diol-3,20-
dione, Steraloids; 25 mg/L of 0.9% saline) and cyclodextrin (0.35 mg/L of 0.9% saline) in their 
drinking water, and a pinch of sea salt pellets was added to the cage daily, until the end of the 
experiment.   
 
Preparation of steroid hormones 
 EB and P were dissolved in 0.1mL reagent grade sesame oil and administered by SC 
injection. EB doses were always diluted down from the 10µg EB solution.  
 
Sexual behavior training and test procedures 
At least one week following surgery, females were made sexually receptive by SC 
injections of 10µg EB 48 hours, and 500µg P 4 hours prior to each of four sexual training 
sessions occurring at 4-day intervals, to reduce variability in sexual responding (Gerall & Dunlap, 
1973). Females were then given a 2-week hormone washout period before the start of testing, to 
reduce residual effects of prior hormone treatments (Kow & Pfaff, 1975).  
Behavioral training and testing were carried out in unilevel pacing chambers 
(38x60x38cm) lined with betachip, and bisected by a clear Plexiglas divider with 4 square holes 
cut into the bottom. The holes were adjusted to the size of the female, such that she could easily 
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traverse to the male’s compartment, whereas the male was too large to cross, allowing her to 
pace the rate of copulation. All tests occurred during the middle-third of their dark cycle.  
Males were selected at random and always placed into the chamber for a five-minute 
habituation period, and only ever used once during a session. Females were subsequently placed 
into the compartment opposite the male for a 30-minute test session. Sessions were digitally 
recorded using a Sony Handycam, and subsequently scored using a computerized event recorder 
customized for rat sexual behavior in a pacing chamber (Cabilio, 1996).  
Experiment 1 EB dose response administered at 4- and 8-day intervals in OVX Long-
Evans rats. As shown in Figure 1, following sexual training and a washout, Long-Evans OVX 
female rats received 2, 5, or 10µg EB (n=12/group) and first tested at 8-day intervals for 8 tests 
(Experiment 1a), followed by a 2-week hormone washout period. Females were next randomly 
re-assigned (counterbalancing prior hormone treatment) to one of the three doses before testing 
at 4-day intervals for another 8 tests (Experiment 1b).  
Experiment 2 EB dose response administered at 4-day intervals in ADX/OVX Long-
Evans rats. As shown in Figure 1, Long-Evans female rats were OVX and either 
adrenalectomized (ADX/OVX) or sham-ADX (SHAM/OVX) and one week later given 4 sexual 
training sessions. Following a 2-week hormone washout ADX/OVX females were treated with 
5µg EB (n=11) or 10µg EB (n=11), and SHAM/OVX females (n=6) were treated with 10µg EB, 
at 4-day intervals for a total of 8 tests. 
Experiment 3 EB dose response administered at 4-day intervals to OVX Wistar rats. As 
shown in Figure 1, Wistar female rats (N=26) were OVX, treated with 2µg (n=8), 5µg (n=9), or 
10µg EB (n=9), and tested 8 times, at 4-day intervals. 
 
Behavioral Measures 
The frequency of female lordosis magnitudes (LM) was scored on a 3-point scale 
according to Hardy and Debold (1971b) and lordosis quotients (LQ) were calculated as a ratio of 
the frequency of LM to the number of mounts (including intromissions and ejaculations), 
multiplied by 100. Frequencies of appetitive behaviors were recorded by taking the sum of 
solicitations (orients head towards male and runs away), and hops/darts. Defensive behaviors 
consisted of kicks, sideways takedowns, boxing postures, and prone positions, as in Barnett 
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(1963). Mounts, intromissions, and ejaculations received from the male were analyzed, since 
their behavior can provide insight into the female’s sexual receptivity (Pfaus et al., 1999).  
 
Statistical analyses 
Using SPSS 16.0 for Windows, data were entered as a 2-way ANOVA (8 tests as the 
repeated measure, and 3 hormonal manipulations as the between subjects factor), and the overall 
effect of hormone manipulation, as well as the linear and quadratic trends (Keppel & Wickens, 
2004), were examined. A significant interaction between test and hormone manipulation 
prompted an examination of the linear contrasts for each treatment group, with significant 
contrasts suggesting the development of sensitization. The one-way repeated measures ANOVA 
was then conducted to determine the development of sensitization, using post-hoc LSD (Least 
Significant Difference). Hormone manipulation effects (between group measure) were also 
analyzed using LSD, with the level of significance for all comparisons set at p<0.05. Missing 
data points were replaced with the group means of the respective test day. In Experiment 2, 
simple linear contrasts were examined on each group to determine whether the patterns of 
sensitization differed following ADX, based on the findings from Experiment 1. These statistical 
techniques were selected to maximize power. The pattern of LM data was similar to that of LQ, 
and therefore not shown for simplification. 
 
Results  
Sexual behaviors of females on training 4 when treated with 10µg EB + 500µg P. 
 Table 1 summarizes the behavior of OVX and OVX-ADX Long-Evans, and OVX 
Wistar rats on the fourth training session when fully primed with EB+P. An independent t-test 
verified that ADX did not affect sexual behavior compared to OVX females in Experiment 2 on 




Figure 1. Experimental timelines. One week following ovariectomy (OVX) or adrenalectomy 
and OVX (ADX/OVX), females were primed with 10µg EB and 500µg P prior to each of 4 
sexual training sessions followed by a 2-week hormone washout. In Experiment 1, females were 
first tested 8 times with varying doses of EB at 8-day intervals followed by a 2-week hormone 
washout period. Next they were randomly re-assigned to the varying EB doses and tested 8 times 
at 4-day intervals. In Experiments 2 and 3, females were tested 8 times with varying doses of EB 
at 4-day intervals. Strain of females used in each experiment is indicated in left-most column.  
 
Table 1.  
Average frequency (±SEM) of sexual behaviors on training 4 when fully-primed with 10µg 
estradiol benzoate and 500µg progesterone. 
  
Experiment 1a 
Long-Evans   
Experiment 2 
Long-Evans   
Experiment 3 
Wistar 
  OVX   OVX ADX/OVX   OVX 
Appetitive 55.60±3.50  53.5±13.12 64.54±6.92 
 
77.73±7.37 
LQ 99.81±0.14  100.00±0.00 95.00±0.04 
 
96.15±2.52 
Defenses 1.00±0.35  0.50±0.34 1.96±1.38 
 
1.12±0.35 
Mounts 15.44±1.93  10±2.52 20.25±2.68 
 
22.31±4.69 
Intromissions 20.17±1.09  16.5±2.47 15.5±1.24 
 
18.73±1.60 
Ejaculations 2.78±0.11  2.17±0.31 2.04±0.20 
 
1.92±0.18 





Experiment 1a EB dose response administered at 8-day intervals in OVX Long-Evans rats 
 Figure 2 depicts the effect of repeated administration of 2, 5, or 10µg EB injected SC at 8 
day intervals on the expression of appetitive and consummatory sexual behaviors in the sexually 
experienced OVX rat, across 8 test sessions. An equipment malfunction occurred on Test 2, 
resulting in the data loss of 4 animals in the 5µg and 10µg groups (2 per group). These data 
points were replaced with their respective group means.  
Appetitive behaviors. As shown in Figure 2A, 10µg EB induced significantly more 
appetitive behaviors overall, compared to the two lower doses, F(2,33)=12.380, p<0.001. 
Following a significant interaction on the linear trend between test and EB group, F(2, 33)=6.327, 
p=0.005, it was found that when administered every 8 days, only 10µg EB induced sensitization 
of sexually appetitive behaviors, Flinear(1,11)=7.315, p=0.020. The development of sensitization 
was characterized following a significant one-way ANOVA, F(7, 77)=2.638, p=0.017, as shown 
in Figure 2A. Sensitization was not detected following 2µg EB, F(7, 77)=1.149, p=0.342, or 5µg 
EB, F(7, 77)=1.960, p=0.072.  
Lordosis. Figure 2B summarizes the LQ for animals in each EB group; only 8 females 
treated with 10µg EB, and 4 with 5µg EB were consistently mounted across all tests (no female 
treated with 2µg EB was mounted on every test). The linear contrast testing the interaction 
between EB group and test day was not statistically significant. Although a linear increase was 
detected across tests when collapsed across EB treatment, F(1,10)=5.660, p=0.039, the one-way 
ANOVA failed to detect a difference between any of the test days, F(7,70)=1.521, p=0.174, 
suggesting that overall, sensitization of LQ in response to repeated EB did not occur at this 
dosing interval.  
Defensive Behaviors. As shown in Figure 2C, collapsing across EB treatment, the number 
of defensive behaviors displayed by females generally decreased across tests, 
Flinear(1,33)=44.971, p<0.001, Fquadratic(1,33)=12.246, p=0.001, such that females were less 
defensive as of test 3 compared to the two first test, F(7,231)=10.291, p<0.001, an effect that 
was generally maintained until the end of the experiment. A main effect of EB dose was also 
found, F(2,33)=4.410. p=0.020. Animals that received 2µg EB displayed less defensive 
behaviors than those treated with 5µg or 10µg EB. The lower expression of defensive behaviors 





Figure 2. Sexual behaviors of OVX Long-Evans females treated with varying doses of EB at 8-
day (left) or 4-day (right) intervals. (A) Appetitive sexual behaviors increased in females treated 
with 10µg EB, but not 2µg or 5µg when treated at 8-day intervals. (B) LQ did not sensitize when 
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treated with EB at 8-day intervals. (C) Collapsed across EB treatment group, females were less 
defensive towards males as of Test 3. (D) When treated at 4-day intervals sexually appetitive 
behaviors sensitized in females treated with 10µg EB. (E) LQ sensitized in females treated with 
5µg and 10µg EB when treated at 4-day intervals. (F) Defensive behaviors were unaffected when 
treated with EB at 4-day intervals. aDifferent from Test 1; bDifferent from Tests 1 and 2 ; 
cDifferent from Tests 1, 2, and 3. dDifferent from Tests 1-4. Numerical superscripts are used to 
indicate differences from specified test day. Brackets represent main effect of EB Group. 




Male Behaviors. The number of mounts received was affected by EB dose, 
F(1,33)=3.319, p=0.049, such that females treated with 10µg EB received significantly more 
mounts than those treated with 2µg EB, as shown in Figure 3A. Collapsing across EB treatment, 
the quadratic trend was significant, F(1,33)=5.703, p=0.023, and the test differences were 
analyzed following a significant one-way ANOVA, F(7,231)=2.122, p=0.042, and are shown in 
Figure 3A. Collapsing across EB treatment, the number of intromissions generally increased 
across tests, Flinear(1,33)=5.658, p=0.023, and test differences were analyzed following a 
significant one-way ANOVA, F(7,231)=3.092, p=0.004, as shown in Figure 3B. EB dose also 
affected the number of intromissions, F(2,33)=9.399, p=0.001, and ejaculations, F(2,33)=7.097, 
p=0.003, such that that females treated with 10µg EB received significantly more intromissions 
and ejaculations than those receiving the two lower doses (Figure 3, panels B and C, 
respectively). 
 
Experiment 1b EB dose response administered at 4-day intervals in OVX Long-Evans rats 
 Appetitive Behaviors. The main effect of EB treatment revealed that more appetitive 
behaviors were induced by 5µg and 10µg EB, compared to 2µg EB. However following up the 
significant test by EB treatment linear interaction, F(2, 33)=4.321, p=0.022, only those treated 
with 10µg EB experienced sensitization of appetitive behaviors across tests, F(1,11)=10.532, 
p=0.008; the one-way ANOVA characterized the development, F(7,77)=4.427, p<0.001, with  
more expressed on Test 4 compared to Tests 1 and 2, and this effect was maintained until the end 
of testing, as shown in Figure 2D.  
Lordosis and Defensive Behaviors. No female in the 2µg EB group, and only three in the 
5µg EB and five in the 10µg EB group were consistently mounted across tests. The linear trend 
was statistically significant when collapsing across EB treatment, F(1,6)=13.239, p=0.011. 
Following a significant one-way ANOVA, F(7,42)=8.342, p<0.001, a greater LQ was detected 
on Test 3 compared to Test 1, and this effect was maintained until the end of the experiment. The 
significant quadratic trend which was also detected, F(1,6)=24.924, p=0.002, suggests a rapid 
onset of sensitization followed by a plateau. 
As shown in Figure 2F, defensive behaviors were unaffected. 
 Male Behaviors. As shown in Figure 3D, EB treatment affected the number of mounts, 




Figure 3. Male sexual behaviors directed towards OVX Long-Evans females treated with 
varying doses of EB at either 8-day (left) or 4-day (right) intervals. (A-C) Number of mounts, 
intromissions, and ejaculations received following varying EB doses administered at 8-day 
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intervals. Test effects are collapsed across EB treatment. (D) Females treated with 2µg EB were 
mounted less than those treated with 5µg or 10µg EB, and females were mounted less frequently 
on Test 1 compared to all subsequent tests. (E) Females treated 2µg EB received fewer 
intromissions than those treated with 5 or 10µg EB, and those treated with 10µg EB received 
fewer intromissions on test 1 compared to all subsequent tests. (F) Females treated with 10µg EB 
received more ejaculations across tests, and received more compared to those treated with 2µg 
EB. aDifferent from Test 1; bDifferent from Tests 1 and 2 ; cDifferent from Tests 1, 2, and 3.  
Numerical superscripts are used to indicate differences from specified test day. Brackets 




compared to the two higher doses of EB. Collapsing across EB treatment, only the quadratic 
trend was significant, F(1,33)=14.736, p=0.001, and the one-way ANOVA F(7,231)=2.985, 
p=0.005, found that fewer mounts were received on Test 1 compared to all subsequent tests.  
In the analysis of intromissions (Figure 3E), the linear interaction between Test and EB 
treatment was statistically significant, F(2,33)=3.928, p=0.03. Only females treated with 10µg 
EB experienced an increase in the number of intromissions received across tests, 
Flinear(1,12)=8.80,p=0.013, Fquadratic(1,11)=13.245, p=0.004. The one-way ANOVA, 
F(7,77)=4.777, p<0.001, detected fewer intromissions on Test 1 compared to all subsequent tests. 
The analysis of ejaculations followed a similar pattern. Following a significant linear 
interaction between Test and EB treatment, F(2,33)=3.984, p=0.028, an increase was only 
detected in females treated with 10µg EB, Flinear(1,11)=10.075, p=0.009, Fquadratic(1,11)=5.087, 
p=0.045, the one-way ANOVA detected differences between tests, F(7,77)=3.444, p=0.003, such 
that fewer ejaculations were received on Tests 1 and 2 compared to all subsequent tests except 
Test 7, when fewer ejaculations were received. 
 
Experiment 2 EB dose response administered at 4-day intervals in ADX/OVX Long-Evans rats.  
Figure 4 shows the effect of repeatedly testing OVX females who were either sham-ADX 
(SHAM/OVX) and treated with 10µg EB, or ADX/OVX and treated with either 5µg or 10µg EB, 
at 4-day intervals. Overall, ADX did not prevent the sensitization of sexual behaviors of OVX 
females when repeatedly tested with 10µg EB.  
 Appetitive Behaviors. A linear trend analysis tested whether sensitization developed in 
each group. As expected, SHAM/OVX females treated with 10µg EB sensitized to repeated EB, 
F(1,5)=9.228, p=0.029, and the development, F(7,35)=4.898, p=0.001, is depicted in Figure 4A. 
ADX/OVX females treated with 10µg EB also sensitized, F(1,11)=7.487, p=0.019, and the 
development is shown in Figure 4A, F(7,77)=2.273, p=0.037. ADX/OVX females treated with 
5µg EB also developed sensitization determined by a significant quadratic trend, F(1,11)=6.615, 
p=0.026; however the ANOVA did not detect overall differences between tests.  
Lordosis. Figure 4B shows the LQ for ADX/OVX females treated with 5µg EB (n=10), 
ADX/OVX females treated with 10µg EB (n=10), and SHAM/OVX animals treated with 10µg 
EB (n=3) who were consistently mounted across tests. A linear trend analysis tested whether 
sensitization developed in each group. The analysis failed to detect sensitization of LQ in  
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Figure 4. Sexual behaviors of OVX Long-Evans females treated with 10µg EB and ADX/OVX 
Long-Evans females treated with either 5µg or 10µg EB at 4-day intervals. (A) Appetitive 
behaviors sensitized following treatment with 10µg EB whether or not OVX females were ADX. 
(B) Sensitization of LQ occurred in ADX/OVX females treated with 10µg EB. (C) Female 
defensive behaviors were less frequent in ADX/OVX females overall compared to OVX females 
who were SHAM-ADX. Brackets represent main effect of EB Group, **p<0.01. aDifferent from 
Test 1, bDifferent from Tests 1 and 2, @Different from Tests 1-7. Numbers are used to indicate 




SHAM/OVX females treated with 10µg EB, F(1,2)=14.488, p=0.063. This is inconsistent with 
Experiment 1b, and may be due to a small number of SHAM/OVX females that were 
consistently mounted by males. However, a linear increase was detected in ADX/OVX females 
treated with 10µg EB, F(1,9)=8.425, p=0.018, and test differences are depicted in Figure 4B, 
F(7,63)=3.885, p=0.001. LQ did not differ across tests in ADX/OVX females treated with 5µg 
EB.  
Defensive Behaviors. As illustrated in Figure 4C, the number of defensive behaviors 
females made towards males was affected by the hormone manipulation, F(2,27)=5.87, p=0.008. 
SHAM/OVX females treated with 10µg EB displayed more defensive behaviors towards males 
compared to both ADX/OVX groups. 
 Male Behaviors. As shown in Figure 5A, although mounts were unaffected, when 
collapsed across hormone manipulation, the number of intromissions, F(1,27)=5.143, p=0.032, 
and ejaculations, F(1,27)=6.361, p=0.018, received generally increased across tests, test 
differences are depicted in panels B and C, respectively, (intromissions: F(7,189)=3.047, 
p=0.005; ejaculations: F(7,189)=3.076, p=0.004).  
 
Experiment 3 EB dose response administered at 4-day intervals to OVX Wistar rats. 
 Two females in the 10µg EB group did not cross to the male’s compartment on Test 5 
because the holes of the barrier were too small, as such their data were replaced with the group 
means. 
Appetitive Behaviors. As shown in Figure 6A, EB dose influenced the number of 
appetitive behaviors, F(2,23)=5.827, p=0.009, which were more frequently observed in females 
treated with 10µg EB compared to 2µg and 5µg EB. In contrast to Experiment 1b (Long-Evans 
females treated at 4-day intervals), the linear contrast testing the interaction between Test and EB 
treatment was not statistically significant, F(2,23)=3.249, p=0.057. The linear contrast collapsing 
across EB treatment was significant, F(1,23)=93.405, p<0.001, suggesting that all groups 
displayed sensitization. To more thoroughly test whether appetitive behaviors sensitized across 
tests in all EB treatment groups, separate linear trend analyses were conducted for each dose. 
Similar to Long-Evans, Wistar OVX females treated with 5µg EB, Flinear(1,8)=28.712, p=0.001, 
and 10µg EB sensitized, Flinear(1,8)=65.639, p<0.001, Fquadratic(1,8)5.646, p=0.045. However, 
contrary to Long-Evans females, OVX Wistars treated with 2µg EB also sensitized,  
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Figure 5. Number of mounts (A), intromissions (B) and ejaculations (C) received from males 
towards ADX/OVX Long-Evans females treated with either 5µg or 10µg EB, or SHAM/OVX 
females treated with 10µg EB at 4-day intervals. Test effects are collapsed across hormone 
manipulation. ADifferent from Test 1; BDifferent from Tests 1 and 2 ; CDifferent from Tests 1, 2, 




Figure 6. Sexual behaviors of Wistar OVX rats tested at 4-day intervals. aDifferent from Test 1; 
bDifferent from Tests 1 and 2 ; cDifferent from Tests 1, 2, and 3. dDifferent from Tests 1-4 
eDifferent from Tests 1-6. Uppercase letters are used when collapsed across EB treatment, and 
lowercase are used following a significant interaction. Numbers are used to indicate differences 




Flinear(1,7)=13.534, p=0.008, confirming that all doses of EB induced sensitization of sexually 
appetitive behaviors in Wistars. The development of sensitization in each group is displayed in 
Figure 6A (2µg, F(7,49)=5.336, p<0.001; 5µg, F(7,56)=9.403, p<0.001; 10µg, F(7,56)=8.275, 
p<0.001). 
Lordosis. One female from the 2µg EB group, and two from the 5µg EB group were not 
consistently mounted across tests resulting in a smaller sample size (2µg EB =6; 5µg EB=8). A 
significant interaction between Test and EB dose was detected on the quadratic trend, 
F(2,20)=5.866, p=0.010. As shown in Figure 6B, 2µg EB induced a significant increase in LQ 
across tests, F(1,5)=17.570, p=0.009, contrary to the Long-Evans data (Experiment 1b; Figure 
2E). LQ also increased across tests following treatment with 5µg EB, Flinear(1,7)=80.118, 
p<0.001, Fquadratic(1,7)=8.825, p=0.021, and 10µg EB, Flinear(1,8)=71.353, p<0.001, 
Fquadratic(1,8)=52.350, p<0.001. The development of sensitization in each group is displayed in 
Figure 6B (2µg EB, F(7,35)=5.159, p<0.001; 5µg EB, F(7,49)=17.169, p<0.001; 10µg EB, 
F(7,56)=36.371, p<0.001). 
 Female Defenses. Collapsed across EB treatment, defensive behaviors decreased across 
tests, Flinear(1,23)=13.874, p=0.001, Fquadratic(1,23)=4.832, p=0.038. The differences between tests 
are shown in Figure 6C, F(7,161)=3.477, p=0.002. A main effect of EB dose was also detected, 
F(2,23)=6.909, p=0.004. Females treated with 10µg EB displayed fewer defensive behaviors 
than those treated with 5µg and 2µg EB.  
 Male Behaviors. Figure 6, panels D to F, show the number of mounts, intromissions and 
ejaculations received from the male, respectively. Following a significant linear trend, 
F(1,23)=15.428, p=0.001, it was found that generally, females were mounted more often on later 
tests compared to earlier tests, F(7,161)=3.811, p=0.001. Following up a significant linear 
interaction on intromissions, F(1,23)=3.591, p=0.044, revealed that all doses of EB resulted in 
increasing numbers of intromissions received across tests, although the effect was less robust in 
females treated with 2µg EB: Flinear(1,7)=13.740, p=0.008, compared to 5µg EB 
Flinear(1,8)=24.983, p=0.001, Fquadratic(1,8)=6.915, p=0.030, and 10µg EB, Flinear(1,8)=60.849, 
p<0.001, Fquadratic(1,8)=38.824, p<0.001. Differences between tests are shown in Figure 6E (2µg 




The analysis of ejaculations detected a main effect of EB treatment, F(1,23)=16.465, 
p<0.001, such that as EB dose increased, the number of ejaculations received increased. A 
significant quadratic interaction between Test and EB treatment was also found, F(2,23)=2.296, 
p=0.024. The number of ejaculations received generally increased across tests in females treated 
with the two higher doses of EB (5µg EB, Flinear(1,8)=23.745, p=0.001; Fquadratic(1,8)=10.573, 
p=0.012; 10µg EB, Flinear(1,8)=71.428, p<0.001, Fquadratic(1,8)=13.004, p=0.007). Differences 
between tests days are shown in Figure 6F (5µg EB, F(7,56)=6.120, p<0.001; 10µg EB, 
F(7,56)=12.217, p<0.001). 
 
Discussion   
 This study characterized the pattern of sexual behavior in sexually-experienced Long-
Evans OVX rats treated repeatedly (8 SC injections) with either 2, 5, or, 10µg EB at 4- or 8-day 
intervals. Behavioral sensitization to repeated EB occurred most readily in females treated with 
10µg EB at 4-day intervals, since sexually appetitive behaviors and lordosis responses increased 
across tests, and a greater number of intromissions and ejaculations were elicited by the males, 
whereas 5µg EB increased LQ but not appetitive behaviors. Females treated with 2µg EB 
displayed few sexual behaviors overall. When tested at 8-day intervals, sensitization induced by 
10µg EB was restricted to appetitive sexual behaviors, and those females received more 
intromissions and ejaculations by the male; whereas 5µg EB produced a relatively stable, low 
level of sexual behaviors.  
Wistar OVX rats displayed a more robust pattern of sensitization compared to Long-
Evans. In contrast to OVX Long-Evans females treated at 4-day intervals, OVX Wistars treated 
with 2µg EB exhibited sensitization of appetitive behaviors and LQ, and received more mounts 
and intromissions across tests. The frequency of appetitive behaviors appeared to be 
approximately double that of Long-Evans rats. Moreover, although Long-Evans rats appeared to 
display fewer appetitive behaviors following repeated EB-alone compared to EB+P as reported 
by others (Blaustein et al., 1987), sexual behaviors in sensitized Wistars treated with 10µg EB 
resemble those following EB+P. We have also observed this strain difference in females tested at 
weekly intervals in bilevel chambers (unpublished observations). This behavioral sensitization to 
2µg EB appears to be specific to Wistar females, since Long-Evans did not sensitize to this dose, 
and others have also reported the absence of sensitization in both Long-Evans (Micevych et al., 
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2008), and Sprague-Dawley females (Kow & Pfaff, 1975) to low doses of EB (<3µg). One 
possible explanation could relate to greater corticosterone in Long-Evans rats compared to 
Wistars (Tohei et al., 2003), since corticosterone inhibits sexual behavior (deCatanzaro, 1987; 
deCatanzaro, Knipping, & Gorzalka, 1981). Interestingly, others have reported that 10µg EB-
alone failed to induce LQ or appetitive behaviors in another strain of albino rat, the Sprague-
Dawley (Mani, Blaustein, Allen, Law, O’Malley, & Clark, 1994), following an even shorter 
hormone washout period (7 days). Long-Evans and Wistar rats may also use different 
reproductive strategies based on multi-sensorial vs. predominant olfactory processing, 
respectively, as proposed by Coria-Avila et al., (2006). This reiterates the importance of 
considering strain effects in research studies.  
This study also determined that the sensitization induced by 10µg EB at 4-day intervals 
does not involve adrenal steroid hormone release (such as progestins). Although ADX did not 
prevent the sensitization of sexually appetitive behaviors when treated with 5µg EB, the effect 
was weak due to a high level of responding on the first test. Moreover, sensitization of LQ was 
not detected in those females, suggesting dose-dependent differences following ADX and 
chronic administration of EB, as proposed by Gorzalka and Moe (1994). However, ADX 
appeared to cause greater variability in responding, which is not surprising since adrenal P may 
be involved in the fine regulation of the timing of sexual behavior (Barfield & Lisk, 1974).  
Has estradiol sensitized sexual behavior or facilitated associative learning? 
 One possible interpretation of these data is nested within the literature on learning and 
memory. Fluctuations in circulating levels of estradiol alter learning and memory strategies in 
female rats (Korol, Malin, Borden, Busby, & Couper-Leo, 2004), and increase synaptic spine 
density within the hippocampus (Woolley & McEwen, 1992), as well as the hypothalamus 
(Flanagan-Cato, 2000). As such, it is possible that the potentiation of sexual behaviors induced 
by EB is the result of enhanced conditioned responding. We attempted to remove confounding 
learning effects by providing sexual training prior to testing. As such, if behavioral sensitization 
to EB is highly dependent on learning, we would expect to see similar levels of responding on 
the first EB-only test following the 2-week hormone washout, or alternately at least some level 
of responding in the low (2µg) dose of EB, which was not seen in the Long-Evans. As such, the 
data support a potentiation of sexual behavior to the same dose of EB during the test phase 
beyond any role of associative learning in the Long-Evans strain. Whether the associative 
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learning plays a greater role in Wistars is unclear, since strain differences on learning and 
memory tasks have been reported, albeit often favoring the Long-Evans strain (e.g., Andrews, 
Jansen, Linders, Princen, & Broekkamp, 1995; Cain, Ko, Chalmers, & Ralph, 2004; Keeley, 
Wartman, Hausler, & Holahan, 2010; van Goethem et al., 2012). This question warrants a more 
thorough investigation. 
 Learning effects during the sexual training phase however, may account for differences 
reported in ADX/OVX animals across studies. Our data suggest that the sensitization of 
appetitive sexual behaviors by 10µg EB does not require the presence of adrenal progestin 
release since ADX animals also sensitized across tests. Although some studies have reported that 
ADX disrupts the expression of appetitive sexual behaviors in OVX females primed with EB+P 
or EB-alone compared to adrenal-intact controls (e.g., Erskine, 1985; Gorzalka & Moe, 1994; 
Tennent et al., 1980), our present findings are in agreement with others (e.g., Davidson et al., 
1968a) in which animals were repeatedly tested. As such, a critical level of sexual experience 
may override any role that the adrenal may play. Although, Tennent et al. (1980) reported that 
adrenal hormones influenced the expression of appetitive behaviors in sexually-experienced 
ADX/OVX rats treated with EB-alone and EB+P compared to sham-ADX/OVX, the rats in that 
study only received two sexual experience tests. This raises the possibility that adrenal steroids 
may be important in the learning of normative sexual behavior in females. In fact, corticosterone 
is important in the formation of memories associated with other motivated behaviors, such as 
maternal behavior (Graham, Rees, Steiner, & Fleming, 2006). Unfortunately, inconsistencies in 
hormone priming regimens across studies make it difficult to draw solid conclusions. For 
example, in Tennent et al. (1980), daily hormone priming began the day following ADX, and 
testing occurred 7 days later. Our testing occurred five weeks post-surgery and included hormone 
washout periods (see Figure 1). Additionally, we replaced corticosterone through drinking water, 
which was not done in the Tennent et al. (1980) or Erskine (1985) studies. Thus, different 
behavioral baselines, hormone dose- and time-response regimens, sexual experience, and 
corticosterone levels likely explain differences in the expression of sexual behaviors of 
ADX/OVX animals across studies.   
What role might a sensitized response to EB play in female reproductive behavior?   
With no sexual stimulation, ovulation and sexual receptivity in gonadally intact female 
rats occur every 4-5 days (Freeman, 1994). With intromissions spaced at optimal intervals, 
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however, females can become pseudopregnant for approximately 12-14 days, after which they go 
back into heat (Erskine, Lehmann, Cameron, & Polston, 2004; Frye & Erskine, 1990). 
Solicitations by the female increase the probability of receipt of intromission (Erskine, 1989), 
and if intromissions are followed by ejaculation, females are likely to become pregnant and enter 
a state of lactational diestrus after parturition that would prevent them from going into heat for 
approximately six weeks.  Vaginocervical stimulation (VCS) received during penile 
intromissions accelerates the onset of estrous termination (characterized by decreased appetitive 
behaviors and increased rejection responses prior to a reduction in lordosis), which occurs more 
readily if the intromissions are paced by the female (Erskine, 1985; Erskine et al., 1989; Erskine 
& Baum, 1982). The present data show that the interval of E2 administration matters greatly in 
the ability of females to express stable baselines of responding. Indeed, the ability of artificial 
VCS to induce estrous termination is eliminated if OVX rats are treated with EB and P at 4- or 7-
day intervals, and reduced if females receive hormone administration at 14-day intervals (Pfaus 
et al., 2000). It was suggested that this mechanism of reduced sensitivity to the inhibitory actions 
of VCS keeps the female sexually active for a longer period of time, thereby increasing the 
probability of being impregnated. Together with the present data, we suggest that the EB-
induced sensitization at 4-day intervals may well reflect a “failsafe” that makes females that did 
not copulate successfully during one periovulatory period far more likely to solicit and copulate 
successfully the next time they ovulate.  
What neural mechanisms might underlie behavioral sensitization to EB? 
The mechanisms underlying the sensitization of lordosis (an estradiol-dependent 
behavior), as well as sexually appetitive behaviors (that are known to be regulated by P after 
estradiol administration), by repeated administration of EB-alone are not well understood. Some 
of the effects on lordosis are likely to be modulated within in the ventromedial hypothalamus 
(VMH) by membrane-receptor mediated effects and genomic mechanisms (Caldwell, 2002; 
Flanagan-Cato, 2000; Kow & Pfaff, 2004), as well as epigenetic factors related to sexual 
differentiation of hypothalamic tissue and subsequent sensitivity to steroid hormones (Gagnidze 
& Pfaff, 2013; Gagnidze, Weil, & Pfaff, 2010), all of which are induced by EB following 
receptor binding. Another potential mechanism might involve P receptor (PR) activation. 
The role of P in the facilitation of appetitive behaviors is apparent from studies showing 
that in EB-primed females, systemic P induces dose-dependent increases in appetitive behaviors 
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(Erskine, 1989; Tennent et al., 1980; Whalen, 1974), and its application directly to the VMH 
potentiates lordosis and induces appetitive behaviors (Rubin & Barfield, 1983). Furthermore, 
blocking PR using systemic injections of RU486 (Blaustein et al., 1987), or 
intracerebroventricular administration of antisense oligonucleotides to PR (Mani, Blaustein, 
Allen, Law, O’Malley, & Clark, 1994), decreases these behaviors in EB+P treated females. It is 
known that P acts on estrogen-induced PR in both the medial preoptic area (mPOA) to activate 
appetitive behaviors (Erskine, 1989), and the VMH to potentiate the expression of lordosis 
(Etgen & Barfield, 1986; Mani, Blaustein, Allen, Law, O’Malley, & Clark, 1994; Meisel, 
Dohanich, McEwen, & Pfaff, 1987; Ogawa, Olazábal, Parhar, & Pfaff, 1994; Rubin & Barfield, 
1984). However, our data suggest that the sensitization of appetitive sexual behavior by 10µg EB 
does not require peripheral P release since ADX/OVX animals also sensitized across tests. 
Moreover, it has been argued that PR is not involved in the induction of sexual behavior by EB 
alone (Blaustein et al., 1987), since the PR antagonist RU486 administered at least 4 hours prior 
to testing does not block sexual behaviors induced by continuous EB (Blaustein et al., 1987), and 
PR knock-out mice display equivalent levels of lordosis as wild-type mice following EB priming 
(Mani, Blaustein, & O'Malley, 1997). 
However, more recently it was shown that EB induces neuroprogesterone synthesis in 
hypothalamic tissue of both OVX and ADX/OVX females (Micevych et al., 2003), and although 
lordosis was not inhibited by RU486 (when treated with 10µg EB every 4 days, and injected with 
EB+RU486 or EB-alone one hour prior to the fourth test), proceptive behaviors were (Micevych 
et al., 2008). Therefore it is possible that neuroprogesterone (or some other ligand) activates PR 
early on to activate lordosis as well as appetitive behaviors at the time of testing in EB-sensitized 
females. In fact, some of the facilitative effects by dopamine (DA) agonists are known to be 
mediated through interactions with PR (Mani, Allen, Clark, Blaustein, & O'Malley, 1994). DA 
increases in the mPOA of female rats during copulation (Matuszewich, Lorrain, & Hull, 2000), 
and in EB-primed females infusions of DA type 2 receptor agonists facilitate solicitations 
(Graham & Pfaus, 2010), whereas in fully-primed females DA type 1 receptor activation 
facilitates solicitations (Graham & Pfaus, 2012). Thus, it is possible that chronic EB increases 
substances within the mPOA to activate DA receptors and/or PR, or alters DA receptor 
subpopulations, to facilitate sexual behaviors. Since EB also facilitates the release of DA within 
the striatum and nucleus accumbens during paced mating (Jenkins & Becker, 2003a; 
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Mermelstein & Becker, 1995) and increases the behavioral sensitization of locomotor activity 
and rotational behavior to psychomotor stimulants in female rats, (Forgie & Stewart, 1994; Hu & 
Becker, 2003; Zhao & Becker, 2010) it would not be surprising to find that DA within these 
regions is further potentiated in females sensitized to repeated EB. 
Part of the underlying mechanisms might also reside in the bidirectional connections 
between the mPOA and VMH. The role of the VMH in the expression of sexual behavior may 
involve the inhibition of glutamate by GABA (Georgescu et al., 2009), and repeated EB might 
sensitize this inhibition. Interestingly, EB treatment increases GAD-65 mRNA in preoptic 
neurons (Mccarthy, 1995), and the VMH receives a large GABAergic projection from the mPOA 
(Georgescu, M., and Pfaus, J.G., in preparation). Infusions of GABAA agonists into the VMH 
facilitate lordosis (Mccarthy, 1995; McCarthy et al., 1990) whereas infusions of glutamate 
receptor agonists rapidly and dose-dependently inhibit lordosis and appetitive behaviors 
(Georgescu & Pfaus, 2006b; Kow et al., 1985; McCarthy et al., 1991). Similar behavioral effects 
occur following VCS, which accelerates the onset of estrous termination (Hardy & Debold, 
1971a; Lodder & Zeilmaker, 1976; Pfaus et al., 2000), and induces Fos in glutamate neurons 
within the ventrolateral VMH (Georgescu et al., 2009). Since appetitive behaviors are the first to 
disappear as the female enters estrous termination, glutamatergic efferents might modulate 
activity within the mPOA. We have recently found that VCS selectively attenuates the 
sensitization of appetitive behaviors by repeated EB, and the attenuation is mimicked by repeated 
infusions of AMPA into the ventrolateral VMH (unpublished observations), which strongly 
supports a role for this system in the behavioral sensitization to repeated EB. Taken together, 
these findings show that EB plays a critical role in regulating neural activity to optimize 






 In Chapter 2.1, it was established that the administration of 5 or 10µg EB administered 
every 4 days sensitizes sexual behaviors in the OVX rat. The next studies addressed hormonal 
(Chapter 2.2) and behavioral (Chapter 2.3) mechanisms contributing to this effect using the dose 
that induced the most robust sensitization (10µg EB).  
 Given that E2 and P act synergistically to activate female sexual behavior, Chapter 2.1 
Experiment 2, tested whether behavioral sensitization to EB occurs in the OVX rat following 
ADX, and this manipulation did not prevent behavioral sensitization to EB, suggesting that 
adrenal P does not play a role. However, given that hypothalamic PR can be activated through 
other ligands such as dopamine (Mani, Allen, Clark, Blaustein, & O'Malley, 1994), or E2 
induced nP (Kuo & Micevych, 2012; Micevych et al., 2008), and nP synthesis appears to play a 
role in the potentation of E2-facilitated sexual behaviors (Micevych et al., 2008), the next 
experiment examined whether chronic blockade of PR would affect the induction and 
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 An acute injection of estradiol benzoate (EB) to the ovariectomized (OVX) rat activates 
low levels of lordosis, but subsequent progesterone (P) administration augments lordosis and 
recruits a complete pattern of sexual behavior including appetitive behaviors (e.g., hops/darts and 
solicitations). However, repeated injections of 5µg or 10µg EB (but not 2µg EB), administered 
every 4 days to sexually-experienced OVX rats results in progressively greater LQs and 
appetitive behaviors, a phenomenon called “estradiol sensitization”. We have shown that adrenal 
P does not play a critical role in this phenomenon because estradiol sensitization is not prevented 
by adrenalectomy. Here we tested whether P receptors play a role by examining the effects of 
chronic administration of the P receptor antagonist RU486 at a dose that reliably inhibits sexual 
behavior in fully primed OVX rats. Females were treated with EB (5 or 10µg), and 5mg RU486 
dissolved in 0.4mL vehicle (VEH; 80% sesame oil, 15% benzyl benzoate, 5% benzyl alcohol) 48 
and 4 hours prior to each of 7 tests, respectively, occurring at 4-day intervals in unilevel 4-hole 
pacing chambers. Control animals were treated with 2, 5, or 10µg EB+VEH. As expected, 
sensitization did not occur in females treated with 2µg EB+VEH, and those females received 
fewer intromissions and ejaculations than all other groups. RU486 did not prevent the 
sensitization of LQ (lordosis quotient), lordosis magnitudes (LM2 and LM3) or appetitive sexual 
behaviors on early tests, and in fact potentiated hops/darts, LM2 and LM3, consistent with its 
facilitative actions in females treated with EB-alone, as we and others have reported previously. 
However, despite the initial facilitation, blocking P receptors by chronic administration of 
RU486 inhibited the maintenance of estradiol sensitization.  
 




Sexual behavior in ovariectomized (OVX) rats can be fully reinstated by administration 
of estradiol benzoate (EB) followed by progesterone (P), 48hrs and 4hrs prior to testing, 
respectively (Beach et al., 1942; Boling & Blandau, 1939). Whereas acute doses of EB dose-
dependently increase lordosis, appetitive sexual behaviors such as hops, darts, solicitations, and 
ear wiggles are increased dose dependently by P following EB (Beach et al., 1942; Whalen, 
1974). Although the acute administration of EB alone partially reinstates sexual behavior in 
OVX rats, it is recognized that they become more sensitive behaviorally to EB with repeated 
administration (Babcock et al., 1988; Beach & Orndoff, 1974; Blaustein et al., 1987; Clark & 
Roy, 1983; Davidson et al., 1968a; Gerall & Dunlap, 1973; Jones & Pfaus, 2014; Jones, Farrell, 
Gardner Gregory, & Pfaus, 2013; Kow & Pfaff, 1975; Parsons et al., 1979; Whalen & Nakayama, 
1965). We recently characterized the development of this EB-induced sensitization in sexually-
experienced OVX Long-Evans rats receiving 2, 5, or 10µg EB at 4- or 8-day intervals, and found 
that 2µg EB does not induce sensitization, and that the effect is most robust in those treated with 
10µg EB every four days (Jones et al., 2013). Although the underlying mechanisms are not well 
understood, Parsons et al. (1979) determined that increased behavioral sensitivity to EB is not 
due to the accumulation of EB in plasma. They administered crystalline 17β-estradiol (E2) via 
subcutaneous capsules and examined sexual behavior for one week followed by their removal. 
Plasma levels of E2 fell to control levels within 12 hours but the females remained in heat five 
days after removal, compared to those not pre-treated with E2, indicating that E2 induced long-
term changes in neuronal responsivity to subsequent E2 treatment. 
Estradiol binding to receptors (ERs) in the ventromedial hypothalamus (VMH) promotes 
the display of lordosis in response to mounting by the male, and induces P receptor (PR) 
synthesis in a number of hypothalamic regions, including the VMH and the medial preoptic area 
(mPOA) (MacLusky & McEwen, 1978; Pfaff, 1980). Subsequent PR activation within the VMH 
potentiates lordosis, whereas the activation of PR within the mPOA stimulates appetitive sexual 
behaviors (Beyer et al., 1997; Glaser et al., 1983; Hoshina et al., 1994; Mani, Allen, Clark, 
Blaustein, & O'Malley, 1994a; Rubin & Barfield, 1983; Sakuma, 1994; 2008). Given the 
importance of PR in the display of sexual behavior, we examined whether adrenal P contributes 
to the sensitization of sexual behaviors by EB and found that sexually-experienced OVX rats that 
had also been adrenalectomized (ADX) and were treated with 5 or 10µg EB every four days 
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displayed behavioral sensitization (Jones et al., 2013). This suggests that adrenal P does not play 
a role, as previously shown with repeated daily injections of EB (Davidson et al., 1968a). This is 
also in agreement with studies showing that the PR antagonist RU486 (administered five hours 
prior to testing) fails to disrupt the potentiated lordosis response following repeated 
administration of EB, in estradiol-induced (continuous exposure to estradiol-alone by 
subcutaneous capsules), and estradiol-facilitated (EB followed 44 hours later by a bolus dose of 
estradiol administered in place of P, 4 hours prior to testing) paradigms (Blaustein et al., 1987; 
Micevych et al., 2008). Indeed, mice lacking P receptors (PR knockouts) display similar (albeit 
slightly lower) levels of lordosis in response to repeated administration of EB (Mani et al., 1996), 
but the hormonal regulation of sexual behavior may be somewhat different between mice and 
rats. However, those studies that failed to find an effect of RU486 on lordosis in rats 
administered it acutely just prior to testing and at least 44 hours after E2 was initially 
administered. 
Although peripheral P is not involved in estradiol sensitization, a role for PR cannot be 
ruled out. First, PR can be activated by agents other than P, for example by second-messenger 
effects of neurotransmitters such as dopamine (Mani, Allen, Clark, Blaustein, & O'Malley, 
1994a), or neuropeptides such as gonadotropin releasing hormone (Mani, Allen, Rettori, 
McCann, O'Malley, & Clark, 1994; Moss & McCann, 1973; Waring & Turgeon, 1992). PRs also 
have a low binding affinity for estradiol (MacLusky & McEwen, 1980; Parsons et al., 1984). 
Moreover, PR activation is involved in the short-term enhancement of lordosis by mating or 
vaginocervical stimulation (VCS), as this effect is blocked by RU486 (Auger et al., 1997).  PRs 
may also be activated by neuroprogesterone, particularly with respect to appetitive sexual 
behaviors. Estradiol induces the production of neuroprogesterone in hypothalamic astrocytes 
(Micevych et al., 2003; Sinchak et al., 2003), and administration of RU486 disrupts the 
potentiation of hops, darts, and ear wiggles using an estradiol-facilitated paradigm in OVX-ADX 
animals (Micevych et al., 2008). This suggests that PRs play a role in the potentiation of 
appetitive sexual behaviors by repeated administration of EB. It is important to note that in 
studies that failed to find an effect of RU486 on the facilitation of lordosis, RU486 was 
administered once, days after the initial exposure to estradiol and after the animals had sensitized. 
As such, it is unclear whether repeated blockade of PR beginning at the onset of the sensitization 
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paradigm would interfere with the development of the sensitization of sexual behaviors by 5µg 
or 10µg EB repeatedly administered SC at 4-day intervals.  
The goal of this study was to examine whether chronic administration of RU486, 
administered at a dosing regimen that is known to block P-activated sexual behaviors, would 
interfere with the sensitization of sexual behaviors in the OVX, Long-Evans rat treated with 5 or 
10µg EB at 4-day intervals. We first confirmed that RU486 inhibits the P facilitation of sexual 
behavior (Experiment 1) by treating sexually experienced EB-primed OVX Long-Evans rats 
with either RU486 or vehicle one hour prior to P administration. In Experiment 2, we 
investigated whether chronic blockade of PR in sexually experienced OVX Long-Evans rats 
treated with 5µg or 10µg EB every 4 days would disrupt the development of the sensitization of 
sexual behaviors by chronic administration of EB.  
 
Materials and methods 
Animals 
Long-Evans rats were purchased from Charles River Canada (St-Constant, QC). Females 
were pair-housed in shoebox cages lined with a mixture of betachip and corncob bedding, and 
males were housed in groups of four lined with betachip. All animals had standard laboratory 
chow (Charles River #5075) and tap water freely available, and were kept in the same colony 
room which was maintained at 21°C, on a 12-hour reverse day-night cycle (lights off at 8:00 
AM). Animals were given one week to acclimate to the animal care facility. All the rats were 
treated in accordance with the guidelines of the Canadian Council on Animal Care and approval 
for all experimental procedures was granted by the Concordia University Animal Ethics 
Committee. 
Ovariectomy 
Bilateral ovariectomies (OVX) were performed under a 4:3 mixture of ketamine 
hydrochloride (50 mg/ml; Ketaset©, Wyeth Canada) and xylazine hydrochloride (4mg/ml; 
Rompum ©, Bayer Healthcare) injected intraperitoneal (1ml/kg body weight), via a single 
lumbar incision, and identified by ear punch. Polysporin© was applied to the incision site, and 
post-operative care included 2.5 mg/kg of Flunixin meglumine (Banamine©),  0.1 mL/rat of 
benzylpenicillin (Penicillin G), and 2 mL/rat of 0.9% saline, followed by a one-week post-
operative recovery prior to sex training.  
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Steroid hormones and RU486 
EB (10 µg) and P (500 µg) were dissolved in 0.1 mL reagent grade sesame oil. EB doses 
(2 µg and 5 µg) were always diluted down from 10 µg EB solution, and administered 48 hours 
prior to testing. Progesterone was administered 4 hours prior to testing. RU486 (mifepristone; 
17β-hydroxy-11β-[4-dimethylaminophenyl]-17α-[l-propynyl]-estra-4,9-dien-3-one; 5 mg/0.4 
mL; Sigma-Aldrich) was dissolved in 80% reagent grade sesame oil, 15% benzyl benzoate and 
5% benzyl alcohol (Blaustein et al., 1987; as in Pleim, Cailliau, Weinstein, Etgen, & Barfield, 
1990), 15 hours prior to use, to ensure adequate dissolution. Preparation of this dose of RU486 
has been demonstrated to attenuate female sexual behavior when given before a P injection 
(Blaustein et al., 1987; Brown & Blaustein, 1984).  All treatments were administered SC. 
Throughout the course of the experiment, animals developed subdermal lumps or scabs at the 
injection sites (regardless of treatment condition); therefore, injection sites were alternated in 
quadrants to reduce irritation. All animals were closely monitored and scabs were treated with 
iodine and polysporin as needed. Following any signs of distress or impaired general health 
animals were immediately removed from the experiment (n=2). Additional details regarding 
chronic administration of this vehicle solution are reported elsewhere (Jones, S.L., Gardner 
Gregory, J., Pfaus, J.G., in preparation). 
Sexual behavior training and testing 
Behavioral training and testing were carried out during the middle-third of the dark cycle, 
in unilevel pacing chambers (38x60x38cm) lined with betachip and bisected by clear Plexiglas® 
divider with 4 square holes cut into the bottom. The holes were adjusted to allow passage of only 
the smaller female, restricting the male to one compartment. Males were first placed on one side 
of the chamber, and allowed a 5-minute habituation period prior to introduction of the female to 
the empty compartment. All training and test sessions were 30 minutes in duration, were video-
recorded using a Sony Handycam Digital camera and subsequently scored using a personal 
computer and the Behavioral Observation Program customized for sexual behavior in the pacing 
chamber (Cabilio, 1996) with the experimenter blind to treatment condition. 
Experiment 1. RU486 inhibits sexual behavior in females primed fully with EB+P. 
Sexually experienced females (N=19) used as stimulus animals in unrelated studies in our lab, 
were primed with 10 µg EB 48 hours, and 500 µg P 4 hours prior to testing. To verify that in our 
hands RU486 inhibits sexual behavior, half the animals were given RU486 (n=9) or the vehicle 
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(n=9) 1 hour prior to P. This pattern of RU486 administration has previously been shown to 
attenuate sexual behavior (Blaustein et al., 1987; Brown, Moore, & Blaustein, 1987).  
Experiment 2. Effects of chronic administration of RU486 on EB-sensitization of sexual 
behavior. Beginning one week post-surgery, females (N=52) were given sexual experience by s.c 
injections of 10µg EB 48 hours, and 500µg P 4 hours prior to each of four training sessions 
which occurred at 4-day intervals. Following the 2-week hormonal washout period animals were 
assigned to one of 5 treatment conditions: 2µg EB+Vehicle (n=8), 5µg EB+Vehicle (n=10), 10µg 
EB+Vehicle (n=10), 5µg EB+RU486 (n=12), or 10µg EB+RU486 (n=12). The females then 
received 7 sexual test sessions. 
Behavioral measures 
The frequency of lordosis magnitudes (LM) was scored on a 3-point scale according to 
Hardy and Debold (1971b)and the lordosis quotient (LQ) was calculated as a ratio of the number 
of LM to the number of mounts (including intromissions and ejaculations), multiplied by 100. In 
Experiment 1, the lordosis rating (total number of points / total number of lordosis postures) was 
also calculated to compare the effects of RU486 on this measure as reported in the literature. 
Measures of sexually appetitive behaviors included hops/darts and solicitations, defined as a 
headwise orientation towards the male, followed by a runaway (Erskine, 1989; McClintock, 
1984; Pfaus et al., 1999). Defensive behaviors included kicks, sideways takedowns, boxing 
postures, and prone positions, as in Barnett (Barnett, 1963). Mounts, intromissions and 
ejaculation by the male were also analyzed, since their behavior provides insight into the 
female’s sexual receptivity (Pfaus et al., 1999). 
Statistical analyses 
 The results of Experiment 1 were analyzed using independent samples t-tests to 
investigate whether RU486 disrupts sexual behavior in EB+P primed females. Data from 
Experiment 2 were analyzed using a (5 groups x 7 tests) mixed ANOVA with group as a 
between subjects factor and test as a within subjects factor. Significant interactions were 
investigated using simple main effect analyses. Tukey’s post-hoc was used to investigate 
differences between groups and Sidak-Bonferroni correction was used to investigate differences 
between tests. Linear trend analyses were also examined (as in Jones et al., 2013), such that a 
linear increase was interpreted as behavioral sensitization, whereas a quadratic trend on an 
inverted u-shaped curve was interpreted as sensitization followed by inhibition. In the event of 
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significant main effects and an interaction, only the interaction is reported. The level of statistical 
significance for all comparisons was set at p<0.05. Eta squared (η2) and Cohen’s d are reported 
as measures of effect size. Data are presented as mean (SEM).  
 
Results 
Experiment 1. RU486 inhibits sexual behavior in females primed fully with EB+P. 
Two females in the RU486 group were not mounted by the male, and were excluded from 
all analyses of lordosis behavior. In accordance with other reports, RU486 significantly 
interfered with the normal display sexual behavior in the OVX rat treated with EB+P. As shown 
in Figure 1 animals who received RU486 1hr prior to P administration displayed a lower LQ, 
t(14)=3.48, p<0.001, d=1.80, and a lower lordosis rating, t(14)=2.19, p=0.046, d=1.11.  
Treatment with RU486 also resulted in significantly fewer hops/darts, t(16)=4.587, 
p<0.001, d=2.16 (Figure 2A) and although it tended to decrease solicitations (Figure 2B), this 
difference did not meet statistical significance, t(16)=1.84, p<0.084, d=2.22, which may be due 
to lack of power given the large effect size. Females treated with RU486 also received fewer 
intromissions, t(16)=2.30, p=0.035, d=7.11, and ejaculations, t(16)=3.96, p<0.001, d=1.55, from 
the male (Figure 2D). There were no significant differences in the number of LMs (Figure 1C), 
defensive behaviors (Figure 2C) or mounts (Figure 2D) between the RU486 and vehicle 
conditions. 
Experiment 2. Effects of chronic administration of RU486 on EB-sensitization of sexual behavior  
 One female treated with 2µg EB displayed an abnormally high level of appetitive 
behaviors on the first test day suggesting abnormal sensitivity to EB (Z=3.96), and was excluded 
from all analyses. Two females were removed from the study over the course of the experiment 
due to signs of illness (one each from 5µg EB+RU, and 10µg EB+RU). On Test 7, the holes of 
the barrier were too small for one female in the 10µg EB + VEH group to cross, and her missing 
data were replaced by her group mean on that day. 
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Lordosis Quotient. No female treated with 2µg EB was mounted on all tests, indicative of 
a lack of sensitization as previously reported (Jones et al., 2013), and thus repeated measures and 
trend analyses could not be conducted. Seven females in the 5µg EB+VEH, 4 in the 5µg 
EB+RU486, and 3 in the 10µg EB+RU group were not consistently mounted across tests, and 
were excluded from the repeated measures analyses of LQ data.  
 Overall, LQ (Figure 3A) was higher on tests 2-6 compared to the first test, but following 
a decline, on test 7 LQ was no different from the first test, reflected in a significant main effect 
of test, F(6,144)=8.02, p<0.001, η2=0.22, and significant linear and quadratic trends, 
Flinear(1,24)=11.53, p=0.002, η2=0.30; Fquadratic(1,24)=21.76, p<0.001, η2=0.43. In addition, 2µg 
EB+VEH elicited a lower LQ compared to all other groups (main effect of group, F(3,24)=10.20, 
p<0.001, η2=0.56). The interaction was not significant.  
LM1. More LM1 (Figure 3B) were observed in females treated with 10ugEB+VEH 
compared to 2µg EB+VEH and 5µg EB+VEH (main effect of group, F(4,44)=4.09, p=0.007, 
η2=0.27). Although there was a significant main effect of test, (F(6, 264)=2.62, p=0.018, 
η2=0.05) Sidak’s post-hoc failed to detect significant differences; however there was a significant 
quadratic trend, F(1,44)=8.84, p=0.005, η2=0.16, suggesting that LM1 initially increased across 
tests followed by an eventual decline. The group by test interaction was not statistically 
significant. 
 LM2. There were no group differences in the display of LM2 on the first test, as expected, 
yet their expression across tests differed between groups (significant interaction, F(24, 264)=2.16, 
p=0.002, η2=0.13), as shown in Figure 3C. The frequency of LM2 did not change across tests in 
2µg EB+VEH or 5µg EB+VEH groups; however in females treated with 10µg EB+VEH, LM2 
was higher on tests 3 (p=0.001, d=1.45) and 4 (p=0.005, d=1.78) compared to the first test, and 
on Test 3 they displayed significantly more LM2 than those females treated with 2µg EB+VEH 
(p=0.005, d=9.97) or 5µg EB+VEH (p=0.029, d=7.60). That increase was followed by a decline 
on test 5 such that the frequency was no different from the first test and no differences were 
detected between any of the groups. This was followed by another increase on tests 6 (p=0.001, 
d=1.07) and 7 (p<0.001, d=1.82) compared to the first test, where they displayed more LM2 on 
test 6 compared to 2µg EB+VEH (p=0.011, d=1.47), and more on Test 7 compared to 
2ugEB+VEH (p=0.004, d=1.43) and 5µg EB+VEH (p=0.006, d=1.31). The test effects are 
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reflected in significant linear (F(1,9)=5.37, p=0.046, η2=0.37), quadratic (F(1,9)=6.91, p=0.027, 
η2=0.43) and cubic trends (F(1,9)=6.58, p=0.030, η2=0.42) in the 10µg EB+VEH group.  
Treatment with RU486 initially facilitated LM2s but later led to their inhibition (Figure 3C). 
When given in combination with 5µg EB there was a significant increase in LM2 on tests on test 
2-5 compared to the first test (all p<0.02), and on Test 3 females treated with 5µg EB+RU486 
displayed more LM2 compared to 2µg EB+VEH (p=0.011, d=2.34). However this facilitation by 
RU declined on the last two tests to levels equivalent to the first test, as reflected in the 
significant quadratic trend, F(1,10)=28.97, p<0.001, η2=0.78, and a lack of group differences on 
any subsequent test. When RU486 was given in combination with 10µg EB, there was also a 
significant increase such that they displayed more LM2 on test 2 compared to those 
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Figure 1. Lordosis measures in ovariectomized rats fully primed with estradiol benzoate (EB) 
and progesterone (P), and treated with either the progesterone receptor blocker RU486 or vehicle 






Figure 2. Hops/darts (A), solicitations (B), defensive behaviors (C) and copulatory stimulation 
received from the male (D) in ovariectomized rats fully primed with estradiol benzoate (EB) and 
progesterone (P), and treated with either the progesterone receptor blocker RU486 or vehicle 





Figure 3. Lordosis measures in ovariectomized rats treated repeatedly with varying doses of EB. 
Blocking progesterone receptors with RU486 did not prevent the sensitization of any of the 
measures; however with chronic administration, it led to an inhibition of LM2 in females treated 
with 5µg and 10µg EB, and an inhibition of LM3 in females treated with 10µg EB. Note that 
10µg EB VEH, there was an initial increase in LM2, followed by a decrease and a subsequent 
increase, reflected in a significant cubic trend, as such only the linear trend is indicated in the 
figure. A: sensitization as supported by a significant linear trend B: sensitization followed by 
inhibition, as supported by a significant quadratic trend. Main effects are displayed in capitalized 
letters, whereas sensitization or inhibition within specific groups following a significant 





treated with 2µg EB+VEH (p=0.004, d=1.92) and 5µg EB+VEH (p=0.005, d=1.74). The greatest 
number of LM2 occurred on Test 4, which was greater than that displayed on the first test 
(p=0.001, d=1.96), and the difference between 10µg EB+RU486 and 2µg EB+VEH was 
maintained on Test 4 (p=0.013, d=1.58). However this increase was followed by a significant 
decline on tests 5, 6, and 7, such that there were no longer any group differences, as reflected in 
the significant quadratic trend, F(1,10)=7.96, p=0.018, η2=0.44.  
 LM3. There were no differences in the display of LM3 on the first test, as expected, yet 
their expression across tests differed between groups (significant interaction, F(24,264)=1.59, 
p=0.043, η2=0.11) as shown in Figure 3D. The display of LM3 did not change in females treated 
with 2µg EB+VEH, or 10µg EB+VEH (neither the main effects of test, nor the linear trends were 
significant); however a slight increase occurred in females treated with 5µg EB+VEH on Test 6 
compared to Test 2 (p=0.034, d=1.06), which was also reflected in the significant linear trend 
(F(1,9)=5.54, p=0.043, η2=0.38; note that the quadratic trend was not significant).  
RU486 facilitated the display of LM3 (Figure 3D), such that females treated with 5µg 
EB+RU486 displayed more LM3 on Test 2 compared to 2µg EB+VEH (p=0.031, d=0.58) and 
5µg EB+VEH (p=0.017, d=0.57) and on Test 3 compared to 2µg EB+VEH (p=0.025, d=1.70). 
By Test 5 the frequency was still greater than those treated with 2µg EB+VEH (p=0.002, 
d=2.16), and they were displaying more LM3 compared to test 1 (p<0.001, d=1.46) and 4 
(p=0.004, d=1.23), and tended to display more on Test 5 compared to tests 2 (p=0.055, d=0.96) 
and 3 (p=0.053, d=0.96), as reflected in a significant linear trend, F(1,10)=8.64, p=0.015, 
η2=0.464. However, the frequency began to decline on tests 6 and 7, such that there were no 
longer any group or test differences, but the quadratic trend was not significant.  
RU486 also initially facilitated but later inhibited the display of LM3 in females treated 
with 10µg EB. They displayed more LM3 compared to 5µg EB+VEH (p=0.045, d=2.40) on Test 
2, and more than 2µg EB+VEH (p<0.001, d=2.07) and 5µg EB+VEH (p<0.001, d=1.75) treated 
animals on Test 3. Moreover, they displayed more LM3 on Tests 3-6 compared to Test 1 (all 
p<0.02), and on Tests 4 and they were still displaying more LM3 than 2µg EB+VEH (p=0.019, 
d=1.80). However this facilitation was no longer apparent on Tests 6 and 7 as no differences 
were found between groups, and the frequency on Test 7 was no different than any other test. 
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This initial facilitatory effect followed by inhibition is also reflected in the significant quadratic 
trend, F(1,10)=14.23, p=0.004, η2=0.59. 
Hops/darts. As shown in Figure 4A, no group differences were detected on the first or 
second tests; however the groups differed in the expression of hops/darts throughout the course 
of the experiment (significant interaction, F(24, 264)=1.66, p=0.031, η2=0.120). In contrast to 
our previous reports, HD did not change across tests in any of the vehicle treated animals, which 
was also reflected in the lack of significant linear or quadratic trends. This lack of effect may be 
due to a higher number of HD on the initial tests, compared to that observed in our prior studies 
(see Jones et al., 2013; Jones & Pfaus, 2014). 
Group differences began to emerge on Test 3, as a result of facilitation by RU486, such 
that 5 and 10µg EB given in combination with RU486 resulted in significantly more HD 
compared to females treated with 2µg EB+VEH (p=0.002, d=1.56; p=0.004, d=1.85, 
respectively) or 5µg EB+VEH (p=0.002, d=1.54; p=0.003, d=1.68). On Test 4, females treated 
with 5µg EB+RU486 displayed more HD than 2µg EB+VEH animals (p=0.031, d=2.26), and the 
increase reached statistical significance on test 5 compared to Test 1 (p<0.001, d=1.43) when 
they displayed more HD compared to all EB treated vehicle groups (2µg EB+VEH: p=0.001, 
d=2.02; 5µg EB+VEH: p=0.004, d=1.44; 10µg EB+VEH p=0.041, d=1.24). However this 
increase was followed by a gradual decline on tests 6 and 7 (p=0.006, d=1.18; p=0.008, d=1.66, 
respectively), compared to test 5, such that their expression was no different from tests 1-4. The 
sensitization followed by inhibition is also supported by a significant quadratic trend, 
F(1,10)=24.83, p=0.001, η2=0.26. 
A similar pattern emerged with 10µg EB+RU, such that more HD were displayed on tests 
4 (p=0.018, d=1.08) and 5 (p=0.031, d=1.02) compared to the first test and compared to 2µg 
EB+VEH (p=0.006, d=1.48 on test 4, p=0.013, d=1.81 on test 5); however following a peak on 
test 4, a gradual decline in HD was observed such that the drop in the number of HD on tests 6 
and 7 were no different from any other test day, and were no different from any other group. The 
initial sensitization by 10µg EB+RU486 followed by inhibition is reflected in a significant 
quadratic trend, F(1,10)=17.31, p=0.002, η2=0.17.  
Solicitations. As shown in Figure 4B, sexual solicitations were higher on tests 2-6 
compared to test 1, (main effect of test: F(6, 264)=4.66, p<0.001, η2=0.09) and the significant 
linear (F(1,44)=4.11, p=0.049, η2=0.08) and quadratic trends (F(1,44)=24.73, p<0.001 η2=0.30),  
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Figure 4. Hops/darts, active solicitations, and defensive behaviors in ovariectomized rats treated 
repeatedly with varying doses of EB. RU486 did not prevent the sensitization of appetitive 
measures of sexual behavior, yet its chronic administration led to an inhibition of hops/darts in 
females treated with 5µg and 10µg EB on later test days. Defensive behaviors declined across 
tests regardless of hormone treatment. A: sensitization as supported by a significant linear trend 
B: sensitization followed by inhibition, as supported by a significant quadratic trend. C: 
significant decline across tests. Main effects are displayed in capitalized letters, whereas 
sensitization or inhibition within specific groups following a significant interaction is displayed 




suggest that following the increase across tests, they declined on the final test day. A facilitation 
by RU486 was detected such in females treated with 5µg EB, RU486 induced significantly more 
solicitations than those treated with 2µg EB+VEH (p=0.004, d=1.07), whereas females treated 
with 10µg EB+RU486 displayed more solicitations than all vehicle treated females (2µg 
EB/VEH: p<0.001, d=0.93; 5µg EB/VEH: p=0.013, d=0.46; 10µg EB/VEH: p=0.016, d=0.53) 
(main effect of group, F(4, 44)=4.84, p=0.003, η2=0.30). The test by group interaction was not 
significant. 
 Defensive Behaviors. Defensive behaviors declined across tests, as shown in Figure 4C, 
such that fewer defensive behaviors were displayed on test 5 (p=0.002, d=1.02) and 7 (p<0.001, 
d=1.40) compared to test 1, and on test 7 compared to test 3 (p=0.002, d=0.97) (main effect of 
test, F(6, 264)=4.32, p<0.001, η2=0.082; Flinear(1,44)=16.80, p<0.001, η2=0.256). The group 
effect and interaction were not statistically significant. 
 Male behaviors. The number of mounts received initially increased across tests, as shown 
in Figure 5A, such that significantly more mounts were received on test 4 compared to test 1, 
before declining on later tests, as reflected in a significant main effect of test (F(6, 264)=2.91, 
p=0.009, η2=0.05), and significant quadratic trend, F(1,44)=8.88, p=0.121, η2=0.16. The group 
effect and interaction were not significant.  
The number of intromissions (Figure 5B) increased across tests (F(6,264)=9.01, p<0.001, 
η2=0.15), reflected in statistically significant linear trend, Flinear(1,44)=15.13, p<0.001, η2=0.24. 
Fewer intromissions were taken on test 1 compared to all other tests (all p<0.001); and despite a 
significant quadratic trend, Fquadratic(1,44)=40.68, p<0.001, ηp2=0.40, no other test differences 
were detected. Overall, 2µg and 5µg EB+VEH received fewer intromissions than all other 
groups (all p<0.01), (main effect of group: F(4,44)=18.87, p<0.001, η2=0.63). The interaction 
effect was not significant.  
More ejaculations (Figure 5C) were received on tests 2-6 compared to the first test, 
followed by a decline on test 7 such that the number of ejaculations was equivalent to test 1, as 
reflected in the main effect of test, F(6,264)=5.68, p<0.001, η2=0.10, and a significant quadratic 
trend, F(1,44)=29.49, p<0.001, η2=0.32. Finally, fewer ejaculations were received overall by 
females treated with 2µg or 5µg EB+VEH compared to all other groups (all p<0.001) (main 
effect of group, F(1,44)=17.814, p<0.001, η2=0.62). The interaction was not significant. 
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Figure 5. Mounts, intromissions and ejaculations received from males, in ovariectomized rats 
treated repeatedly with varying doses of EB. RU486 did not prevent the increase in the receipt of 
sexual stimulations from the male. B: sensitization followed by inhibition, as supported by a 






The goal of this study was to examine whether repeatedly blocking PR by administration 
of RU486 just prior to testing would prevent the sensitization of sexual behaviors in the Long-
Evans OVX rat treated with 5µg or 10µg EB every four days. Behavioral sensitization to EB 
occurred in both groups treated with RU486, and had no effect on sexual stimulations received 
from the male, or the occurrence of defensive behaviors. However hops/darts, LM2 and LM3 
were attenuated following its chronic administration. These results suggest that PR activation is 
required to maintain estradiol sensitization of certain aspects of sexual behavior.  
We first established that 5mg RU486 inhibited female sexual behaviors when 
administered one hour prior to P in EB-treated females, replicating an effect that has been well 
documented in the literature. However, we note that although RU486 was effective at inhibiting 
hops/darts, a common measure of appetitive sexual behaviors in the literature, it did not attenuate 
full solicitations significantly. This is important because it indicates that the mechanism that 
induces full sexual solicitations is different from that which induces hops/darts (as suggested by 
Erskine, 1989).  
We also established that PR activation is involved in the maintenance of the sensitization 
of appetitive sexual behaviors by repeated estradiol treatment. This finding extends a report 
showing that PRs are involved in the display of appetitive sexual behaviors using an E2 
facilitated paradigm. Micevych et al. (2008) reported that following repeated administration of 
E2 (i.e., after the animals had sensitized), an acute injection of RU486 inhibited the facilitation 
of sexually appetitive behaviors (hops, darts, ear wiggles), an effect that was dependent on 
estradiol-induced neuroprogesterone synthesis. Thus, our findings are in agreement with those of 
Micevych et al. (2008) since appetitive sexual behaviors were inhibited by RU486 but only on 
later tests, after sensitization had occurred. In fact RU486 initially facilitated the sensitization of 
appetitive behaviors, particularly hops/darts. Together the findings suggest that the initial 
potentiation may not depend upon PR activation, but that PRs are important in the maintenance 
of the behavioral sensitization to EB.  
The effect of RU486 on the expression of lordosis following administration of EB alone 
is partly in agreement with previous reports. RU486 failed to block LQ in estradiol-induced 
(chronic administration of E2 by SC capsules) (Blaustein et al., 1987) and estradiol-facilitated 
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(E2 given in place of P) (Blaustein et al., 1987; Micevych et al., 2008) paradigms. Our findings 
parallel those reports, since we did not find a specific effect of RU486 on the frequency of 
lordosis displayed in response to a mount (LQ) in our paradigm. However, we found that the 
quality of lordosis was affected, particularly the frequency of the two higher magnitudes. In both 
groups treated with RU486, LM2 and LM3 initially sensitized yet they declined on later tests, 
suggesting that PR are also involved in the maintenance of the quality of lordosis displayed. 
These findings illustrate the importance of considering not only LQ, but also the frequency of 
lordosis magnitudes displayed in the study of female sexual behavior.  
There was no effect of PR blockade on the display of defensive behaviors when females 
were treated acutely with EB+P (Experiment 1), or repeatedly with EB-alone (Experiment 2), 
suggesting that PRs are not directly involved in their expression. In fact, defensive behaviors 
appear to be inversely related to estrogen receptor activation in the VMH (e.g., Anchan, Gafur, 
Sano, Ogawa, & Vasudevan, 2014), possibly through descending pathways to the periaqueductal 
grey that inhibit defensive behaviors while permitting lordosis (Pfaff, Kow, Loose, & Flanagan-
Cato, 2008).  
Although we have shown that PRs are important in the maintenance of estradiol 
sensitization, we cannot yet rule out a role for PR in the induction of sensitization, because it is 
possible that neuroprogesterone (or some other ligand) had activated PR prior to RU486 
administration. This is a possibility, since lordosis is induced as early as 16-24hrs following E2 
administration (Green et al., 1970; McEwen et al., 1975), and some of the facilitative effects of 
subsequent E2 treatment occur rapidly via membrane-bound receptors (Kow & Pfaff, 2004). 
Moreover, E2 upregulates PR mRNA within six hours in vitro (Lee & Górski, 1996), and 
induces PR mRNA and protein in hypothalamic sites, particularly the VMH, within 16-24 hours 
(Moguilewsky & Raynaud, 1979; Parsons, Maclusky, Krey, Pfaff, & Mcewen, 1980; Parsons, 
Rainbow, Pfaff, & McEwen, 1981; 1982; Romano, Krust, & Pfaff, 1989). Thus estradiol-induced 
PRs may have been activated by endogenous compounds such as neuroprogesterone (Micevych 
et al., 2008) or dopamine (Mani et al., 1996; Mani, Allen, Clark, Blaustein, & O'Malley, 1994a) 
prior to administration of RU486. Because RU486 has a relatively long half-life, ranging from 
24-90 hrs (Johanssen & Allolio, 2007), it is possible that with its repeated administration, 
hypothalamic PRs were increasingly less available for binding by endogenous compounds 
leading to eventual inhibition. This would suggest a role for PR in the mechanisms underlying 
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the induction and maintenance of the sensitization of sexual behavior by EB. Thus it is possible 
that the induction of behavioral sensitization by EB may have been blocked had RU486 been 
administered earlier or by continuous chronic administration, for example through subcutaneous 
pellets, which might also prevent the adverse cutaneous effect that we observed.  
The initial facilitative effect of RU486 on sexual behavior is also consistent with reports 
in OVX females primed with EB alone. It has been proposed that RU486 takes on agonistic 
qualities when co-administered with EB in the absence of P, thereby facilitating lordosis (Pleim 
et al., 1990). Similarly, agonistic qualities have been reported in breast cancer cell lines (Horwitz, 
1985), and when administered alone, RU486 has progestational actions in the endometrium of 
postmenopausal women yet elicits antagonistic activities when co-administered with 
progesterone (Gravanis et al., 1985). The administration of RU486 to the VMH of OVX rats 
primed with 5µg EB facilitates lordosis as effectively as P (Pleim, Lipetz, Steele, & Barfield, 
1993), suggesting that the agonistic nature of RU486 may occur through similar mechanisms to 
P. However we found that the facilitation of RU486 did not occur on the first test; thus if RU486 
is acting via a similar mechanism to P, that first exposure must be subthreshold, since a single P 
injection administered to EB-primed rats maximizes sexual behavior. Moreover, since we found 
that the facilitation of sexual behaviors only becomes apparent as of the second test (i.e., 
following the second injection of EB), it suggests that the priming dose of EB increases the cell’s 
ability to respond to subsequent sexual-behavior enhancing treatments (e.g., in this case EB or 
RU486). One mechanism through which this could occur is through membrane receptor binding, 
which may open new estrogen (or other ligand) binding sites as proposed by Caldwell (2002).  
The agonistic actions of RU486 in the absence of P, but antagonistic actions in the 
presence of P can explain why certain sexual behaviors eventually became inhibited in our 
paradigm, if repeated administration of E2 sensitizes the production of neuroprogesterone. 
RU486 may act as a partial agonist on earlier tests when females display sensitization to EB; 
however, if neuroprogesterone synthesis is upregulated with chronic EB administration, RU486 
may then take on antagonistic qualities due to competitive binding with the newly synthesized 
progesterone. One way to address this possibility would be to measure hypothalamic 
neuroprogesterone levels as a function of increasing numbers of EB injections. It is interesting to 
note that RU486 has agonistic qualities when sexual behavior is in an inhibitory state (i.e., when 
their expression is typically low or absent), as occurs in lactational Diestrus (Barbosa-Vargas, 
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Pfaus, & Woodside, 2009) and in OVX rats treated with EB alone (Pleim et al., 1990; 1993) and 
early tests in the current study). The potential confounding role of the agonistic qualities of 
RU486 may be overcome using APR19 a novel PR antagonist that prevents the recruitment of 
co-activators and co-repressors, obliterating the agonistic qualities reported with RU486 (Khan et 
al., 2013). 
The lack of sensitization of appetitive sexual behaviors by EB that occurred in the 5µg 
EB and 10µg EB+VEH groups suggests that a compound in the vehicle interfered with the 
mechanism of sensitization, an effect that was overridden (or potentially reversed) by the 
addition of RU486.  The vehicle was composed of 80% sesame oil, 15% benzyl benzoate, and 
5% benzyl alcohol, and a literature search in PubMed failed to find any interaction of these 
compounds with steroid hormone receptors. It is thus unclear why the vehicle treated animals 
failed to sensitize to 5µg or 10µg EB. However, one plausible reason is that the vehicle 
facilitated sexual behavior. In our previous studies few solicitations were ever observed, nor did 
they increase in OVX females repeatedly treated with 10µg EB when given the opportunity to 
copulate at four day intervals (Jones & Pfaus, 2014), whereas in the current study solicitations 
did initially sensitize (Figure 2B). We also note that on the initial test hops/darts were higher 
than that observed in our previous studies, suggesting that the vehicle had a facilitative effect in 
the 5µg and 10µg EB treated groups, masking any sensitization effect, since that facilitation was 
maintained throughout the experiment. If that is true, then any facilitation by the vehicle was 
overridden by chronic administration of RU486, since only in those treatment groups did 
hops/darts decline on later tests. Together this suggests that despite any facilitation by the vehicle, 
chronic blockade of PR with RU486 is inhibitory to the sensitization of sexual behaviors.  
What neural mechanisms might underlie behavioral sensitization to EB? 
Auger and colleagues (1997) found that PRs within the mPOA and VMH are involved in 
the enhancement of lordosis in OVX and OVX/ADX rats treated acutely with EB when tested in 
a repeated mating paradigm. In this paradigm, females are given experimenter-applied VCS 48 
hours following an injection of EB followed by four 15-minute exposures to a sexually vigorous 
male at 30-minute intervals. Fifteen minutes after the last mating session, the experimenter 
applies manual flank stimulation. In control animals, LQ is significantly higher on the third and 
fourth mating tests compared to the first, but this increase does not occur if PR are blocked with 
RU486, suggesting that PR activation is involved in that enhancement. Moreover, VCS induced 
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Fos in OVX and OVX/ADX rats in a number of brain regions including the vlVMH, mPOA and 
medial amygdala. Blocking PR with RU486 only prevented the increase in Fos expression in the 
vlVMH and POA, regions that contain PR, suggesting that mating-induced enhancement occurs 
via PR within those regions (Auger et al., 1997).  
Those findings suggest that PR activation by mating stimulation received during repeated 
testing in our paradigm may also contribute to the sensitization of sexual behaviors by EB. 
However, if that is true, it could only be part of the mechanism since we recently reported that 
giving the female access to copulate with a sexually vigorous male attenuates estradiol 
sensitization of sexually appetitive behaviors (Jones & Pfaus, 2014). Moreover, we found that 
the attenuation was driven by the receipt of VCS (Jones, S.L., Germé, K., Graham, M.D., Roy, P., 
Gardner Gregory, J., Rosenbaum, S., Parada, M., Pfaus, J.G., submitted), and mimicked by 
AMPA receptor infusions to the ventrolateral VMH (vlVMH) in place of copulation (Jones, S.L., 
Farisello, L., Mayer-Heft, N., Pfaus, J.G., submitted).  Together those findings show that 
glutamate signaling in the vlVMH opposes the sensitization of appetitive sexual behaviors by EB, 
and suggests that the induction of sensitization may involve the removal of inhibitory glutamate 
signaling via an increase in GABA-ergic signaling in the vlVMH (Booth, Wayman, & Jackson, 
2010; Georgescu et al., 2009; 2014; McCarthy et al., 1990). Repeated treatments with EB may 
potentiate the release of GABA within the vlVMH (thereby inhibiting glutamatergic signaling) 
(Georgescu et al., 2009; 2014), and/or potentiate the synthesis of neuroprogesterone synthesis. 
Neuroprogesterone may, in turn, not only bind to estrogen-induced PR, but upregulate of GABA-
a receptor subunits (Arbo, Andrade, Osterkamp, Gomez, & Ribeiro, 2014), and/or P or its 
metabolites may also bind to GABA-a receptors directly (Frye & Walf, 2008a; 2008b), leading 
to a facilitation of sexual behaviors with time. One way a role of GABA can be addressed is by 
measuring GABA release via microdialysis following repeated treatments with EB, or 
administering GABA receptor antagonists to test whether estradiol sensitization can be blocked. 
In conclusion, the repeated blockade of PR did not disrupt the induction of sensitization 
by repeated administration of EB, yet hops/darts, LM2, and LM3 were inhibited on later tests, 
suggesting that PR may play a role in the maintenance of estradiol sensitization. However, given 
the timing of RU486 administration in this and similar studies, we cannot yet rule-out a role for 
PR in the induction of estradiol sensitization of sexual behaviors. Part of the underlying 
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 In Chapter 2.1 it was determined that the repeated administration of EB sensitizes sexual 
behaviors in the OVX rat. However, characterizing the sensitization required not only the 
administration of EB but also access to a sexually vigorous male on each test. Thus, the 
following study tested whether the administration of EB alone, in the absence of the opportunity 
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Ovariectomy (OVX) abolishes the expression sexual behaviors in the rat, but they can be 
fully reinstated by sequential administration of estradiol benzoate (EB) followed by progesterone 
(P). When administered alone, 5 or 10µg EB (but not 2µg) acutely induce only low levels of 
lordosis, whereas repeated administration potentiates lordosis and induces sexually appetitive 
behaviors (e.g., hops, darts, solicitations, ear wiggles). The mechanisms mediating this 
behavioral sensitization are poorly understood, and it is not clear whether stimulation from the 
male during repeated copulation plays a role. OVX Long-Evans rats were given 4 sexual training 
sessions with EB (10µg) and P (500µg) 48 and 4 hours prior to testing, respectively, in a unilevel 
4-hole pacing chamber followed by a 2-week hormone washout. Females were then treated with 
2µg or 10µg EB 48 hours prior to copulation on tests 1 and 8. On tests 2-7, a group of females 
was treated with 10µg EB and allowed to copulate with a male (10µgEB/Male, n=16), or treated 
with 2µg or 10µg EB and placed in the chamber alone  (2µgEB/Alone, n=6; 10µgEB/Alone, 
n=18). A negative control group was treated with the oil vehicle and placed in the chamber alone 
(Oil/Alone, n=6) on tests 2-7, but treated with 2µg EB prior to copulatory tests 1 and 8. All 
groups, except Oil, displayed behavioral sensitization to EB, suggesting that repeated 
administration EB is both necessary and sufficient to induce sensitization. Appetitive behaviors 
were attenuated in those that copulated on every session. Pacing was disrupted in all groups. 
Together these results suggest that EB activates excitatory mechanisms to promote the 
expression of sexual behaviors, which are potentiated across time under certain conditions. In 
contrast, copulatory stimulation attenuates behavioral sensitization to EB. 
 




 Sexual behavior in the female rat is dependent on the release of ovarian steroid hormones. 
Ovariectomy (OVX) completely extinguishes the behavior, but it can be reliably reinstated by 
mimicking ovarian release with the sequential exogenous administration of estradiol benzoate 
(EB) followed by progesterone (P) (Beach et al., 1942; Boling & Blandau, 1939). The acute 
administration of EB alone induces low levels of lordosis, the concave arching of the back that 
permits penile intromission, and subsequent P priming potentiates lordosis and induces sexually 
appetitive behaviors such as hops, darts, solicitations, and ear wiggles. Repeated administration 
of EB alone however, induces a behavioral sensitization such that there is an increase in the 
frequency of lordosis (lordosis quotient, LQ), and the occurrence of sexually appetitive behaviors 
increases with each subsequent injection until a plateau is reached. We recently characterized 
this behavioral sensitization to EB when administered in varying doses and intervals, and found 
that 5 or 10µg EB, but not 2µg EB, administered every 4 days to the sexually experienced OVX 
Long-Evans rat induces a robust sensitization (Jones et al., 2013). The effect is not dependent on 
adrenal progestin release, since it was not prevented by adrenalectomy (Jones et al., 2013). Here 
we examined whether the somatosensory stimulation received from the male on each test 
contributes to the sensitization of sexual behaviors by repeated administration of EB.  
The female rat exerts a great deal of control over the rate of sexual stimulation received 
from the male, and prefers to mate in pacing chambers which are designed to allow her to 
regulate copulatory stimulation at her preferred interval (Jenkins & Becker, 2003b; Paredes & 
Alonso, 1997; Paredes & Vazquez, 1999), an effect that appears to be mediated by the pattern of 
VCS received (Meerts & Clark, 2007; 2009a). Pacing is reproductively relevant as it decreases 
the number of intromissions required to induce pregnancy or pseudopregnancy, and results in 
larger litters (Erskine et al., 1989). The unilevel 4-hole paced mating chamber is bisected with a 
perforated divider with holes large enough for only the female to pass through, restricting the 
male to one side, and allowing her to approach and withdraw from the male at her preferred 
interval. The intensity of sexual stimulation received from the male affects her copulatory pattern. 
Stimulation progressively increases with mounts, intromissions, and ejaculations, which coincide 
with increased exit latencies, contact return latencies (CRL), and greater percent exists (Clark, 
Robinson, Meerts, Quill, & Boisvert, 2011; Erskine, 1989). Pacing is observed in sexually-naïve 
and experienced females (Erskine, 1985; 1989), and following long-term treatment with EB 
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alone (5µg for 6 consecutive days) pacing measures are indistinguishable from treatment with 
EB+P (Brandling-Bennett, Blasberg, & Clark, 1999). It has recently been shown however that 
sexually-experienced OVX females primed with EB+P return quicker to the male following an 
intromission and stay away from him longer following an ejaculation (using 30 minute tests), 
suggesting that they are capable of altering their reproductive strategies to promote reproductive 
success (Meerts et al., 2014). Whether pacing patterns differ between sexually-experienced 
females repeatedly treated with EB and not given access to a male compared to those that 
repeatedly copulate across test sessions, is not known.  
The role of somatosensory stimulation received from the male in the enhancement and 
subsequent termination of sexual behaviors across a single episode has been examined (Bennett, 
Blasberg, & Blaustein, 2001; Blaustein et al., 2009; Hardy & Debold, 1973). Early in an episode, 
both lordosis and appetitive sexual behaviors (e.g., solicitations, hops/darts, ear wiggles) 
progressively increase regardless of whether a female receives intromissive stimulation 
(Blaustein et al., 2009). However, more ear wiggles are displayed if females do not receive 
intromissions (by masking the vaginal opening), and a similar pattern emerges for hops/darts 
(Blaustein et al., 2009), suggesting that intromissive stimulation counteracts the behavioral 
enhancement of sexually appetitive measures within an episode of heat. As the session 
progresses, repeated VCS accelerates the onset of estrous termination, defined as a reduction in 
sexually appetitive behaviors and an increase in antagonistic behaviors prior to the decline in 
lordosis intensity and magnitude (Erskine, 1985; 1989; Erskine & Baum, 1982; Hardy & Debold, 
1972; Lodder & Zeilmaker, 1976; Pfaus et al., 2000). Local anesthesia applied to the vaginal and 
cervical regions decreases the female’s operant responding to gain access to a male (Bermant & 
Westbrook, 1966), (albeit without interfering with pacing behaviors, see Meerts, Boisvert, Spjut, 
& Clark, 2010), and removing the sensory stimulation via pelvic nerve transection decreases the 
latency to return to the male following VCS, increases the time spent with males, and results in 
more hops, darts, and ear wiggles, and fewer defensive behaviors (Meerts & Clark, 2009b). 
Together those data suggest that feedback from the vagina and cervix can both facilitate and 
inhibit aspects of female sexual behavior over an episode of heat. Thus, it is unclear whether 
copulatory stimulation from the male plays a role in the development of behavioral sensitization 
following repeated administration of EB, particularly since in our previous study females were 
administered EB and exposed to sexually vigorous males on every test.  
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The primary goal of this study was to determine whether repeated treatment with EB in 
the absence of copulation is sufficient to induce behavioral sensitization in the OVX Long-Evans 
rat. To examine this, females were treated with 10µg EB, a dose which we have previously 
shown to robustly induce behavioral sensitization, as well as 2µg EB, a dose that has repeatedly 
been reported in the literature to be subthreshold for inducing sexual behavior when administered 
alone to the Long-Evans rat. Groups of females were then given access to a sexually vigorous 
male on each of eight tests, or placed in the chamber alone on all but the first and last test 
sessions. A secondary goal of this study was to examine the patterns of pacing behavior between 
those groups. 
 
Materials and methods 
Animals 
Long-Evans females rats were purchased from Charles River Canada (St-Constant, QC) 
and housed in pairs in clear Plexiglass shoebox cages lined with beta chip. Male rats were 
received from the same supplier and housed in groups of four in clear Plexiglass cages lined with 
beta chip. Males were sexually experienced in the 4-hole pacing chamber.  All procedures were 
conducted in accordance with the guidelines of the Canadian Council on Animal Care, and 
approved by the Concordia University Animal Research Ethics Committee. 
 
Ovariectomy 
One week after arrival to the facilities, females were bilaterally OVX under a mixture of 
ketamine:xylazine, via a single lumbar incision, ear punched, and allowed a week of recovery, as 
in Jones et al., (2013). 
 
Hormone preparation and administration  
EB (17β-estradiol benzoate) and P (progesterone) were dissolved in 0.1mL reagent grade 
sesame oil (Sigma-Aldrich) and administered by SC injection, 48hrs and 4hrs prior to testing, 
respectively. Steroid hormones were purchased from Steraloids (Newport, RI). The 2µg EB dose 
was always diluted down from the 10µg EB solution. An equivalent volume of sesame oil was 




Training and Testing Apparatus 
 All copulatory sessions occurred in the unilevel 4-hole pacing chamber (60 X 38 X 
38cm), lined with beta-chip below a metal grid floor, and bisected with a clear Plexiglass divider 
with 4 square holes cut into the bottom. The size of the holes were adjusted to the size of the 
female such that she could easily cross to the male’s compartment, while restricting the larger 
male to his side. This allowed the female to pace the rate of contact with the male. 
 
Training and Testing Procedures  
One week following OVX, females were injected SC with 10µg EB followed 44 hours 
later by 500µg P and given sexual behavior training four hours later, for a total of 4 training 
sessions. Each training and test session occurred during the middle third of the dark cycle, was 
30 minutes in duration, and occurred at 4-day intervals. Following training, females were taken 
off hormones for a two-week hormone washout period before experimental testing.  
To assess the development of behavioral sensitization to EB, female sexual behavior was 
measured in all four groups on the first and final test day (tests 1 and 8), and manipulations were 
made on intermediate tests (tests 2-7). To determine whether stimulation received from the male 
during repeated testing plays a role in the development of behavioral sensitization, two groups of 
females were treated with 10µg EB prior to each test, but on intermediate tests were either given 
access to a sexually vigorous male in a four-hole unilevel pacing chamber (10µg EB/Male, n=16), 
or placed in the chamber alone (10µg EB/Alone, n=18). To assess whether EB treatment is 
necessary for the development of the sensitization of sexual behaviors, two control groups were 
used; one was treated with oil (Oil/Alone, n=6) and the other treated with 2µg EB (2µg 
EB/Alone, n=6) and placed in the chamber alone on intermediate tests. However, since OVX 
completely abolishes the expression of sexual behavior, both groups were treated with 2µg EB 
prior to the first and last tests to examine whether sensitization of sexual behaviors occurred. It 
has been repeatedly shown in the literature that this low EB dose does not induce sexual behavior 
in the OVX Long-Evans rat without subsequent P priming (Jones et al., 2013; Kow & Pfaff, 
1975; Micevych et al., 2008; Sinchak & Wagner, 2012). As such, neither group was expected to 




Behavioral Analyses  
Lordosis magnitude (LM) was measured on a 3-point scale according to its intensity as in 
Hardy and Debold (1971b), and the frequency of each was recorded. Lordosis quotient (LQ) was 
measured by taking the total number of lordosis postures (LM1+LM2+LM3) and dividing by the 
total number of mounts (mounts + intromissions + ejaculations) multiplied by 100. Partial 
solicitations (i.e., hops/darts) and full solicitations (headwise orientation made towards the male 
followed by a runaway, usually to her side of the chamber) (Gelez et al., 2013; McClintock, 
1984) were analyzed separately, as well as combined into a general measure of sexually 
appetitive behaviors. Kicks, sideways takedowns, boxing postures, and prone positions made by 
the female were coded as defensive behaviors (Barnett, 1963). Mounts, intromissions, and 
ejaculations by the male were also analyzed. Pacing behaviors of females included the number of 
entrances to the male’s compartment, contact return latencies (CRL), percent exits from the 
male’s compartment (Erskine, 1989), and the latency to exit the male’s chamber following a 
mount, intromission, or ejaculation (Clark et al., 2011).  
 
Statistical Analyses 
Data were analyzed by two-way mixed ANOVA (test X group) followed by Tukey’s 
post-hoc analyses for significant groups effects, and interactions were followed by simple main 
effect analyses. Since very few male sexual behaviors were coded on the first test day, pacing 
data were assessed on the final test day only. Group differences were assessed using the one-way 
ANOVA. The one-way repeated measures ANOVA was used to determine whether females 
were capable of differentiating between mounts, intromissions, and ejaculations, and significant 
main effects were investigated using Bonferroni’s post-hoc. Significance was considered with 
p<0.05. In the event of significant main effects and an interaction, only the interaction is reported. 
Data are presented as mean ± SEM. Eta squared (η2) and Cohen’s d (correcting for sample size 
where appropriate) are reported as measures of effect size (Lakens, 2013).  
 
Results 
One female in the 10µg EB/male group displayed an abnormally high level of sexually 
appetitive behaviors on Test 8, (199, Z=5.00) and was removed from all statistical analyses. On 
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test 7, an equipment failure resulted in the loss of data for two animals, and as such those data 
were replaced with that of the group mean. 
Lordosis. Three of the 15 females in the 10µg EB/Male, 4/6 females in the Oil/Alone, 3/6 
in the 2µg EB/Alone, and 5/18 in the 10µg EB/Alone conditions, were not consistently mounted 
on both tests, and were excluded from the statistical analyses on LQ. Figure 1A illustrates the 
significant interaction on LQ, F(1,26)=6.77, p=0.002, η2=0.30. LQ was greater on the final test 
compared to the first in both groups treated with 10µg EB (10µg EB/Male: p<0.001, d=3.10; 
10µg EB/Alone: p<0.001, d=3.34), whereas there was no change in LQ across tests if females 
were treated with Oil or 2µg EB and placed in the chamber alone (p’s>0.903). On test 1 there 
were no differences between groups as expected (all p>0.05), however on the final test day LQ 
was significantly greater in females treated with 10µg EB regardless of whether they copulated 
with a male on every test or not compared to Oil/Alone (10µg EB/Male: p<0.001, d=6.78; 10µg 
EB/Alone: p<0.001, d=4.52) and 2µg EB/Alone females (10µg EB/Male p<0.001, d=3.10; 10µg 
EB/Alone p=0.002, d=2.27), no other differences were detected. 
Few LM1s were observed overall (Figure 1B). The frequency of LM1 did not change 
across tests (main effect of test, F(1,41)=3.31, p=0.076, η2=0.07, and although a main effect of 
group was detected, F(1,3)=4.23, p=0.046, η2=0.18, Bonferroni’s test failed to detect any 
specific group differences. The interaction was not statistically significant. 
More LM2s were displayed on the final test day compared to the first as shown in Figure 
1C, (main effect of Test, F(1,41)=8.50, p=0.006, η2=0.15, and the 10µg EB/Male group tended to 
display more LM2 compared to those treated with Oil (p=0.057, d=0.87) (main effect of group, 
F(3,41)=4.28, p=0.010, η2=0.24). The interaction was not statistically significant. 
 Similarly, more LM3 (Figure 1D) were detected on the final test compared to the first, 
F(1,41)=11.55, p=0.002, η2=0.21, however no differences were detected between groups, 
F(3,41)=1.85, p=0.153, η2=0.12. The interaction was not statistically significant. 
 Sexually appetitive and defensive behaviors. When hops/darts and solicitations were 
combined into a general measure of sexually appetitive behaviors, an interaction was detected, 
F(3,41)=14.89, p<0.001, η2=0.31. As expected and shown in Figure 2A, the number of appetitive 
behaviors did not change across tests in the Oil/Alone group, however they did increase in all 
groups treated with EB (2µg EB/Alone: p=0.003, d=2.61; 10µg EB/Alone: p<0.001, d=2.11; 
10µg EB/Male: p<0.001, d=1.45). There were no group differences in the number of appetitive  
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Figure 1. Lordosis Quotient (LQ) and magnitudes (LM) on Tests 1 and 8, of females treated 
with Oil, 2µg or 10µg EB and placed in the chamber alone, or treated with 10µg EB and 
repeatedly mated on Tests 2-7. aSignificantly greater than Test 1. *Different from 10µgEB/Alone 
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Figure 2. Appetitive and defensive behaviors on Tests 1 and 8, of females treated with Oil, 2µg 
or 10µg EB and placed in the chamber alone, or treated with 10µg EB and repeatedly mated on 




sexual behaviors displayed on test 1 as expected, however on the final test day, significantly 
more sexually appetitive behaviors were observed in the 10µg EB-alone group compared to all 
other groups (Oil/Alone: p<0.01, d=2.44; 2µg EB/Alone: p=0.011, d=1.33; 10µg EB/Male: 
p<0.001, d=1.54). 
 When appetitive behaviors were broken down into its components, an interaction was 
detected on hops/darts, F(3,41)=9.54, p<0.001, η2=0.23. As shown in Figure 2B, hops/darts 
increased across tests in all groups treated repeatedly with EB (2µg EB: p=0.001, d=2.59; 10µg 
EB/Alone: p<0.001, d=1.81; 10µg EB/Male: p<0.001, d=1.41), but did not change in the oil 
controls. No group differences were detected on hops/darts on the first test, however females in 
the 10µg EB/Alone group displayed significantly more hops/darts compared to the Oil/Alone 
(p<0.001, d=1.85), and 10µg EB/Male (p=0.011, d=1.04) groups on the final test day. 
 An increase in solicitations was only detected in the 10µg EB/Alone group (p<0.001, 
d=1.27), and on the final test day they displayed more solicitations than all other groups 
(Oil/Alone: p=0.003, d=1.34; 2µg EB/Male: p=0.005, d=1.28; 10µg EB/Male: p=0.001, d=1.32) 
as shown in Figure 2C (significant interaction, F(3,41)=4.86, p=0.006, η2=0.24). 
 As shown in Figure 2D, the number of defensive behaviors decreased on the final test day 
compared to the first in the 10µg EB/Male group (significant interaction, F(3,41)=6.04, p=0.002, 
η2=0.31). On the final test day, the 2µg EB/Alone group was more defensive towards males than 
the 10µg EB/Male (p=0.003, d=0.76) group. 
Pacing data. As shown in Figure 3A, females in the 10µg EB/Alone group entered the 
male’s compartment more frequently on the final test day compared to the first (p<0.001, 
d=2.67), and on the final test day, entered the male’s compartment more frequently than all other 
groups (Oil/Alone: p<0.001, d=1.82; 2µg EB/Male, p<0.001, d=1.95; 10µg EB/Male: p<0.001, 
d=1.71) (significant interaction, F(3,41)=15.56, p<0.001, η2=0.42). 
As shown in Figure 3B, 10µg EB/Alone females withdrew from the male’s compartment 
more frequently following a mount than the 10µg EB/Male condition (p=0.034, d=1.17), 
F(3,35)=2.91, p=0.048, η2=0.20, and more frequently following an intromission, F(2,24)=8.12, 
p=0.002, η2=0.40, compared to the 2µg EB/Alone (p=0.006, d=2.49) and 10µg EB/Male 
(p=0.023, d=1.49) conditions; since no female in the Oil/Alone condition received an 
intromission, they were excluded from the analysis. Females in the Oil/Alone and 2µg EB/Alone 
groups did not receive ejaculations and as such could not be analyzed, and no differences were  
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Figure 3. Number of entrances (A) on Tests 1 and 8, of females treated with Oil, 2µg or 10µg 
EB and placed in the chamber alone, or treated with 10µg EB and repeatedly mated, on Tests 2-
7. Percent exits (B), exit latencies (C), and contact return latencies (D) following mounts, 
intromissions, and ejaculations on Test 8. * Group differences. aSignificantly greater than Test 1. 





detected between 10µg EB/Alone or 10µg EB/Male females, as both exited 100% of the time 
following an ejaculation (Figure 3B), as expected (Erskine, 1989).  
Figure 3B also shows that females in the 10µg EB/Alone group were less likely to exit 
following a mount, compared to an intromission (p=0.032, d=1.26) or ejaculation (p=0.021, 
d=1.89), F(2,14)=12.00, p=0.001, η2=0.63. And although females in the 10µg EB/Male group 
exited more frequently as the stimulus increased, F(2,6)=11.66, p=0.009, η2=0.80, significance 
was only achieved between mounts and ejaculations (p=0.011, d=5.89).   
The latency to exit following the different stimulations (Figure 3C) was different in the 
10µg EB/Male group only, F(2,28)=6.59, p=0.005, η2=0.32, such that the greater the intensity of 
stimulation, the quicker she withdrew from the male, however the difference was only significant 
between mounts and ejaculations (p=0.030, d=1.10). The one-way ANOVA failed to detect 
group differences in contact return latencies for any group (Figure 3D). 
Male behaviors. The number of mounts received (Figure 4A) increased from the first to 
final test, F(1,41)=9.23, p=0.004, η2=0.16. And a group effect was observed, F(3,41)=5.68, 
p=0.002, η2=0.50, such that the Oil/Alone group received fewer mounts than the 10µg EB/Alone 
group (p=0.008, d=1.63) and tended to receive fewer than the 10µg EB/Male group (p=0.052, 
d=1.34), and the 2µg EB/Alone received fewer mounts than the 10µg EB/Alone group (p=0.042, 
d=1.34). The interaction was not significant. 
 The number of intromissions received (Figure 4B) increased across tests F(1,41)=8.39, 
p=0.006, η2=0.16, and a group effect was found, F(3,41)=3.68, p=0.020, η2=0.79, such that the 
10µg EB/Alone females received more intromissions than Oil/Alone females (p=0.047). The 
interaction was not significant. And no significant effects were detected on ejaculations (for main 
effects and the interaction p>0.05) (Figure 4C).  
  
Discussion 
The main purpose of this study was to examine whether or not copulation with the male 
affects the sensitization of sexual behaviors by repeated administration of EB in the sexually 
experienced OVX rat. Regardless of whether females had access to a sexually vigorous male on 
every test, sensitization occurred in females treated with 10µg EB suggesting that repeated 
administration of 10µg EB is sufficient to induce behavioral sensitization. However, not 
providing access to the male on intermediate tests resulted in a greater sensitization of sexually  
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Figure 4. Mounts, intromissions, and ejaculations that females received from the male on Tests 1 
and 8, when treated with Oil, 2µg or 10µg EB and placed in the chamber alone, or treated with 
10µg EB and repeatedly mated on Tests 2-7. aSignificantly greater than Test 1, *Group 




appetitive behaviors (but not lordosis), suggesting that repeated copulation counters the 
sensitization of sexually appetitive behaviors induced by repeated administration of EB. 
Surprisingly, sensitization of sexually appetitive behaviors also occurred in females treated 
repeatedly with 2µg EB and not given access to a male on intermediate tests, an effect driven by 
hops/darts. This is in stark contrast to females treated with 2µg EB and given access to a male on 
every test (Jones et al., 2013), and shows that a suboptimal dose of EB alone is sufficient to 
sensitize some components of appetitive sexual behaviors in the sexually experienced female rat. 
Moreover, that females treated with oil and not given access to the male on intermediate tests 
(i.e., Oil/Alone) did not display sensitization, suggests that the repeated administration of EB is 
necessary for this behavioral sensitization to occur.  
A secondary goal of this study was to examine whether pacing behavior differed between 
groups. Meerts et al. (2014) have recently shown that the OVX rat primed with EB+P responds 
differently to mating stimuli following sexual experience, such that females return to the male 
quicker following an intromission, and stay away from him longer after ejaculation on the fourth 
30-minute sexual behavior test in the pacing chamber compared to the initial test. Our findings 
extend those data. All the females in our study were sexually experienced in the unilevel four-
hole pacing chamber prior to testing. Contact return latencies were disrupted in both groups 
repeatedly treated with 10µg EB on the final test day, and although the stair-step pattern was 
pictorially (but not statistically) observed in the 10µg EB/Alone group, it was completely 
disrupted in the 10µg EB/Male condition, and in fact their latency to exit following sexual 
stimulation was reversed. Similarly, percent exits were disrupted in the 10µg EB/Male condition. 
This suggests that repeated sexual contact with a male alters normal pacing behavior to a greater 
extent than repeated episodes of heat. This further illustrates plasticity in female sexual behavior, 
and the ability of females to alter their reproductive strategies, an effect that depends on test 
parameters and sexual stimulation received within a test session (see Meerts et al., 2014) as well 
as sexual stimulation received across multiple test sessions. Together with the data presented by 
Meerts et al., (2014), it appears that contact return latencies are sensitive to repeated testing 
conditions. Moreover, exit latencies were particularly sensitive to the disruptions induced by 
repeated testing conditions, further illustrating that exit latencies can provide additional 




Induction of behavioral sensitization by a subthreshold EB dose 
Although the literature has repeatedly reported that 2µg EB does not induce sexual 
behaviors in the OVX Long-Evans female rat without subsequent P priming (Jones et al., 2013; 
Kow & Pfaff, 1975; Micevych et al., 2008; Sinchak & Wagner, 2012), this appears to only be 
true when females are given repeated access to a male. When females were primed with 2µg EB 
and placed in the pacing chamber alone on multiple test days, by the 8th test, appetitive sexual 
behaviors had increased significantly compared to the first test, though the increase was lower 
than that induced by 10µg EB/Alone (but equal to that of 10µg EB/Male). This shows that sexual 
behavior can be expressed with a suboptimal dose of EB given the appropriate context and 
repeated administration. If Long-Evans females are treated with 2µg EB and given repeated 
access to a male, they fail to display sexual behavior (Jones et al., 2013) and typically respond to 
mounts by the display of defensive behaviors. This may condition an aversive state that is 
inhibitory to sexual behavior. In addition, given that sensitization occurs with 5µg EB given in 
combination with repeated copulation (Jones et al., 2013), there must be a threshold EB dose 
required to override that inhibition, which is potentiated in a dose-response manner (since 10µg 
EB led to a greater increase in appetitive behaviors compared to 2µg EB in those females that 
were not given the opportunity to copulate).  
Sexual reward states do not require the presence of ovarian hormones. Oil treated rats 
continue to display a place preference for a context that was previously coupled with sexual 
behavior (Parada et al., 2012). However, the place preference can be partially extinguished by 
placing the fully primed female (EB+P) in the sexual context, in the absence of copulation 
(Parada et al., 2012). Although extinction did not occur if females were treated with EB-alone, it 
is possible that they may require more pairings. Nonetheless, it appears that sexual reward states 
in the absence of both EB+P persist, and would suggest that 2µg EB/Alone females continued to 
associate the pacing chamber with sexual reward (as they were sexually experienced in these 
same chambers), whereas repeatedly placing the sub-primed female in a context where she must 
fight off the male, overrides the excitatory state induced by EB. Whether this increased sexual 
motivation in EB/Alone females is driven by, or potentiated by, repeatedly placing the partially 
EB-primed female in a previously rewarding context cannot be determined by the current study 
but could be easily tested by training females in a different context (e.g., a bilevel chamber). 
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Answering this question could potentially lead to a non-pharmacological animal model of 
hypoactive sexual desire. 
Similarities and contrasts can be made between the potentiation of sexual behaviors 
within a single episode relative to repeated episodes. Similar to the results of Blaustein et al. 
(Blaustein et al., 2009) preventing copulation led to a greater increase in sexually appetitive 
behaviors, suggesting that the mechanisms involved in the potentiation of sexual behaviors 
within a single episode of heat are similar to those across multiple episodes of heat. In contrast, 
whereas Blaustein et al. (2009) found that preventing intromissive stimulation blocked the 
increase in defensive (i.e., rejection) responses observed in copulating animals, we found that for 
females treated with 10µg EB, if they were not given the opportunity to copulate on intermediate 
tests defensive behaviors were unaltered across test days, whereas those that copulated on every 
test were less defensive on the final test. This suggests differential mechanisms between the 
potentiation of sexual behaviors within a single episode, compared to repeated episodes. Changes 
here could occur within midbrain structures given their role in defensive behaviors and anxiety 
(Pfaff et al., 2008). Blaustein et al., suggested a dissociation between the structures involved in 
the display of lordosis and competing behaviors such as aggression, for example, in the 
periaqueductal gray which may permit the expression of lordosis while suppressing defensive 
behaviors (Blaustein et al., 2009; Pfaff et al., 2008). It remains to be tested whether deactivation 
of the periaqueductal gray is involved in the underlying mechanism of behavioral sensitization to 
10µg EB. If such deactivation occurs, it must interact with the amount of stimulation received 
from the male on previous sexual encounters, given that only those females that copulated on 
every test showed the decrease. 
Another brain region that may participate in the sensitization of sexual behaviors by 
repeated EB is the medial preoptic area (mPOA). The mPOA is critical for appetitive 
solicitations (Graham & Pfaus, 2010; 2012; Kato & Sakuma, 2000), and lesions to this area 
reduce solicitations, hops and darts, and ear-wiggling (Guarraci, Megroz, & Clark, 2004; 
Hoshina et al., 1994; Whitney, 1986). In the present study we found that appetitive sexual 
behaviors were increased by repeated administration of EB in the absence of repeated copulation 
on every test (i.e., EB-alone), but this increase was selectively attenuated by repeated copulation. 
The mPOA appears to normally oppose the inhibitory signal that occurs from vaginocervical 
stimulation, (i.e., intromissions, ejaculations), since mPOA lesions increase the contact return 
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latency following intromission or ejaculation (Guarraci et al., 2004; Yang & Clemens, 2000). In 
the current study, contact return latencies were disrupted in all groups suggesting that the mPOA 
may play a role, although it is difficult to interpret the Oil/Alone and 2µg EB/Alone pacing data 
since they received very little stimulation from the male. However, the latency to exit the male’s 
chamber following an ejaculation was significantly shorter than following a mount in females 
treated with 10µg EB that copulated on every test, whereas this difference was not found in 10µg 
EB/Alone females. In addition, the percentage of exits following a mount or intromission was 
increased in the 10µg EB/Alone females compared to those that copulated on every test, 
suggesting a disruption in the ability to discriminate between the different stimulus intensities. 
However, despite an increase in the number of exits following mounts and intromissions, 10µg 
EB/Alone females also entered the male’s compartment more frequently, suggesting an increase 
in sexual motivation. This alteration in pacing behavior coincident with the increase in appetitive 
sexual behaviors (which serve to increase the male’s attention towards the female and stimulate 
the receipt of mounts and intromissions), suggests that estradiol sensitization serves to enhance 
reproductive strategies that may facilitate the induction of pregnancy/pseudopregnancy.  
 
Attenuation of behavioral sensitization by repeated copulation 
Providing the female repeated access to a sexually vigorous male attenuated the 
behavioral sensitization of sexually appetitive behaviors to repeated injections of EB. Although it 
is unclear what induced the attenuation, one likely mechanism is the receipt of VCS. VCS 
received during mating, or experimenter-applied, accelerates the onset of estrous termination 
(Erskine, 1985; 1989; Erskine & Baum, 1982; Hardy & Debold, 1972; Lodder & Zeilmaker, 
1976; Pfaus et al., 2000), characterized by a reduction in appetitive sexual behaviors and 
increased defensive behaviors prior to the decline in lordosis intensity and frequency (Pfaus et al., 
2000). Fos-IR is generally expressed in higher levels in female rats that receive VCS, compared 
to no stimulation or flank stimulation alone (Pfaus, Kleopoulos, Mobbs, Gibbs, & Pfaff, 1993). 
However, steroid hormone priming alters Fos expression in response to VCS differently in 
different estrogen-concentrating brain regions. For example, EB potentiates the ability of VCS to 
induce Fos in the mPOA (Pfaus et al., 1996), whereas it decreases the induction of Fos in the 
ventromedial hypothalamus (VMH) and in particular within glutamate neurons in the 
ventrolateral portion of the VMH (Georgescu et al., 2009; Pfaus et al., 1996). It is known that 
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frequent hormone priming counters the onset of estrous termination; as the interval between 
priming with EB and P prior to manually applied VCS decreases (from 28 to 4 days) the onset of 
estrous termination is delayed (Pfaus et al., 2000). We have shown that behavioral sensitization 
to repeated EB is not only dose-dependent but temporally dependent, as increasing the frequency 
of hormone priming from every 8 days to every 4 days resulted in a more robust sensitization 
(Jones et al., 2013). Together with the decreased sensitivity to VCS, this finding suggests that 
frequent hormone priming prevents the activation of systems that are inhibitory to sexual 
behavior (Jones et al., 2013). As such, the systems activated by steroid hormones appear to act in 
opposition to inhibitory systems activated by VCS (Pfaus, 2009). Perhaps repeated VCS over 
multiple testing sessions progressively summates inhibitory signaling (e.g., by altering glutamate 
receptor densities, or upregulating enzymes involved in glutamate synthesis released into the 
VMH) to counteract the effect of repeated hormone priming. To answer this question it will be 
important to first determine whether different somatosensory information from the male (e.g., 




Frequent hormone priming delays the onset of estrous termination following VCS (Pfaus 
et al., 2000), and increasing the dose and interval of EB administration augments the behavioral 
sensitization to repeated EB (Jones et al., 2013). Here we have shown that repeated episodes of 
heat in the absence of repeated sexual stimulation induces a greater sensitization of sexually 
appetitive behaviors, and altered pacing behaviors, both of which typically serve to enhance 
reproductive success. Together these results extend the idea that a mechanism of EB-induced 
behavioral sensitization may reflect a ‘failsafe’ that increases the likelihood of successful 
copulation (i.e., impregnation) following repeated episodes of heat, given eventual contact with a 
sexually vigorous male.   









CHAPTER 3: ATTENUATION OF ESTRADIOL-SENSITIZATION 
	  
The experiments presented in Chapter 2 established that EB is necessary and sufficient to 
induce behavioral sensitization, but that the sensitization of appetitive aspects of sexual 
behaviors is attenuated by copulation. The goals of the next chapter were to examine behavioral 




Chapter 3 Part 1 
Preface 
 The previous study determined that the repeated administration of EB in the absence of 
the opportunity to copulate facilitated the sensitization of sexual behaviors, whereas giving the 
female access to a sexually vigorous male on every test attenuated the sensitization of appetitive 
sexual behaviors. The goal of the next study was to assess the role of varying types of 
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The acute administration of estradiol benzoate (EB) to the ovariectomized (OVX) rat 
induces low levels of lordosis while sexually appetitive behaviors (e.g., hops, darts, solicitations) 
are absent, yet the repeated administration of EB results in a behavioral sensitization in which 
lordosis is potentiated and sexually appetitive behaviors are induced. We have shown that 
repeated copulation attenuates the sensitization of appetitive sexual behaviors. Here, we assessed 
which component of male stimulation during copulation is involved in the attenuation. On 8 
occasions, sexually experienced OVX Long-Evans rats were treated with 10µg EB and 48h later 
assigned to one of six groups that differed in their experience on intermediates tests (2-7). One 
was given repeated access to a male (EB/Male), and another was placed in the copulation 
chamber alone (EB/Alone) on intermediate tests. Three groups were given one of three 
somatosensory stimuli by the experimenter: manual flank stimulation (FLS), clitoral stimulation 
(CLS), or vaginocervical stimulation (VCS). Finally, the control group was left undisturbed in 
the animal care facility (ACF). Sexual behaviors were measured on Tests 1 and 8. VCS received 
from the experimenter (VCS) or from the male during copulation (EB/Male) attenuated 
appetitive sexual behaviors on test 8 compared to those that were not brought to the testing 
rooms (ACF), and the effect was most pronounced on sexual solicitations. These results suggest 
that VCS received during penile intromission inhibits the sensitization of sexually appetitive 
behaviors by repeated administration of EB. As such, repeated administration of EB may oppose 
neural mechanisms that are inhibitory to sexual behavior (e.g., those that induce estrous 
termination). 
 
Key Words: Estradiol, sexual behavior, vaginocervical stimulation, clitoral stimulation, flank 




Sensitization of sexual behaviors occurs in the ovariectomized (OVX) rat following the 
repeated administration of estradiol alone. The acute administration of 5 or 10µg estradiol 
benzoate (EB), without subsequent progesterone priming, induces low levels of lordosis and very 
few, if any, sexually appetitive behaviors (e.g., hops, darts, ear wiggles, solicitations). However, 
its repeated administration induces a behavioral sensitization, potentiating lordosis and activating 
sexually appetitive behaviors. We have previously shown that the administration of 10µg EB 48 
hours prior to copulation every four days results in a robust sensitization (Jones et al., 2013; 
Jones & Pfaus, 2014), but that the effect on appetitive behaviors is greater when EB is repeatedly 
administered in the absence of copulation (Jones & Pfaus, 2014). Since repeated copulation 
attenuates the sensitization of appetitive behaviors, it is possible that somatosensory stimulation 
received from the male during mating inhibits this sensitization.   
During a typical copulatory bout, which begins with anogenital sniffing from either 
animal, the female will typically entice the male to chase and mount her by displaying partial 
(i.e., hopping and darting) or full solicitations (defined as a headwise orientation toward the male 
followed by a runaway, referred to here as solicitations), which occur in proximity or more distal 
to the male, respectively (McClintock, 1984; Pfaus, 1996). Solicitational behaviors entice the 
male to mount (Erskine, 1989) which result in palpation of the flanks, and when coupled with 
thrusting, stimulates the anogenital region including the clitoris (Pfaff, Montgomery, & Lewis, 
1977; Pfaus et al., 2014). Solicitations also increase the probability of intromission (Erskine, 
1989; McClintock & Adler, 1978), which occurs when the erect penis penetrates the vagina 
during a mount with a single deep thrust (Bermant, 1965), stimulating the external and internal 
vagina and presumably the cervix. Ejaculation occurs following approximately 7-9 intromissions 
and provides strong and sustained stimulation of the vagina and cervix by the deposit of the 
copulatory plug which congeals and protects sperm transport (Toner, Attas, & Adler, 1987). 
Behaviorally the female holds the lordosis posture while the male’s pelvis is maintained in close 
contact with the perineal region (Bermant, 1965). The female will then typically engage in a 
bursting dismount and run away from the male (Pfaus, 1996; Pfaus et al., 2014). A refractory 
period follows, lasting a few minutes, before the female revisits the male and solicits him to 
stimulate mounting and a new bout begins. Thus during copulation, the female receives flank, 
clitoral, and vaginocervical stimulation from the male. 
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Sensory stimulation of the genitals that is received during mating can potentiate or inhibit 
sexual behavior. The pattern of clitoral stimulation (CLS) for example, can facilitate or reduce 
sexually appetitive behaviors, depending on the pattern of stimulation such that solicitations are 
facilitated when an experimenter applies continuous stimulation prior to copulation, and reduced 
when applied in a distributed manner (Cibrian-Llanderal et al., 2010). Similarly, vaginocervical 
stimulation (VCS), induced by penile intromissions, or experimentally applied with a glass rod, 
potentiates sexual behavior at the beginning of a mating session (Bennett et al., 2001; Foreman 
& Moss, 1977; Rajendren et al., 1991; Rajendren & Moss, 1993). However, as the amount of 
VCS increases, sexually appetitive behaviors decline coincident with an increase in defensive 
behaviors in response to mounts, prior to a decline in lordosis frequency and magnitude, as the 
female enters estrous termination (Erskine et al., 1989; Erskine & Baum, 1982; Hardy & Debold, 
1972; Lodder & Zeilmaker, 1976; Pfaus et al., 2000). The receipt of 10-15 VCS accelerates the 
onset of estrous termination (Coopersmith et al., 1996; Hardy & Debold, 1971a; Lodder & 
Zeilmaker, 1976; Pfaus et al., 2000) and pseudopregnancy (Adler, 1969; Erskine et al., 1989; 
Frye & Erskine, 1990; Lehmann & Erskine, 2004). However, frequent hormone priming offsets 
the ability of VCS to induce estrous termination (Pfaus et al., 2000) and reduces the activation of 
glutamatergic signaling in the vlVMH which is associated with inhibition of sexual behavior 
(Georgescu et al., 2009; 2014; Georgescu & Pfaus, 2006a; 2006b; Georgescu, Cyr, & Pfaus, 
2012), suggesting that the mechanisms of repeated hormone administration act in opposition to 
those that are inhibitory to sexual behavior. Given that VCS is a well-known inhibitory stimulus 
to sexual behavior, and that frequent hormone priming offsets that inhibition, we selected a 
stimulation frequency that is known to induce estrous termination and pseudopregnancy 
following VCS. The stimulation pattern was kept constant in all manual stimulation groups. 
Since varying forms of somatosensory stimulation during mating have been shown to 
both facilitate and inhibit sexual behavior, the aim of the current study was to mimic the 
stimulation received from the male by experimentally-applying 15 VCSs, CLSs, or flank 
stimulations (FLSs), to examine whether any of those somatosensory components contribute to 
the attenuation of the sensitization of sexual behavior by repeated administration of EB, as 
occurs with repeated copulation (Jones & Pfaus, 2014). Since we also previously reported that 
repeatedly treating the OVX rat with EB and placing her in the testing chamber alone was more 
effective at inducing sensitization compared to those that copulated (Jones & Pfaus, 2014), we 
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also assessed whether sensitization would occur if females were treated with EB but left in their 
home cages in the animal care facility (ACF). We hypothesized that all groups would display 
estradiol sensitization, and that a lack of somatosensory stimulation (ACF and EB/Alone groups) 
would result in higher levels of sexual behavior, whereas the receipt of VCS from the male 
(EB/Male) or experimenter (VCS) would result in lower levels of sexual behavior on the final 
test day. 
 
Materials and methods  
Animals 
 Two cohorts of 36 Long-Evans females (200-250g) were purchased from Charles River, 
St-Constant, QC, Canada) three months apart, and housed in pairs in clear Plexiglas shoebox 
cages lined with either beta chip or corncob bedding. A group of 36 Long-Evans males (300-
350g) were also purchased from the same supplier, housed in groups of four in clear Plexiglas 
cages lined with Betachip, and used as stimulus males for both cohorts. Prior to the experiment, 
males were given 4 sexual experience sessions in the 4-hole unilevel pacing chamber with 
stimulus OVX females primed with estradiol benzoate and progesterone. Each cohort included 6 
females per group, for a final sample size of 12 females per group (N=72). 
Ovariectomy 
All animals were given one week to acclimate to the ACF. Females were then bilaterally 
ovariectomized (OVX) via a single lumbar incision under a mixture of 4:3 ketamine 
hydrochloride (50mg/mL; Ketaset ©, Wyeth Canada) and xylazine (4mg/mL; Rompum©, Bayer 
Healthcare, Canada), injected IP (1mL/kg). They were then identified by ear punch and given SC 
injections of PenG (0.1mL/rat) and 5 mg/kg/mL Enrofloxacin (Baytril ©) and rehydrated with 
2mL of saline. They were given one-week post-operative recovery, as in Jones et al., (2013) 
prior to sexual training. 
Hormone preparation  
 Estradiol benzoate (EB; 10µg) and progesterone (P; 500µg) were dissolved in 0.1mL 
reagent grade sesame oil administered SC, 48 hours and 4 hours prior to testing respectively. 




All behavioral training and tests occurred in the unilevel 4-hole pacing chamber, lined 
with beta chip below a metal grid floor elevated approximately 2.54 cm. Both the grid and the 4-
hole partition were removed for groups receiving manual stimulation to prevent females escaping 
the experimenter’s grasp. All tests occured in chambers where animals had previously copulated.  
Training and testing procedures 
All training and tests occurred during the middle third of the dark cycle. Females were 
injected with EB and P prior to each of four sexual training sessions occurring at 4-day intervals 
and given a 2-week hormone washout. Females were then treated with EB alone, at 4-day 
intervals for the remainder of the experiment. For each copulatory session, the male was placed 
on the right hand side of the chamber, and allowed a 5-minute acclimation period prior to 
introduction of the female. The animals were then left undisturbed for 30 minutes. All copulatory 
tests were recorded using a Sony Handycam digital camera and scored using the Behavioral 
Observation Program (Cabilio, 1996).  
All animals copulated on Tests 1 and 8, and groups of animals received one of six 
experimental manipulations on tests 2 through 7: one group copulated with a sexual experienced 
Long-Evans male in a 4-hole pacing chamber on all tests (EB+Male), a second was placed in the 
4-hole pacing chamber alone (EB-Alone), and a third group was left in their home cage in the 
ACF. The three remaining groups received experimenter-applied vaginocervical (VCS), clitoral 
(CLS), or flank (FLS) stimulation as described in detail below. For these groups, the female was 
first placed in a testing chamber alone, and a 30-minute timer was set. After one minute had 
lapsed, the first stimulation (described below) was given, and each subsequent stimulation was 
applied every 2 minutes thereafter, for a total of 15 stimulations over 30 minutes. Following the 
final stimulation, animals were left in the chamber until the 30 mins had elapsed (i.e., <1min) 
before returning them to their home cage.  
The amount of experimenter-applied stimulation was chosen based on work showing that 
10-15 vaginocervical stimulations (VCS) induce estrous termination and pseudopregnancy in a 
non-paced mating setting (Adler, 1969; Erskine et al., 1989; Frye & Erskine, 1990; Lehmann & 
Erskine, 2004), whereas 15 paced intromissions or manually applied VCS induce conditioned 
place preference (Meerts & Clark, 2009a; Paredes & Vazquez, 1999). The experimenter applied 
artificial VCS using a glass rod with round polished ends lubricated with K-Y® jelly. Females 
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were lifted by the tail taking care not to stimulate the flanks, and the rod was quickly inserted 
into the anterior vaginal opening three times at approximately half-second intervals without 
touching the cervix, followed by a fourth insertion that put pressure against the cervix, held for 
about two seconds and removed similar to our previous studies (Pfaus et al., 1993; 1996). Those 
receiving FLS were gently held by the base of the tail and manually palpated three times at 
approximately half-second intervals followed by a fourth grasp of the flanks lasting 
approximately two seconds. Finally, clitoral stimulation (CLS) was administered with a number 
4 paintbrush lubricated with K-Y® Jelly (as in Parada, Chamas, Censi, Coria-Avila, & Pfaus, 
2010). CLS was administered by lifting the tail, taking care not to stimulate the flanks, and three 
quick strokes of the paintbrush were applied to the clitoris at approximately half-second intervals, 
followed by a final longer stroke lasting about two seconds that aimed to maximally stimulate 
the clitoris from the most anterior portion to the most posterior portion of the external structure. 
Behavioral measures  
Lordosis magnitude (LM) was measured on a 3-point scale (Hardy & Debold, 1972), and 
the lordosis quotient (LQ) was measured by taking the ratio of the total number of lordosis 
postures to the total number of mounts (mounts + intromissions + ejaculations) multiplied by 100.  
Partial (i.e., hops/darts) and full solicitations (headwise orientation made towards the male 
followed by a runaway) (Gelez et al., 2013; McClintock, 1984) were analyzed separately, as well 
as combined into a general measure of sexually appetitive behaviors. Kicks, sideways takedowns, 
boxing postures, and prone positions made by the female were coded as defensive behaviors 
(Barnett, 1963). Mounts, intromissions, and ejaculations by the male were also analyzed.  
Statistical analyses 
To assess whether each group displayed behavioral sensitization to EB, separate repeated 
measures ANOVAs were used to assess whether the frequency of sexual behaviors increased 
from the first to the final test in each group. Planned comparisons were then used, based on a 
priori hypotheses, to examine whether females injected with EB but not given any type of 
somatosensory stimulation on intermediate tests (ACF and EB/Alone) were different from all 
other stimulus groups on the final test day. Additional analyses using difference scores on each 
behavior (frequency on Test 8 – frequency on Test 1), which take into account the animal’s 
baseline level of responding, were also used to examine group differences in estradiol 
sensitization. Despite expected directional effects, two-tailed tests were used. All levels of 
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significance were set at p<0.05. Eta squared (η2) and Cohen’s d are reported as measures of 
effect size.  
 
Results 
 Two females (one from each of the FLS and EB/Alone groups) displayed abnormally 
high LQ and the combined measure of appetitive behaviors (Z scores > 2.96 on both measures) 
on test 1, suggesting heightened sensitivity to EB, and were therefore excluded from all 
statistical analyses. 
 Lordosis. As expected, LQ sensitized across tests in all groups as shown in Figure 1A 
(ACF, F(1,10)=22.69, p=0.001, η2=0.69; EB/Alone, F(1,9)=18.27, p=0.002, η2=0.67; EB/Male, 
F(1,10)=26.03, p<0.001, η2=0.72; FLS, F(1,7)=21.85, p=0.002, η2=0.76; CLS, F(1,11)=51.12, 
p<0.001, η2=0.82; VCS, F(1,10)=21.24, p=0.001, η2=0.68). No group differences were detected. 
 LM1 (Figure 1B) increased across tests in the ACF, and FLS groups only (ACF: 
F(1,11)=5.81, p=0.035, η2=0.35; FLS: F(1,10)=5.86, p=0.036, η2=0.37), although a trend was 
detected in females that received VCS from the experimenter, F(1,11)=4.18, p=0.066, η2=0.28. 
All groups displayed more LM2 (Figure 1C) and LM3 (Figure 1D) on the final test compared to 
the first (LM2, ACF: F(1,11)=18.78, p=0.001, η2=0.63; EB/Alone: F(1,10)=7.56, p=0.020, 
η2=0.43; EB/Male: F(1,11)=9.23, p=0.011, η2=0.46; FLS: F(1,10)=14.23, p=0.004, η2=0.59; 
CLS: F(1,11)= 11.26, p=0.006, η2=0.51; VCS: F(1,11)= 10.00, p=0.009, η2=0.48), (LM3, ACF: 
F(1,11)=9.55, p=0.010, η2=0.46; EB/Alone: F(1,10)=13.04, p=0.005, η2=0.57; EB/Male: 
F(1,11)=6.22, p=0.030, η2=0.36; FLS: F(1,10)= 9.93, p=0.010, η2=0.50; CLS: F(1,11)= 9.60, 
p=0.010, η2=0.47; VCS: F(1,11)=6.11, p=0.031, η2=0.36). No group differences were found.  
 Appetitive behaviors. As expected appetitive behaviors sensitized across tests in all 
groups as shown in Figure 2A (ACF: F(1,11)=66.95, p<0.001, η2=0.86; EB/Alone: 
F(1,10)=14.25, p=0.004, η2=0.59; EB/Male: F(1,11)=7.72, p=0.018, η2=0.41; FLS: 
F(1,10)=28.59, p<0.001, η2=0.74; CLS: F(1,11)=22.67, p<0.001, η2=0.67; VCS: F(1,11)=8.92, 
p=0.012, η2=0.45). However females that received VCS from the male (EB/Male, p=0.010, 
d=1.15) or experimenter (VCS, p=0.031, d=0.94) displayed fewer appetitive behaviors compared 




Figure 1. Lordosis measures of OVX rats on the first and final test days following repeated 
treatment of EB 48 hours prior to each of eight tests. On tests 2-7 females were left in the animal 
care facility (ACF), placed in the 4-hole pacing chamber with a sexually vigorous male 
(EB/Male) or alone (EB/Alone), or received 15 manual flank (FLS), clitoral (CLS), or 
vaginocervical (VCS) stimulations by the experimenter. Sensitization occured on LQ (panel A) 
and the two higher magnitudes of LM (LM2 and LM3, panels C and D respectively), whereas 
only ACF and FLS females displayed more LM1 (panel B) on the final test compared to the first. 
No groups differences in sensitization were found on the final test day. a Greater than test 1. b 





Figure 2. Appetitive sexual behaviors (hops/darts and solicitation) and defensive behaviors of 
OVX rats on the first and final test days following repeated treatment of EB 48 hours prior to 
each of eight tests. On tests 2-7 females were left in the animal care facility (ACF), placed in the 
4-hole pacing chamber with a sexually vigorous male (EB/Male) or alone (EB/Alone), or 
received 15 manual flank (FLS), clitoral (CLS), or vaginocervical (VCS) stimulations by the 
experimenter. Although the combined measure of appetitive behaviors (panel A) suggests that 
sensitization occured (panel A) the effect was driven by hops/darts (panel B) since all groups 
sensitized; however solicitations (panel C) failed to sensitize if females were given VCS from the 
male (EB/Male) or experimenter (VCS). Moreover, on the final test day, females that copulated 
on every test (EB/Male) displayed fewer solicitations than those left in the ACF. Although 
defensive behaviors did not change across tests (panel D), those left in the ACF were more 
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defensive than those that copulated on every test (EB/Male). a Greater than test 1. b Different 
from ACF on the final test day. 




also occurred when difference scores were analyzed, (ACF vs EB/Male, p=0.018, d=1.04; ACF 
vs VCS, p=0.036, d=0.91). Although more appetitive behaviors were observed in the EB/Alone 
group compared to VCS (p=0.628, d=0.20) and EB/Male (p=0.446, d=0.32) on the final test day, 
the difference did not meet statistical significance and the effect sizes were small. A similar 
pattern also occurred with the difference scores (EB/alone vs VCS, p=0.657, d=0.18; EB/alone 
vs EB/Male, p=0.498, d=0.29). 
Breaking appetitive behaviors down into its components revealed that hops/darts 
sensitized in all groups as displayed in Figure 2B (ACF: F(1,11)=35.61, p<0.001, η2=0.76; 
EB/Alone: F(1,10)=10.69, p=0.008, η2=0.52; EB/Male: F(1,11)=7.55, p=0.019, η2=0.41; FLS: 
F(1,10)=27.81, p<0.001, η2=0.74; CLS: F(1,11)=14.27, p=0.003, η2=0.56; VCS: F(1,11)=9.18, 
p=0.011, η2=0.45), all of which were strong effects. Animals that were left in the ACF tended to 
display more hops/darts on the final test than those that received manual VCS (p=0.069, d=0.78), 
or VCS from the male (EB/Male, p=0.064, d=0.80), with correspondingly large effect sizes. This 
pattern was retained when difference scores were analyzed, (ACF vs VCS, p=0.076, d=0.91; 
ACF vs EB/Male, p=0.085, d=1.04). Solicitations (Figure 2C) also sensitized in all groups (ACF: 
F(1,11)=18.34, p=0.001, η2=0.62; EB/Alone: F(1,10)=5.07, p=0.048, η2=0.34; FLS: 
F(1,10)=16.88, p<0.002, η2=0.63; CLS: F(1,11)=26.07, p<0.001, η2=0.71), except those females 
that received VCS either from the male (EB/Male: F(1,11)=3.15, p=0.103, η2=0.22), or 
experimenter (VCS: F(1,11)=3.14, p=0.104, η2=0.22), and significantly more solicitations were 
displayed by ACF compared to EB/Male (p=0.004, d=1.32) on the final test day, and this effect 
was retained when difference scores were analyzed, (p=0.007, d=1.21).  
 Defensive behaviors. Defensive behaviors, shown in Figure 2D, did not change across 
tests in any of the groups, (ACF: F(1,11)=0.03, p=0.874, η2=0.02; EB/Alone: F(1,10)=9.18, 
p=0.683, η2=0.02; FLS: F(1,10)=2.42, p<0.151, η2=0.20; CLS: F(1,11)=1.33, p=0.273, η2=0.11; 
VCS: F(1,11)=0.53, p=0.483, η2=0.05), although females that copulated on every test tended to 
display fewer defensive behaviors on the final test day compared to the first (EB/Male: 
F(1,11)=4.43, p=0.059, η2=0.29). On the final test day, ACF females displayed more defensive 
behaviors than EB/Male (p=0.001, d=1.58), yet when difference scores were analyzed, this effect 
was no longer found, (p=0.314, d=0.42), suggesting that the group differences found on Test 8 
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were an artifact of higher defensive behaviors overall in the ACF group regardless of the 
experimental manipulation. No other group differences were detected. 
 Male behaviors. The number of mounts (Figure 3A) received were higher on test 8 
compared to the first test in females that were left in the ACF on tests 2-7 F(1,11)=6.34, p=0.029, 
η2=0.37, and tended to be higher on test 8 in females that received FLS, F(1,10)=3.86, p=0.078, 
η2=0.28. On test 8, ACF animals received more mounts than EB/Male (p=0.019, d=1.04), and 
CLS (p=0.002, d=1.42), yet these differences were attenuated when difference scores were 
analyzed (ACF vs EB/Male, p=0.361, d=0.38; ACF vs CLS, p=0.081, d=0.75. No other group 
differences were detected. 
 Females in all groups received more intromissions on the final test day compared to the 
first, as shown in Figure 3B (ACF: F(1,11)=23.52, p=0.001, η2=0.68; EB/Alone: F(1,10)=8.65, 
p=0.015, η2=0.46); EB/Male: F(1,11)=7.08, p=0.022, η2=0.39; FLS: F(1,10)=36.54, p<0.001, 
η2=0.78; CLS: F(1,11)=20.62, p=0.001, η2=0.65; VCS: F(1,11)=8.21, p=0.015, η2=0.43). No 
group differences were detected in the number of intromissions received on Test 8. However, the 
analyses on difference scores suggest that EB/Alone females tended to receive fewer 
intromissions compared to those that received FLS, p=0.054, d=0.87 
 As shown in Figure 3D, the number of ejaculations received was higher in all groups on 
the final test day compared to the first (ACF: F(1,11)=10.16, p=0.009, η2=0.48; EB/Male: 
F(1,11)=6.71, p=0.025, η2=0.38), FLS: F(1,10)=5.99, p=0.034, η2=0.38; CLS: F(1,11)=20.12, 
p=0.001, η2=0.65; F(1,11)=6.06, p=0.032, η2=0.36) except for the EB/Alone group, 
F(1,10)=3.20, p=0.106, η2=0.24. On the final test day, FLS (p=0.035, d=0.96) and CLS (p=0.030, 
d=0.97) received more ejaculations than EB/Alone, yet the statistically significant effect was 
only maintained between EB/Alone and CLS (p=0.019, d=1.06) when differences scores were 
analyzed (EB/Alone vs FLS, p=0.134, d=0.67). No other group differences were found. 
 
Discussion 
 This study shows that repeated administration of 10µg EB every four days to OVX rats 
without any other manipulation (ACF) induces a robust sensitization of both appetitive and 
consummatory measures of sexual behaviors, and that repeated VCS received from the male 
(EB/Male) or experimenter (VCS) attenuates the sensitization of sexually appetitive behaviors. 
The effect was most robust on full solicitations, since this behavior did not sensitize if females  
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Figure 3. Receipt of mounts (panel A), intromissions (panel B), or ejaculations (panel C) of 
OVX rats on the first and final test days following repeated treatment of EB 48 hours prior to 
each of eight tests. On tests 2-7 females were left in the animal care facility (ACF), placed in the 
4-hole pacing chamber with a sexually vigorous male (EB/Male) or alone (EB/Alone), or 
received 15 manual flank (FLS), clitoral (CLS), or vaginocervical (VCS) stimulations by the 





received VCS (from the male or experimenter), and females that copulated with a male on every 
test (EB/Male) displayed significantly fewer solicitations than those that received no 
manipulation (ACF) on the final test day. Together these findings suggest that the systems 
activated by VCS act in opposition to those that induce sensitization of sexually appetitive 
behaviors by EB.    
Sexually appetitive behaviors sensitized when females were repeatedly treated with EB, 
yet repeated VCS attenuated the effect. Moreover, when the two subcomponents were analyzed 
separately, it became apparent that active solicitations did not sensitize in females that received 
VCS (from the male or experimenter). This is important since active solicitations are commonly 
interpreted as indicative of a female displaying higher levels of sexual motivation (McClintock 
& Adler, 1978; Pfaus et al., 1999). VCS also accelerates the onset of estrous termination, which 
is characterized by a reduction in the number of sexually appetitive behaviors and an increase in 
antagonistic behaviors, before a decline in the quality and frequency of lordosis. Although 
female rats tend to show high levels of sexual solicitations in the bi-level chamber (Pfaus et al., 
1999), Pfaus et al., (2000) reported observing few solicitations using a paradigm to examine 
estrous termination following experimenter applied VCS, suggesting that sexual solicitations 
decline prior to the decrease in other sexually appetitive behaviors such as hop/darts. This is 
consistent with the idea that full solicitations (i.e., those involving a runaway component) are 
indicative of greater sexual motivation, as not only are they more readily observed in the fully 
primed (EB+P) female (Pfaus et al., 1999), they are also first to be inhibited during estrous 
termination (just as other appetitive measures are inhibited prior to the decline in lordosis). In the 
current study, females that received VCS from the male on every test (EB/Male) displayed fewer 
sexual solicitations compared to those left in the ACF, likewise, hops/darts were dampened in 
those that copulated (EB/Male) or received manual VCS. This suggests that mechanisms that 
mediate estrous termination may be involved in the attenuation of sensitized sexual behaviors by 
repeated administration of EB.  
Somatosensory stimulation received during copulation alters the expression of female 
sexual behavior within a test session. This is true for VCS and CLS, and both stimulations have 
the ability to induce sexual reward and alter reproductive measures. Artificial VCS applied by 
the experimenter, even in OVX rats that are not hormone primed, can induce lordosis, and this 
effect is potentiated if females are pretreated with estradiol (Komisaruk & Diakow, 1973). Early 
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in a copulatory session VCS can facilitate the expression of sexual behavior, and a minimum of 
six intromissions increases the probability of impregnation following ejaculation (Adler, 1969). 
On the other hand, the receipt of 10-15 VCS is inhibitory to sexual behavior as it accelerates the 
onset of estrous termination and pseudopregnancy (Adler, 1969; Erskine et al., 1989; Frye & 
Erskine, 1990; Lehmann & Erskine, 2004), yet produces a conditioned place preference when 
received either by male intromissions or when artificially applied by the experimenter (Arzate et 
al., 2011; Meerts & Clark, 2009a; Paredes & Vazquez, 1999). Similarly, CLS given just prior to 
a sexual behavior test can either facilitate sexual solicitations when applied continuously 
(defined as one stimulation every second for a minute, with 1-2 min intervals for five rounds) or 
inhibit their expression when applied in a distributed manner (defined as one stimulation every 
five seconds for a minute, with 1-2 min intervals for five rounds) (Cibrian-Llanderal et al., 2010). 
Distributed CLS also increases the probability of impregnation (Cibrian-Llanderal et al., 2010) 
and induces conditioned place (Parada et al., 2010) and partner preferences (Parada et al., 2011), 
supporting the idea that certain patterns of sexual stimulation that are inhibitory to sexual 
behavior can not only be rewarding, but also increase reproductive success. The data presented 
here show that sexual stimulation received on prior episodes of heat also have the ability to alter 
subsequent sexual behavior patterns, but whether they translate into changes in reproductive 
success is not currently known. 
Although repeated stimulation of the clitoris or flanks on intermediate tests did not 
significantly alter behavioral sensitization of appetitive and consummatory measures of sexual 
behavior compared to other groups, this does not rule out any role of these stimulations in the 
sensitization. Here we applied the same stimulation parameters (i.e., 15 stimulations over a 30 
minute period) to all conditions based on the large body of work on the neuroendocrine and 
behavioral effects of VCS, and its role in sexual inhibition. However since the pattern of CLS 
can either facilitate or inhibit the expression of sexual solicitations depending on the pattern in 
which it is applied (Cibrian-Llanderal et al., 2010), if a different pattern of stimulations had been 
given we may have seen further facilitation or an attenuation. In fact, the FLS and CLS 
manipulations may have had some facilitatory effects given that those females received more 
intromissions (FLS females) and ejaculations (particularly those that received CLS) compared to 
EB/Alone. Our CLS manipulation more closely resembled a pattern of distributed stimulation, 
since the stimulations were applied every two minutes.   
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The strong sensitization that occurred in females that were left in the ACF on 
intermediate tests further demonstrates the robustness of the ability of EB to sensitize sexual 
behavior in the Long-Evans rat, beyond any role of associative learning as we have previously 
proposed (Jones et al., 2013). Importantly, the animals in our ACF are housed in same-sex 
groups, but male and females co-exist in the housing rooms. Thus, we cannot rule out a role of 
auditory or olfactory stimulation in the sensitization. For example auditory stimulation can 
enhance sexual responding (e.g., McGinnis & Vakulenko, 2003; Thomas, Howard, & Barfield, 
1982), and olfactory cues from male rats can increase sexually appetitive behaviors in females 
(Afonso, Woehrling, & Pfaus, 2006). Moreover, we have recently found that the inhibitory 
effects of corncob bedding on female sexual behavior (Markaverich, Alejandro, et al., 2002a; 
Markaverich et al., 2007a; Markaverich, Mani, et al., 2002b) are overcome by housing females 
and males in the same room suggesting that constant exposure to male cues can overcome that 
inhibition (Jones, S.L., Antonie, R., Pfaus, J.G., submitted).  However, the strongest group 
differences between animals that received VCS and the non-stimulated groups (ACF and 
EB/Alone) occurred with ACF animals. This suggests that at least some level of sexual inhibition 
may have occurred by bringing EB/Alone females to the testing rooms, and placing them in the 
pacing chambers alone, where they presumably were exposed to higher levels of auditory and 
olfactory (and visual) sexual stimulation than ACF animals. Hormonally priming the females and 
placing them in a context where they previously experienced sexual reward, and therefore expect 
to copulate, may be somewhat aversive, particularly when they are hormone primed. In fact, the 
application of CLS to hormonally primed females (with EB+P) in the presence of an inaccessible 
almond scented male not only prevents conditioned partner preference to a male bearing the 
almond odor, it actually produces a partner preference for the male not bearing the odor (Parada 
et al., 2011). Moreover, conditioned placed preference is rapidly extinguished if hormone-primed 
females are repeatedly placed in a previously sexually-rewarding context in the absence of the 
opportunity to copulate, whereas this extinction does not occur in oil-treated controls (Parada et 
al., 2012). Thus, if olfactory and auditory (and potentially visual) signals from sexually vigorous 
males residing in the same housing rooms as the females contribute to the sensitization, they may 
interact with the context in which those signals occur. 
Frequent hormone administration potentiates sexual excitation and reduces the ability of 
VCS to inhibit sexual behavior. Increasing the EB dose and decreasing the dosing interval, 
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enhances the sensitivity of the OVX rat to the activational effects of EB (in the absence of 
subsequent P priming) on sexual behaviors (Jones et al., 2013). Moreover, although VCS 
accelerates the onset of estrous termination, as the frequency of hormone priming with EB+P in 
the OVX rat is increased from 28 to 14 to every four days, the onset of estrous termination 
following VCS is delayed (Pfaus et al., 2000). We have shown that although repeated 
administration of EB alone sensitizes sexual behaviors, the sensitization of appetitive measures 
of sexual behavior are attenuated in those that are given the opportunity to copulate (Jones & 
Pfaus, 2014), or given manual VCS 48 hours following each injection (the current study). 
Together those data set up the hypothesis that repeated episodes of heat in the absence of VCS 
potentiates the display of sexual behaviors when the female eventually gains access to a male, 
and that the increase in full sexual solicitations may serve as a mechanism to increase the 
probability of the receipt of VCS (Erskine, 1989; McClintock & Adler, 1978). They also suggest 
that inhibitory systems that are activated by VCS act in opposition to those that are involved in 
the sensitization of sexual behaviors by EB. If that is true, then manipulations that induce 
behavioral patterns reminiscent of estrous termination should mimic the attenuation of EB 
induced sensitization by VCS. 
 Part of the mechanism of estrous termination lies within the ventromedial hypothalamus 
(VMH), a region that is critical for the display of lordosis and involved in the induction of 
sexually appetitive behaviors (Pfaff, 1968; 1980). This region contains a high density of estrogen 
receptors (Pfaff, 1968), and crystalline estradiol applied to the ventrolateral division of the VMH 
(vlVMH) activates lordosis (R. J. Barfield & CHEN, 1977). VCS accelerates the onset of estrous 
termination, and induces Fos-immunoreactivity (a marker of neuronal activation) in 
glutamatergic neurons within the vlVMH (Georgescu et al., 2009). In fact, whereas infusions of 
glutamate or its selective ionotrophic receptor agonists to this region inhibit female sexual 
behavior in a behavioral pattern that is reminiscent of estrous termination (Georgescu & Pfaus, 
2006b), sexual behavior is activated following infusions of GABA or glutamate antagonists to 
the vlVMH (McCarthy et al., 1990), suggesting that glutamate signaling in the vlVMH must be 
inhibited for sexual behavior to occur. Moreover, antagonizing the AMPA/kainate receptor 
subtype blocks the ability of VCS to induce estrous termination (Georgescu et al., 2012). 
Experimenter applied VCS induces Fos in the vlVMH to a greater extent in OVX rats that are 
not given hormone replacement compared to those treated with EB+P, and the activation occurs 
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in a threshold pattern, with one increase occurring between 1-20 stimulations and a second 
occurring between 30-50 (Pfaus et al., 1996). This pattern is interesting given that 15 VCS 
induce pseudopregnancy and generate a conditioned place preference (Adler, 1969; Arzate et al., 
2011; Erskine et al., 1989; Frye & Erskine, 1990; Lehmann & Erskine, 2004; Meerts & Clark, 
2009a; Paredes & Vazquez, 1999), as well as increases the probability of impregnation in ovary-
intact females following an ejaculation (Adler, 1969), suggesting that as the amount of VCS 
increases, systems that are inhibitory to sexual behavior are increasingly potentiated. However, 
hormone priming opposes this inhibition, as it reduces the activation of glutamatergic neurons by 
VCS (Georgescu et al., 2009), and attenuates the release of glutamate in the VMH compared to 
oil treated controls when presented with a sexually vigorous male (Georgescu et al., 2014).  
Together those data illustrate that in the VMH, GABA-ergic signaling activates, whereas 
glutamate transmission inhibits sexual behavior, and that hormone priming appears to disrupt the 
ability of VCS to activate glutamatergic systems in the vlVMH that are inhibitory to sexual 
behavior. Since in the current study we found that VCS attenuated the sensitization of sexually 
appetitive behaviors, it is possible that glutamate transmission within the vlVMH (possibly 
acting primarily on the AMPA/kainate receptor subtype) is repeatedly activated by VCS in those 
females, disrupting the ability of EB to further potentiate appetitive sexual behaviors and this 
inhibition may be additive with each test. If this is true, then increasing the amount of VCS 
received (e.g., by allowing a longer test period, or experimentally applying more VCS), or 
extending the number of intermediate tests would likely lead to an increase in antagonistic 
behaviors and the inhibition of lordosis (reminiscent of the behavioral pattern of estrous 
termination). Similarly, we would predict that females that copulate on every test (EB/Male) 
would enter estrous termination quicker than those that are not given the opportunity to copulate 
(EB/Alone or ACF), which would suggest that part of the mechanism underlying the 
sensitization of sexual behaviors by EB involves an increase in GABA-ergic, and/or an 
attenuation of glutamatergic signaling within the vlVMH, but that repeated VCS opposes those 
effects. 
 The vlVMH contains a large number of GABAergic afferent fibers from the medial 
preoptic area (mPOA) (Georgescu, Graham, & Pfaus, in preparation), and estradiol 
administration upregulates GABA-A receptors on glutamate neurons within the VMH 
(Georgescu, Del Corpo, & Pfaus, in preparation), and increases GAD-65 mRNA (an enzyme 
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involved in the synthesis of GABA from glutamate) in the mPOA (McCarthy et al., 1995). 
Whereas the vlVMH is critical for the display lordosis, it is generally believed that the mPOA is 
inhibitory to lordosis yet facilitatory to sexually appetitive behaviors and pacing (Guarraci et al., 
2004; Hoshina et al., 1994; Pfaus et al., 1996; Whitney, 1986). Estradiol increases the synthesis 
of progesterone receptors within the vlVMH and mPOA (MacLusky & McEwen, 1978; Mani, 
Blaustein, Allen, Law, O’Malley, & Clark, 1994) and subsequent P priming reliably reinstates 
lordosis and sexually appetitive behaviors following an acute injection of EB (Etgen & Barfield, 
1986; Mani, Blaustein, Allen, Law, O’Malley, & Clark, 1994; Rubin & Barfield, 1983). The 
selective destruction of cell bodies (sparing fibers of passage) within the mPOA by excitotoxic 
lesions facilitates lordosis and antagonistic behaviors, but impairs sexually appetitive and pacing 
behaviors (Hoshina et al., 1994), which supports the notion that the mPOA contains systems that 
are inhibitory to lordosis yet facilitative to sexually appetitive behaviors. Those data suggest that 
the induction of sexual behavior by estradiol acting within the VMH occurs via a process of 
disinhibition, whereby GABA transmission (possibly coming from the mPOA) on glutamatergic 
cells is increased, leading to an inhibition of glutamate release whose normal function is to 
inhibit sexual behavior. As such, it is possible that repeated administration of EB sensitizes this 
disinhibitory process.  
 In summary, the repeated administration of EB in the absence of any other manipulation 
leads to a sensitization of sexual behaviors in the OVX rat, and repeated VCS attenuates the 
sensitization of appetitive sexual behaviors. Since VCS accelerates the onset of estrous 
termination, we suggest that an increase in GABA signaling and/or a decrease in glutamatergic 
signaling within the vlVMH may be potential mechanisms involved in the sensitization of sexual 







In Chapter 3 Part 1 it was found that VCS inhibited the sensitization of sexual behaviors 
by repeated administration of EB. It is well recognized that VCS is inhibitory in at least one 
other situation, estrous termination. AMPA receptor activation within the vlVMH is believed to 
play a role in the induction of estrous termination. Thus, Experiment 1 assessed the role of 
AMPA receptor activation in estradiol sensitization. Experiment 2 examined whether the pattern 
of estrous termination differed between females that copulated on every test and those that did 
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Repeated administration of 10µg of estradiol benzoate (EB) every 4 days to the ovariectomized 
(OVX) rat induces a behavioral sensitization of sexual behaviors. Repeated copulation or the 
receipt of vaginocervical stimulation (VCS) attenuates the sensitization of appetitive sexual 
behaviors, suggesting that VCS acts in opposition to the mechanisms that induce the sensitization. 
Since it is known that VCS accelerates the onset of estrous termination (characterized by a 
decrease in appetitive sexual behaviors, and an increase in defensive behaviors prior to the 
decline in lordosis), and glutamate transmission in the ventromedial hypothalamus (VMH) is an 
important regulator of this effect, the current studies examined whether mechanisms of estrous 
termination are involved in the attenuation of sensitization to EB. In the first study, OVX rats 
received infusions of AMPA to the VMH on Tests 2-4, and sexual behavior was measured on 
Tests 1 and 5. Appetitive sexual behaviors were lower in females that received AMPA infusions 
in place of copulation compared to saline, suggesting that AMPA receptor activation by VCS 
may be playing a role in the attenuation of sensitization. In the second study, females that were 
not given the opportunity to copulate on tests 2-4 fell out of behavioral estrus faster than those 
that did, suggesting that both excitatory and inhibitory mechanisms of sexual behavior become 
sensitized with repeated administration of EB.  Together these findings extend our hypothesis 
that repeated episodes of heat sensitize the activation of sexual behaviors to increase the 
probability of eventual fertilization. 
 
Keywords: Estradiol sensitization, sexual behavior, estrous termination, vaginocervical 
stimulation, ventromedial hypothalamus, AMPA 




 The acute administration of estradiol benzoate (EB) to the ovariectomized (OVX) rat 
induces a low frequency of lordosis in response to mounts from a male, and very few sexually 
appetitive behaviors such as hops, darts, solicitations, and ear wiggles. Sexually appetitive 
behaviors are reliably and maximally induced, and lordosis is potentiated, four hours following 
an acute injection of progesterone (P) administered 36 to 48 hours following the EB injection 
(Boling & Blandau, 1939). However, chronic administration of 5µg or 10µg EB alone every four 
days results in a behavioral sensitization such that following the fourth injection, lordosis is 
maximally induced and sexually appetitive behaviors occur more frequently compared to the 
initial injection and reach a plateau (Jones et al., 2013).  This behavioral sensitization occurs 
independently of adrenal P (Jones et al., 2013). Interestingly, sensitization of appetitive 
behaviors is attenuated if females receive vaginocervical stimulation (VCS) during each episode 
of heat (either from penile intromission or experimenter-applied; Jones, S.L., Germé, K., Roy, P., 
et al., submitted). VCS has also been shown to accelerate the onset of estrous termination, which 
is characterized by a decrease in sexually appetitive behaviors and an increase in defensive 
behaviors before a decline in lordosis frequency and magnitude is observed (Pfaus et al., 2000). 
Thus, here we investigated whether a mechanism underlying estrous termination might be 
involved in the attenuation of sensitized sexually appetitive behaviors by repeated copulation.  
 Glutamatergic signaling in the ventrolateral portion of the ventromedial hypothalamus 
(vlVMH) inhibits sexual behavior yet the inhibition is delayed or reduced if females are primed 
with EB. Presenting the OVX rat with a sexually vigorous male induces glutamate release into 
the vlVMH, and the release is attenuated by prior treatment with EB (Georgescu et al., 2014).  
Moreover, sexual behavior is facilitated in OVX EB-primed rats by infusions of GABA-a 
agonists (Mccarthy, 1995; McCarthy et al., 1990), or glutamate receptor antagonists (Georgescu 
& Pfaus, 2006a) into the vlVMH whereas infusions of glutamate or its ionotropic receptor 
agonists rapidly inhibit lordosis (Georgescu & Pfaus, 2006b; Kow et al., 1985; McCarthy et al., 
1991) and hops and darts, while activating defensive behaviors (Georgescu & Pfaus, 2006b), 
similar to the behavioral pattern characteristic of estrous termination. Importantly, that 
endogenous glutamate within the VMH is inhibitory to lordosis and is under the control of 
GABA and steroid hormones has also been supported electrophysiologically in tissue slices 
examined across the natural estrous cycle (Booth et al., 2010). The onset of estrous termination is 
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accelerated by the receipt of VCS from penile intromissions or experimenter applied with a glass 
rod (e.g., Erskine & Baum, 1982; Lodder & Zeilmaker, 1976; Pfaus et al., 2000); however if the 
frequency of hormone priming is increased from every 28 days to every 14 days to every 4 days, 
the inhibitory effect of VCS becomes progressively less robust (Pfaus et al., 2000). The 
administration of VCS also activates Fos, a marker of neuronal activation, within numerous 
sexually-relevant brain regions (Pfaus et al., 1996), including glutamate neurons of the vlVMH 
(Georgescu et al., 2009), but the number of Fos-labelled glutamate cells in the vlVMH following 
VCS is reduced by EB+P priming compared to oil treated controls (Georgescu et al., 2009). 
Importantly, the ability of VCS to induce estrous termination is prevented by blocking the 
AMPA/kainate glutamate receptor subtype (Georgescu et al., 2012). Together those data suggest 
that EB prevents the inhibition of sexual behavior by VCS that appears to be mediated, at least in 
part, by glutamate transmission and more specifically the activation of AMPA/kainate receptors 
within the vlVMH.  
 Because VCS attenuates the sensitization of sexually appetitive behaviors by EB, the first 
behaviors that decline in frequency as estrous termination sets in (Pfaus et al., 1999), the 
overarching goal of these studies was to examine whether mechanisms related to estrous 
termination are involved in the attenuation of appetitive behaviors in females that are repeatedly 
treated with EB and given the opportunity to copulate on every test. Since glutamate and its 
ionotrophic receptor agonists infused in the vlVMH inhibit sexual behavior in a pattern 
reminiscent of estrous termination (Georgescu & Pfaus, 2006b), and antagonizing the AMPA 
receptor subtype blocks the effect of VCS on estrous termination (Georgescu et al., 2012), in the 
first experiment we hypothesized that AMPA infusions to the vlVMH would mimic the effect of 
repeated copulation in females repeatedly treated with EB, resulting in an attenuation of the EB 
induced sensitization compared to vehicle infused animals. In the second study we hypothesized 
that estrous termination would be accelerated in females that copulate during each episode of 
heat (i.e., that repeatedly receive VCS through copulation) compared to those restricted from 




Materials and methods 
Animals 
 Animals were purchased from Charles River Canada (St-Constant, Québec, Canada), and 
given one week to acclimate to our facilities. Females were housed in pairs in clear Plexiglas® 
cages lined with a mixture of corncob and sanichip bedding (females), or in groups of four in 
large gang cages lined with sanichip (males). Food (Charles River, 5075) and tap water were 
freely available. Rooms were maintained at 21C, on a 12-hour reverse cycle (lights off at 8AM). 
Following approximately one-week acclimatization to the animal facility, females were OVX 
and males were given four sexual training sessions in the pacing chambers with a separate group 
of OVX stimulus females primed with EB+P. Two cohorts of animals were used for the AMPA 
study occurring at 3-month intervals. A group of sexually-experienced OVX rats, used in 
unrelated studies, were used as stimulus females in the estrous termination study. 
 Animal pain and discomfort was minimized throughout the duration of the animal’s stay 
in our facilities. All experiments were conducted in accordance with the guidelines of the 





Ovaries were removed bilaterally following a 1 mL/kg IP injection of a 4:3 mixture of 
ketamine hydrochloride (50mg/mL; Ketaset ©, Wyeth Canada) and xylazine hydrochloride 
(4mg/mL; Rompum ©, Bayer Healthcare). Animals were also ear punched for identification 
purposes, and post-operative care was given with SC injections of PenG (0.1mL/rat) and 2.5 
mg/kg/mL of flunixin meglumine (Banamine©), and rehydrated with 2 mL of saline 
administered SC. Animals were given one week post-operative recovery prior to sexual behavior 
training. 
Cannulation.  
Cannulations occurred within 3 days of the final sexual training session (described 
below), during the 2-week hormone washout period. Females were anesthetized using an 
isofluorane:oxygen gas mixture (2.5-5% isofluorane:0.8L/min O2) and placed into a Kopf 
stereotaxic instrument.  A mixture of 0.05% lidocaine (CDMV-3913) and 0.05% Marcaine 
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(0.25%, CDMV-95865) in an 8.4% sodium bicarbonate solution (CDMV-93-500-EV) was 
injected below the scalp prior to incision. Painkiller (0.2mL Anafen) and antibiotic (0.2mL 
PenG) were then injected SC, and 2mL of saline was administered both before and after surgery 
for rehydration purposes, and eyes were kept hydrated with an ocular gel (Natural Tears®, 
Alcon).  Using the flat skull technique, bilateral guide cannula (C232G-1.5/SPC 11mm; Plastics 
One) were then implanted targeting the vlVMH according to the following coordinates: AP 
2.6mm, ML ±0.75mm, DV 8.4mm. Guide cannulae were fixed to the skull by three stainless 
steel screws and dental cement. The dummy cannula (C232DC-1.5; Plastics One, Roanoke, VA) 
was then inserted, extending 0.5mm beyond the guide, and covered with a dust cap (303DC/1; 
Plastics One, Roanoke, VA). Finally, Polysporin ® was applied to the incision site. Infusion 
cannulae (C232i-1.5/SPC; Plastics One, Roanoke, VA) extended 1mm beyond the guide.  
 
Hormone and drug preparation and administration 
 EB (10µg) and P (500µg) were dissolved in 0.1mL reagent grade sesame oil and 
administered by SC injection 48 and 4 hours, respectively, prior to behavioral training or testing 
as indicated. Steroids were obtained from Steraloids (Hanover, NH). 
 AMPA (2mmol) was dissolved in 0.9% physiological saline and infused into the bilateral 
cannulae using a Hamilton syringe connected to PE50 tubing connected to an infusion pump 
(Hamilton Apparatus, Pump 22) at a rate of 1µl/2 minutes on test days 2 through 4. The infuser 
was left inside for an additional 1.5min in order for the drug to be absorbed by the tissue 
(Georgescu & Pfaus, 2006b; Kow et al., 1985). Controls were infused with saline vehicle. 
 
Testing apparatus 
 All training and behavioral testing occurred in unilevel 4-hole pacing chambers (38 x 60 
x 38 cm) lined with sanichip below a grid floor (2.54 cm elevation). The chamber is bisected 
with a clear Plexiglas® divider that has 4 square holes cut in the bottom, which can be adapted to 
the size of the animals, and is used to restrict the larger male to one compartment while the 
smaller female is free to traverse to either side, allowing her to pace the sexual interactions with 





 All training and testing began during the middle third of the rat’s dark cycle. One week 
following OVX, females were primed with EB and P prior to each of four sexual training 
sessions occurring at 4-day intervals. A male was randomly selected and placed on the right side 
of the chamber for a 5-minute acclimation period before introducing the female for a 30-minute 
sexual training session. Each male was only used once on each training or test day. Next females 
were given a 2-week hormone washout period prior to testing. The training and test procedures 
for each experiment are summarized in Figure 1. 
 
Test procedures 
 Experiment 1. AMPA infusions to the vlVMH. 
One week following cannulation surgery (i.e., during the hormone washout period), 
cannulated females were habituated to the test procedures by placing them into the infusion 
chamber (a clear Plexiglas® cage lined with corncob), removing and immediately replacing the 
dummy and running the Hamilton Apparatus without any infusion. Next they were placed into 
the 4-hole pacing chamber for 15-minutes for 3 consecutive days, to habituate movement 
through the chamber holes with the head caps. In a pilot project we found that females quickly 
learned to lower their head to facilitate movement through the holes. No hormones or drugs were 
administered during this habituation period. 
Following the hormone washout period, EB was administered SC 48-hours prior to each 
of 5 test sessions. On the first and fifth test days, males were placed on one side of the 4-hole 
pacing chamber and given a 5-minute habituation period before introducing the female, and the 
pair was left undisturbed for a 30-minute sexual behavior test period. On tests 2-4, females were 
infused with either saline (n=12) or AMPA (n=12), before being placed in the 4-hole pacing 
chamber alone for 30-minutes.  
 Experiment 2. Tests of estrous termination.  
Females were injected with 10µg EB 48 h prior to each test day, and assigned to one of 
two copulatory conditions, where they either copulated (EB+Male) or were placed in the 
chamber alone (EB-Alone) (as in, Jones & Pfaus, 2014) on tests 2-4. All animals copulated on 
the first test day. To assess the effect of VCS on estrous termination, on test day 5 females were 




Figure 1. Timeline and procedures. A. In both studies, females were ovariectomized (OVX) one 
week after arrival to the facilities and given a week to recover. Next they were treated with 
estradiol benzoate (EB) 48 hours prior, and progesterone (P) 4 hours prior to each of four sexual 
training tests in the 4-hole pacing chamber, followed by a 2-week hormone washout prior to the 
start of the experimental phase. B. In Experiment 1, females were cannulated within the first 
three days of the washout period, given a week to recover, then given three consecutive days of 
habituation to the experimental procedures (see Test Procedures for details). At the end of the 
washout period, females were treated with EB prior to each test day. On test 1, females copulated 
with a sexually vigorous male, and manipulations were made on tests 2-4. Females were then 
infused with AMPA or Saline to the vlVMH and placed in the pacing chamber alone. Sexual 
behavior was again measured on Test 5. In Experiment 2, following the washout period, females 
were treated with EB 48 hours prior to each of four test days. On test 1 they were given access to 
a sexually vigorous male in the 4-hole pacing chamber. On tests 2-4 they were placed in the 4-
hole pacing chamber with a sexually vigorous male, or alone. Two days later they were injected 
with EB and on Test day 5, they were given VCS or SHAM at 9PM. The following morning at 
9AM they were placed in the 4-hole pacing chamber and sexual behavior was measured. Full 
triangles represent injection of 10µg EB. Open squares indicate that all females had access to a 




course of 1 h, as in Pfaus et al., (Pfaus et al., 1996; 2000), creating a total of four groups 
(EB+Male/SHAM, EB-Alone/SHAM, EB+Male/VCS, EB-Alone/VCS, n=6/group), and their 
sexual behavior was tested 12 h later (Pfaus et al., 2000). To administer VCS, females were 
placed in a clear Plexiglas® cage lined with Sani-chip® bedding, gently held at the base of the 
tail, and a glass rod with polished ends lubricated with K-Y Jelly® was inserted into the vagina 
four times at 1 second intervals for approximately 0.5 seconds; the first three insertions only 
entered the anterior vagina, whereas the rod was pressed firmly against the cervix on the fourth 
insertion for approximately 2 seconds then removed. VCS was applied in clusters of 5, every 6 
minutes, such that they received a total of 50 VCS over the course of an hour (Pfaus et al., 1996; 
2000). SHAM animals were handled in the same way for the same amount of time, without 
insertion of the rod. Rats were returned to their home cage between clusters.  
Twelve hours following VCS or SHAM (i.e., beginning at 9AM the following day) 
females were tested for estrous termination. Male rats were first exposed to fully primed EB+P 
stimulus females to ensure they were sexually aroused (determined by intromissions with the 
stimulus female), then placed in the 4-hole pacing chamber for a 5-minute habituation period. 
Experimental females were then introduced to the chamber until one ejaculation or up to ten 
minutes, whichever came first (similar to Pfaus et al., (2000)).   
 
Histology  
Within seven days of the final behavioral test, cannulated females were bilaterally 
infused with methylene blue (40 mg/mL distilled water; 0.5µL over 1 min) and were then 
sacrificed via an overdose of sodium pentobarbital injected IP (120 mg/kg/mL). Intracardial 
perfusions were then conducted using 120 mL of cold phosphate buffered saline (PBS) followed 
by 120 mL of 4% paraformaldehyde in 0.1M PBS. Brains were then removed and post-fixed in 
4% paraformaldehyde for 4 hours then transferred into a 30% sucrose solution overnight at 4ºC, 
flash-frozen over dry ice and stored at -80ºC until slicing. 
Brains were mounted onto a chuck and sliced using a cryostat set at -21ºC. Coronal 
sections (40 µm) were taken just before and after cannula tracks and were immediately mounted 
onto gel-coated microscope slides. Sections were stained in an 8% cresyl violet solution, 
dehydrated, cleared with xylene and cover-slipped using Permount. Placements were then 
examined under a light microscope. Cannulation tracks located beyond the anterior or posterior 
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regions of the VMH or more than 1mm dorsal to it were omitted from all statistical analyses (as 
in Georgescu & Pfaus, 2006b). Correct cannula placements from all animals included in the 
statistical analyses are shown in Figure 2. 
 
Behavioral measures 
 The occurrence of each lordosis magnitude (LM) was coded on a 3-point scale (Hardy & 
Debold, 1971a), and the lordosis quotient (LQ) was calculated as a ratio of the total number of 
LM divided by the total number of mounts with or without intromission and expressed as a 
percentage. Appetitive measures of sexual behavior included partial solicitations (hops/darts) and 
full solicitations (defined as a headwise orientation followed by a runaway, (Erskine, 1989; 
McClintock, 1984)). Full solicitations are indicative of greater sexual motivation compared to 
hops and darts, since they are observed more frequently in females treated with EB+P compared 
to those treated acutely with EB alone (Pfaus et al., 1999). Kicks, sideways takedowns, boxing 
postures, and prone positions made by the female were coded as defensive behaviors (Barnett, 
1963). Mounts, intromissions, and ejaculations by the male were also analyzed, as they provide a 
more thorough overview of the female’s behavior (Pfaus et al., 1999).  
 
Statistical analyses 
Experiment 1. AMPA infusions.  
Statistical analyses were conducted using SPSS version 16.0 for Windows. For each 
cohort, raw data were standardized across tests, as such data are presented as Z-scores. Outliers 
on appetitive behaviors and LQ, the two main outcome variables, were detected using boxplots. 
Planned comparisons were used to test whether 1) each group would display sensitization of 
appetitive behaviors and LQ using dependent t-tests, and 2) whether behavioral sensitization 
differed between saline and AMPA infused animals on the final test day using independent t-
tests. Eta squared (η2) and Cohen’s d are reported as measures of effect size.  
 Experiment 2. Estrous termination.  
Tests of estrous termination were analyzed using a two-way ANOVA with male exposure 
condition (Male or Alone) and VCS (VCS or SHAM) as between subject factors. Chi square (𝛘𝛘2) 
was used to examine the proportion of females that received an ejaculation across groups. All 




Figure 2. Cannula placements into the vlVMH for all rats included in statistical analyses. 
Placements represent bilateral coordinates of saline (open circles) and AMPA (full circles) 
infused animals with correct placements in the same plane. Triangles indicate placements from 
each hemisphere that were on different planes (i.e., same animal). Figures reproduced from 




Experiment 1. AMPA infusions to the vlVMH  
 Two saline treated females had placements outside the VMH and were excluded from all 
analyses. Five animals did not recover well following cannulation surgery and two AMPA 
treated females did not respond well to the first infusion, as they displayed erratic hyperactivity, 
or became catatonic, and were immediately excluded from the study. Two females were 
excluded from the statistical analyses due to a high number of appetitive behaviors on Test 1 
(one from each group), or test 5 (one AMPA treated female) as determined by boxplots. Final 
group sizes were 6 for saline and 7 for AMPA.  
Lordosis measures are shown in Figure 3. Females that were not mounted could not be 
included in the statistical analyses on LQ. As expected and supported by the large effect sizes, 
LQ sensitized whether females received infusions of saline, t(3)=2.56, p=0.083, d=1.42, or 
AMPA, t(6)=2.96, p=0.025, d=1.10. Saline treated females displayed more LM3 on the final test 
day compared to the first, t(5)=2.51, p=0.054, d=1.99, and although not statistically significant, 
the medium effect sizes suggest that LM1, t(5)=0.79, p=0.465, d=0.63 and LM2, t(5)=0.84, 
p=0.438, d=0.56, also increased across tests. In AMPA treated females, the frequencies of LM2, 
t(6)= 3.57, p=0.012, d=0.50, and LM3, t(6)=3.51, p=0.013, d=1.29 also increased, while there 
was no effect on the frequency of LM1, t(6)=0.15, p=0.887, d=0.09. AMPA infusions did not 
reduce LQ compared to saline treated animals on the final test day, t(11)=0.17, p=0.865, d=0.10, 
nor did it affect LM1, t(11)=0.24, p=0.815, d=0.14, although the medium and large effect sizes 
respectively, suggest that AMPA treated animals displayed more LM2, t(11)=1.08, p=0.302, 
d=0.65, and LM3, t(11)=1.83, p=0.094, d=1.10 compared to saline treated animals. 
As shown in Figure 4, appetitive sexual behaviors sensitized in both groups, (saline: 
t(5)=2.53, p=0.053, d=0.71; AMPA: t(6)=5.60, p=0.001, d=1.97), which was driven by the effect 
on hops/darts (saline: t(5)=2.54, p=0.051, d=0.71; AMPA: t(6)=5.40, p=0.002, d=1.83) given 
that solicitations did not sensitize in either group (saline: t(5)=1.00, p=0.363, d=0.45; AMPA: 
t(6)=1.55, p=0.173, d=0.77), and in fact, the raw data indicate that very few solicitations were 
displayed at all (<1 solicitation on average per group in both cohorts, as such data are not shown). 
On the final test day, the medium effect size suggests that AMPA infused animals displayed 





Figure 3. Standardized lordosis measures of OVX rats repeatedly treated with EB and allowed to 
copulate with a sexually vigorous male on tests 1 and 5. On tests 2-4 females received an 
infusion of saline, or AMPA into the vlVMH. aDifferent from test 1, p<0.05. bDifferent from test 









Figure 4. Appetitive behaviors of OVX rats treated repeatedly with EB and allowed to copulate 
with a sexually vigorous male on tests 1 and 5, standardized across cohorts. On tests 2-4 females 
received an infusion of saline, or AMPA into the vlVMH. aDifferent from test 1, p<0.05. 





driven by the effect on hops/darts, t(11)=0.71, p=0.492, d=0.428, the only appetitive component 
that had sensitized (solicitations: t(11)=0.95, p=0.363, d=0.57, data not shown). 
Defensive behaviors, shown in Figure 4, did not change across tests in saline treated 
animals, (saline: t(5)=0.578, p=0.588, d=0.26), although the large effect size suggests that 
AMPA infusions increased defensive behaviors on the final test day compared to the first, 
(AMPA: t(6)=1.74, p=0.133, d=0.93). The medium effect size suggests that on the final test day 
AMPA treated animals were more defensive towards males than were saline treated animals, 
t(11)=0.97, p=0.353, d=0.58.  
Male behaviors are shown in Figure 5. The large effect sizes suggest that saline treated 
females received more mounts, t(5)=0.94, p=0.391, d=0.66, intromissions, t(5)=1.24, p=0.271, 
d=0.94, and ejaculations, t(5)=1.46, p=0.203, d=0.74 on the final test day compared to the first, 
whereas in AMPA treated females, the large and medium effect sizes, respectively, suggest that 
mounts, t(6)=2.44, p=0.05, d=1.20, and intromissions, t(6)=1.19, p=0.278, d=0.60 increased 
across tests, while the number of ejaculations received did not, t(6)=0.19, p=0.858, d=0.09. 
Large effect sizes suggest that on the final test day AMPA treated animals received more mounts, 
t(11)=2.00, p=0.070, d=1.20, and intromissions, t(11)=1.63, p=0.131, d=0.98, than saline treated 
animals, but did not differ in the number of ejaculations received, t(11)=0.16, p=0.880, d=0.09. 
 
Experiment 2. Estrous termination 
Lordosis. Two females in the Male/SHAM group were not mounted and as such were 
excluded from the statistical analyses on LQ. As expected, those that were given VCS the 
evening prior had a lower LQ the following morning as shown in Figure 6 (main effect of VCS 
condition, F(1,18)=7.86, p=0.012, η2=0.17). In contrast to our prediction, those that copulated on 
every test (EB/Male) had a higher LQ on the following morning compared to those that did not 
(EB/Alone) (main effect of male exposure condition, F(1, 18)=21.00, p<0.001, η2=0.45). The 
interaction was not statistically significant, F(1,18)=0.03, p=0.857, η2=0.000.  
Those females that copulated on every test (EB/Male) displayed more LM3 (Figure 6) 
compared to those that were not given the opportunity to copulate (EB/Alone) (main effect of 
male exposure condition: F(1,20)=4.86, p=0.039, η2=0.19). The effect of VCS, F(1,20)=0.36, 
p=0.555, η2=0.01, and the interaction, F(1,20)=0.36, p=0.555, η2=0.01, were not significant. 
LM1 and LM2, shown in Figure 6, did not differ between VCS (LM1: F(1,20)=0.08, p=0.774,  
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Figure 5. Mounts, intromissions and ejaculations that females received from the male on tests 1 
and 5, standardized across cohorts. On tests 2-4 females received an infusion of saline, or AMPA 





Figure 6. LQ of OVX rats repeatedly treated with EB and allowed to copulate with a sexually 
vigorous male (EB/Male) on every test, or placed in the chamber alone (EB/Alone) on 
intermediate tests (tests 2-4). Females were given VCS or SHAM on test day 5 and sexual 
behavior was examined the following morning, to test estrous termination. aSignificantly lower 




η2=0.00; LM2: F(1,20)=0.09, p=0.766, η2=0.10) or male exposure conditions (LM1: 
F(1,20)=2.12, p=0.161, η2=0.10; LM2: F(1,20)= 2.28, p=0.147, η2=0.00), and the interactions 
between conditions were not significant, LM1: F(1,20)=0.08, p=0.774, η2=0.00; LM2: 
F(1,20)=0.25, p=0.620, η2=0.01).  
 Appetitive behaviors. The breakdown of appetitive behaviors is shown in Figure 7. Very 
few solicitations were observed overall (all group means <1), as such, no effect of VCS 
condition, F(1,20)=1.45, p=0.242, η2=0.06, or male exposure condition, F(1,20)=1.45, p=0.242, 
η2=0.06, was found, and their interaction was not significant, F(1,20)=0.16, p=0.692, η2=0.01. 
There were no effects on hops/darts, regardless of male exposure, F(1,20)=0.89, p=0.357, 
η2=0.04, or VCS conditions, F(1,20)=0.52, p=0.479, η2=0.02, and the interaction was not 
statistically significant, F(1,20)=0.03, p=0.870, η2=0.00. Given that nearly no solicitations were 
coded, the sum of appetitive behaviors is not shown, as they closely resemble hops/darts. 
 Defenses. As expected, females that received VCS the night before testing were 
significantly more defensive compared to those that received SHAM, F(1,20)=8.76, p=0.008, 
η2=0.28, as shown in Figure 7. However whether or not they copulated on every test had no 
effect, F(1,20)=2.49, p=0.131, η2=0.08, and the interaction was not statistically significant, 
F(1,20)=0.40, p=0.532, η2=0.01. 
 Mounts and intromissions. Those females that received VCS were mounted more 
frequently compared to those that received SHAM stimulation (F(1,20)=7.212, p=0.014, 
η2=0.26) (Figure 8). The main effect of male exposure condition, F(1,20)=0.01, p=0.924, 
η2=0.00 and the interaction, F(1,20)=0.06, p=0.804, η2=0.00, were not significant. As shown in 
Figure 8, no differences were detected on the number of intromissions received, (VCS condition: 
F(1,20)=0.35, p=0.559, η2=0.02, male exposure condition: F(1,20)=0.63, p=0.438, η2=0.03, 
interaction: F(1,20)=0.04, p=0.845, η2=0.00). 
Ejaculations. As expected, there tended to be fewer females that received an ejaculation 
from the male if they received VCS (1/12) the prior evening compared to those that received 
SHAM (5/12) (collapsed across copulatory condition), 𝛘𝛘2=3.556, p=0.059. 
When examining whether copulatory condition played a role, we found that of those 
females that copulated on every test (EB/Male), there were no differences between SHAM (2/6) 
and VCS (1/6) conditions in the number of females that received an ejaculation within the first 
10 minutes 𝛘𝛘2=0.44, p=0.505. However, in those females that were not given the opportunity to  
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Figure 7. Solicitations and hops/darts displayed by OVX rats repeatedly treated with EB and 
allowed to copulate with a sexually vigorous male (EB/Male) on every test, or placed in the 
chamber alone (EB/Alone) on intermediate tests (tests 2-4). Females were given VCS or SHAM 
on test day 5 sexual behavior was examined the following morning, to test estrous termination. 






Figure 8. Mounts and intromissions received from males by OVX females repeatedly treated 
with EB and allowed to copulate with a sexually vigorous male (EB/Male) on every test, or 
placed in the chamber alone (EB/Alone) on intermediate tests (tests 2-4). Females were given 
VCS or SHAM on test day 5 sexual behavior was examined the following morning, to test 
estrous termination. aSignificantly lower than EB/Male condition. *Significantly different from 




copulate on intermediate tests (EB/Alone), whereas half the animals received an ejaculation if 
they received SHAM the prior evening (3/6) no female received an ejaculation if they were given 
VCS the prior evening (0/6), 𝛘𝛘2=4.00, p=0.046. 
 
Discussion 
 The purpose of these studies was to examine whether mechanisms related to estrous 
termination are involved in the attenuation of the EB-induced sensitization of appetitive sexual 
behaviors in OVX females that receive repeated VCS. In the first study we confirmed that 
following repeated administration of EB, lordosis measures and hops and darts sensitized 
whether females received infusions of saline or AMPA into the vlVMH on intermediate tests, 
further demonstrating that estradiol sensitization is a robust effect (Jones et al., 2013; Jones & 
Pfaus, 2014). As predicted and supported by the large effect sizes, we found that repeated AMPA 
infusions to the vlVMH mimicked the behavioral pattern of attenuated sensitization of appetitive 
sexual behaviors observed in females that receive VCS from repeated mating, and increased 
defensive behaviors, a behavioral pattern reminiscent of estrous termination. These data suggest 
that glutamate transmission in the vlVMH induced by VCS plays a role in the attenuation of 
sensitized appetitive sexual behaviors by repeated EB, as predicted. In the second study we 
examined the patterns of estrous termination following VCS between EB-sensitized females that 
copulated on every test (EB/Male) versus those that were not given that opportunity (EB/Alone). 
As expected, females that received VCS the prior evening had a lower LQ, expressed more 
antagonistic behaviors towards the male, and tended to take fewer ejaculations compared to those 
that received SHAM. We also found that females that were not given the opportunity to copulate 
on every test (EB/Alone) had a lower LQ and displayed fewer LM3 compared to those that 
copulated on every test (EB/Male), and none of the EB/Alone females that received VCS the 
prior evening received an ejaculation during the estrous termination test, suggesting that the 
onset of estrous termination was accelerated in that group, contrary to our expectation. Together 
these findings suggest that mechanisms underlying estrous termination act in opposition to those 
activated by repeated administration of EB. 
The sensitization of lordosis measures following AMPA infusions was somewhat 
surprising. Whether females were infused with AMPA or saline on intermediate tests, both LQ 
and the quality of the lordosis sensitized, and in saline treated animals the sensitization effect 
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was strongest on LM3. Interestingly, in AMPA treated animals, both LM2 and LM3 sensitized 
and the effect was also strongest on LM3; however the quality of their lordosis magnitudes 
appeared to be greater on the final test day compared to saline, reflected in the large between 
groups effect size on LM2 and LM3. This is intriguing since AMPA infusions to the vlVMH just 
prior to testing decreases LQ and lordosis magnitudes (Georgescu & Pfaus, 2006b), and 
antagonizing AMPA receptors just prior to experimenter applied VCS completely blocks the 
decrease in LQ and lordosis magnitude (Georgescu et al., 2012). Although in a previous study 
we did not see any group differences in the quality of LM3 between females that were given the 
opportunity to copulate on every test compared to those that did not (Jones & Pfaus, 2014), a 
similar pattern was observed following experimenter-applied VCS on intermediate tests (in place 
of copulation) (Jones, S.L., Germé, K., Graham, M.G., et al., submitted), and more LM3 were 
also observed in EB+Male compared to EB/Alone during the estrous termination test. Thus, 
repeated AMPA receptor activation (which may occur with repeated VCS) on the three episodes 
of heat prior to the final test day in the current study did not attenuate the sensitization of LQ, 
and in fact may have potentiated the quality of the lordosis magnitude, which suggests that a 
component of the consummatory aspect of sexual behavior (i.e., lordosis magnitude) may 
sensitize following repeated activation of the AMPA receptor subtype in the vlVMH during 
previous episodes of heat. Together with the literature showing that glutamate or its ionotropic 
agonists infused into the vlVMH rapidly inhibit lordosis (Georgescu & Pfaus, 2006b; Kow et al., 
1985; McCarthy et al., 1991) our findings that repeated AMPA receptor activation in the vlVMH 
led to an attenuation of appetitive behaviors coincident with a facilitation of the lordosis quality 
support the idea first proposed by Kow et al., (1985) that the vlVMH contains lordosis inhibiting 
and excitatory subsystems.  
A mechanism whereby the lordosis quality becomes potentiated with repeated AMPA 
receptor activation may make it more likely for the female to become pregnant/pseudopregnant. 
Using experimenter-applied VCS in ovary-intact females in proestrus, Lehmann and Erskine 
(2004) found that females that displayed at least one LM3 became pseudopregnant (indicating 
that the neuroendocrine events necessary for the maintenance of pregnancy had been activated) 
following just two VCS, and this effect did not occur with the two lower magnitudes. To contrast 
the mechanisms through which EB induced sensitization can differentially optimize reproductive 
success, it makes intuitive sense that repeated episodes of heat would sensitize appetitive and 
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consummatory aspects of sexual behaviors. An increase in appetitive solicitational behaviors is 
adaptive, as they make it more likely she will receive an intromission upon the eventual 
encounter with a male (Erskine, 1989). On the other hand, if on multiple episodes of heat she 
receives intromissions (and thus AMPA receptor activation in the vlVMH), an alternate strategy 
to optimize reproductive success may be to further sensitize the consummatory component, thus 
increasing the occurrence of LM3, and therefore the probability of activating the neuroendocrine 
events necessary for the maintenance of pregnancy. However, it is not clear from the current 
study under which contexts such a mechanism might become activated.   
 Repeated AMPA infusions in place of copulation resulted in a behavioral pattern on the 
final test day that is consistent with estrous termination. As predicted, AMPA infusions on 
intermediate tests attenuated the display of sexually appetitive behaviors; thus it appears that 
glutamatergic signaling (particularly via AMPA receptors) in the vlVMH, which is involved in 
the induction of estrous termination, is inhibitory to the sensitization of appetitive sexual 
behaviors induced by repeated administration of EB. We also replicated our previous finding that 
repeated treatment of EB in the absence of copulation on intermediate tests (the saline group in 
the current study) had no effect on defensive behaviors (Jones & Pfaus, 2014), yet we found that 
repeated AMPA infusions on intermediate tests increased the incidence of defensive behaviors 
towards males on the final test day compared to saline treated animals. This is consistent with 
previous findings that agonizing AMPA receptors in the vlVMH activates defensive behaviors 
(Georgescu & Pfaus, 2006b); however it is in contrast to our previous findings that defensive 
behaviors generally decline in females repeatedly treated with EB and given the opportunity to 
copulate (Jones et al., 2013; Jones & Pfaus, 2014), which suggests that repeated copulation 
opposes the process that facilitates the onset of defensive behaviors by AMPA receptor 
activation. Although the mechanism is unclear, we have previously suggested a role for the 
periaqueductal gray (PAG) (Jones & Pfaus, 2014), which has bi-directional connections with the 
VMH (Calizo & Flanagan-Cato, 2002), based on a model proposed by Blaustein et al. (2009) and 
Pfaff et al. (2008).  
Blaustein et al. (2009) examined the potentiation of sexual behaviors by mating 
stimulation within a single episode of heat in females treated with a low dose of EB and found 
that preventing VCS from intromissions (by masking the vaginal opening) prevented the increase 
in defensive behaviors found in copulating animals. We reported that repeatedly treating OVX 
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rats with EB (every 4 days) but not allowing them to copulate sensitized sexual behaviors when 
tested on the 8th test, yet defensive behaviors were unchanged compared to their initial 
behavioral test (similar to that reported by Blaustein et al. 2009). On the other hand, defensive 
behaviors were significantly lower on the final test day if females were given the opportunity to 
copulate on each test (in contrast to the effect of mating stimulation on defensive behaviors 
within an episode of heat). Together those data suggest that although intromissive stimulation 
can initially activate defensive behaviors, presumably through activation of AMPA receptors as 
shown by Georgescu and Pfaus (2006b), repeated mating across episodes of heat overrides the 
activation of defensive behaviors (Jones & Pfaus, 2014). Since repeatedly treating females with 
AMPA (in place of copulation) in the current study resulted in an increase in defensive behaviors, 
it is possible that AMPA receptor activation in the vlVMH, (or some downstream mechanism), 
may be reduced in the EB/Male condition. To extend our prior discussion related to a potential 
role of the PAG (Jones and Pfaus, 2014), it is hypothesized that if AMPA receptor activation 
within the vlVMH (following VCS) interacts with the PAG to inhibit lordosis and facilitate 
defensive behaviors, this pathway must be overridden in those females that are repeatedly treated 
with EB and allowed to copulate. Overall, these findings are important as they further 
demonstrate that glutamate signaling in the vlVMH via AMPA receptors, is inhibitory to sexual 
behavior, and induces a behavioral pattern reminiscent of estrous termination (Booth et al., 2010; 
Georgescu et al., 2009; 2012; 2014; Georgescu & Pfaus, 2006a; 2006b).  
This is the first study to examine estrous termination using an estradiol sensitization 
paradigm. We have shown that VCS accelerated the onset of defensive behaviors and the offset 
of lordosis, and nearly no solicitations were observed as previously reported in estrous 
termination studies using fully primed females in bilevel chambers (Pfaus et al., 2000). However, 
no effect of VCS was observed on hops/darts, which is likely a floor effect since few hops/darts 
were observed overall, (although the patterns suggest that those that received VCS displayed 
fewer hops/darts compared to SHAM). Therefore it is likely that estrous termination was already 
well underway. For future studies to capture the gradual onset of estrous termination following 
repeated EB treatment some minor changes should be made to the methodology. Our method 
was based on a well-established estrous termination paradigm in OVX rats fully-primed with 
EB+P, which induce maximal levels of sexual behavior. Thus, perhaps earlier administration of 
VCS (such as 48 hours following EB administration as opposed to a 56 hours as is customary 
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when using fully EB+P primed females), and running estrous termination tests 12 hours later 
would be a better method to assess the offset of the full array of sexual behaviors (i.e., including 
appetitive sexual behaviors). Nonetheless, it is clear that VCS accelerates the onset of estrous 
termination in EB sensitized females, as reported in EB+P primed females, albeit the onset 
latency appears to be shorter. 
Although we predicted that estrous termination would be accelerated in the EB/Male 
group, in fact the EB/Alone females were at a later stage of estrous termination since their LQ 
was lower, and of those that received VCS, none received an ejaculation. This suggests that the 
sexual behavior system as a whole (i.e., those that activate sexual behavior and those that inhibit) 
sensitizes with repeated administration of EB. Thus it appears that the system is set up such that 
repeated administration of EB (or repeated episodes of heat) sensitizes the activation as well as 
the termination of sexual behavior. Moreover, the system appears to be more sensitive to the 
receipt of VCS if prior episodes of heat occurred without copulation, such that once it does occur, 
mechanisms that are inhibitory to sexual behavior are more effective, resulting in an earlier 
termination of behavioral estrus and presumably in eliciting the neuroendocrine events required 
for the maintenance of pregnancy. If the latter is true, then the medial amygdala (MeA) must be 
an important brain region involved in these effects. 
 
What neural mechanisms might underlie behavioral sensitization to EB? 
We have previously suggested that neural regions underlying the sensitization of sexual 
behaviors by repeated administration of EB may involve the mPOA and VMH (Jones et al., 
2013; Jones & Pfaus, 2014) given their roles in the expression of solicitational behaviors and 
lordosis respectively, which is further supported by the current data. We now propose that the 
MeA must also play an important role given that EB/Alone females were more sensitive to the 
induction of estrous termination by VCS, and the heightened sensitivity on lordosis intensity that 
appears to have occurred in those females repeatedly infused with AMPA. We previously 
proposed that GABA within the vlVMH may inhibit glutamate signaling to allow the expression 
of sexual behavior and that repeated administration of EB might sensitize this inhibition (Jones et 
al., 2013). GABAergic projections to the vlVMH arise largely from the mPOA, a region that is 
critical in the display of sexually appetitive behaviors, but a smaller projection also arises from 
the MeA (Georgescu, Graham, & Pfaus, in preparation). The posterodorsal MeA (pdMeA) is 
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implicated in the neuroendocrine changes necessary for the maintenance of pregnancy (or 
pseudopregnancy) following VCS, via activation of the ionotropic glutamatergic receptors 
AMPA (Oberlander et al., 2009) and NMDA (Lehmann et al., 2005; Polston & Erskine, 2001). 
The MeA contains a large number of estrogen receptors (Pfaff & Keiner, 1973), and crystalline 
estradiol applied to this region facilitates lordosis as it does in the VMH (Lisk & Barfield, 1975). 
Moreover, neurons within the MeA appear to sensitize to EB, since long-term exposure to EB 
increases their firing rate (Pfaus et al., 1996; Schiess et al., 1988). We propose that glutamatergic 
signaling through NMDA receptors in the pdMeA may be sensitized, given their role in the 
induction of neuroendocrine signals necessary for pregnancy/pseudopregnancy following VCS. 
How this mechanism would interact with activity within the vlVMH (and potentially the mPOA) 
is not clear, but one potential pathway may involve glutamatergic and/or GABAergic signaling 
between these regions.  
VCS accelerates the onset of estrous termination (Hardy & Debold, 1971a; Lodder & 
Zeilmaker, 1976; Pfaus et al., 2000), particularly if intromissions are paced by the female 
(Coopersmith et al., 1996; Erskine, 1985; Erskine et al., 1989; Erskine & Baum, 1982), and it 
induces Fos within the mPOA, vlVMH and pdMeA (Erskine, 1993; Pfaus et al., 1993; 1996; 
Polston & Erskine, 1995; Tetel, Getzinger, & Blaustein, 1993). Mating stimulation leads to the 
release of glutamate within the VMH (Georgescu et al., 2014) and presumably the pdMeA, since 
NMDA receptor activation within the pdMeA induces twice daily prolactin surges, required for 
the maintenance of pregnancy, mimicking the effect of mating, and VCS in particular (Lehmann 
et al., 2005; Lehmann & Erskine, 2005; Polston & Erskine, 2001), and AMPA receptor 
activation in this region is critical for the induction of pregnancy/pseudopregnancy. Bilateral 
pelvic nerve transections (which innervate the vagina and cervix) prevents the induction of Fos 
within the pdMeA (Rowe & Erskine, 1993), while stimulation of NMDA glutamate receptors 
within the pdMeA induces Fos expression in a number of sexually relevant brain regions 
including the mPOA and vlVMH (Lehmann & Erskine, 2005), indicating that the pdMeA sends 
efferents to these regions following VCS.  
Thus glutamate release within the vlVMH could be modulated by glutamatergic activity 
in the pdMeA, for example if those NMDA (and possibly AMPA) receptors within the pdMeA 
are themselves located on glutamate neurons that project to the vlVMH. Importantly, the 
induction of pseudopregnancy (which requires twice daily prolactin surges) depends on repeated 
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and temporally distinct activation of NMDA receptors within the pdMeA, indicating that it plays 
an important role in the intromission mnemonic within a mating session required for initiating 
pseudopregnancy/pregnancy (Lehmann et al., 2005), and our data suggest that this mnemonic 
may summate across mating sessions. We know that VCS activates glutamate neurons within the 
vlVMH (Georgescu et al., 2009), and that the vlVMH sends efferents to the pdMeA (Akesson, 
Ulibarri, & Truitt, 1994); however it is not known whether the glutamatergic neurons of the 
vlVMH are the same that project to the pdMeA, but if so, they may play a role in that mnemonic. 
Thus, an important pathway implicated in the sensitization of sexual behaviors by EB likely 
occurs through complex interactions between the vlVMH, mPOA and pdMeA, which is possible 
given the bilateral connections between all these regions (Akesson et al., 1994; Behbehani, 1995; 
Flanagan-Cato, 2000; Georgescu, Graham, & Pfaus, in preparation; Lehmann & Erskine, 2005). 
Finally, the integration of afferents within the vlVMH would subsequently be relayed down to 
the PAG to influence the occurrence of defensive behaviors and lordosis (Pfaff et al., 2008). 
 
Conclusion 
Together the findings from these studies suggest that repeated administration of EB 
sensitizes mechanisms that are not only permissive to the display of sexual behavior, but also 
those that are inhibitory to its duration. Repeated administration of EB increases both sexual 
solicitations, which increase the probability of receipt of mounts and intromissions from the male, 
as well as consummatory behaviors (lordosis), which is required for successful intromission and 
thus VCS that is necessary for the induction of twice daily prolactin surges required for the 
maintenance of pregnancy. Moreover, the data suggest that a neural mechanism exists whereby 
repeated activation of AMPA receptors within the vlVMH, presumably from the receipt of VCS, 
attenuates the display of appetitive sexual behaviors while facilitating maximal lordosis intensity, 
which has been shown to trigger pseudopregnancy. Therefore it appears that the system has the 
potential to switch reproductive strategies not merely to maximize the probability of receiving 
VCS (by potentiating solicitational behaviors) necessary for fertilization, but to enhance 








CHAPTER 4. APPLICATIONS OF THE ESTRADIOL SENSITIZATION PARADIGM 
 The primary findings of the data presented to date have shown that behavioral 
sensitization to EB is a robust effect, as it can be reliably induced in different strains of animals, 
by varying doses of EB. Given this robust behavioral effect, the aim of the next chapter was to 
use the paradigm as a diagnostic tool to test the female’s behavioral sensitivity to E2 in two 
models of female sexual inhibition. Animal care facilities are moving towards the use of corncob 
bedding in their housing procedures in order to improve environmental conditions for the 
animals and staff. However there is some evidence in the literature that corncob bedding 
interferes with E2 signaling, and disrupts female ovarian cyclicity as well as rodent sexual and 
aggressive behaviors, which are dependent on ER signaling. The primary goal of the first study 
(Chapter 4.1) was to determine whether any deficits in sexual behavior due to corncob bedding 
could be overcome by the repeated administration of EB. In a second model (Chapter 4.2) of 
sexual inhibition we asked whether females that were prenatally androgenized, and thus show 
sexual behavior deficits in response to hormone priming when OVX and tested in adulthood, 
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The mechanisms underlying the sensitization of sexual behaviors by repeated 
administration of estradiol benzoate (EB) to ovariectomized (OVX) rats are not well understood. 
Here we tested whether two housing conditions play a role. Sexual behavior in the female rat is 
dependent on the activation of ERα (estrogen receptor alpha) by estradiol. Corncob (CC) 
bedding has been reported to have adverse effects on the reproductive behavior and physiology 
of rats, and to disrupt ERα signaling in mice. In addition, some rodent behaviors are stimulated 
by olfactory stimuli and enhanced in the presence of estradiol. Upon arrival to the facilities OVX 
Long-Evans rats were housed on either Sani-Chips (SC) or CC in a room that housed only 
females (F) or males and females (M). Females were first given four sexual training sessions 
with 10µg EB+500µg progesterone (P; administered 48hrs and 4hrs prior to training, 
respectively), followed by a 2-week hormone washout period. Next, 10µg EB was administered 
sc every 4-days, 48hrs prior to each of 8 test sessions in a unilevel 4-hole pacing chamber. On 
the final training day (i.e., when primed with EB+P), no inhibitory effects of corncob bedding 
were found, but a facilitation of the lordosis quality occurred in SC/F. Although all groups 
appear to have sensitized to the repeated administration of EB, CC/F animals displayed fewer 
high quality lordosis magnitudes and hop/darts, and received fewer mounts and intromissions 
overall. They also had a lower lordosis quotient (LQ) on tests 2-4 although this effect 
disappeared by test 5. These results suggest that although CC may inhibit some components of 
female sexual behavior when primed with EB alone, cues from sexually vigorous males can 
overcome that inhibition. Moreover, they suggest that male cues can facilitate mechanisms of 
estradiol sensitization. We recommend that quality control studies be conducted at individual 
institutions to assess any impact of corncob bedding on animal physiology and behavior. 
 






Ovariectomized (OVX) rats are behaviorally more sensitive to subsequent injections of 
estradiol benzoate (EB) administered alone compared to the initial injection (Babcock et al., 
1988; Beach & Orndoff, 1974; Blaustein et al., 1987; Clark & Roy, 1983; Gerall & Dunlap, 
1973; Jones et al., 2013; Kow & Pfaff, 1975; Parsons et al., 1979; Whalen & Nakayama, 1965). 
Whereas the acute administration of EB alone partially activates lordosis, repeated 
administration potentiates lordosis and activates sexually appetitive behaviors (such as 
solicitations, hops/darts and ear wiggles). Recently we examined the time-course of this 
behavioral sensitization using three doses of EB that are commonly used to induce sexual 
behavior in the OVX rat. We found that in two strains of rats (Long-Evans and Wistars), 
sensitization is robust following administration of 5 or 10µg EB every four days (Jones et al., 
2013), particularly if females are not given the opportunity to copulate on every test (Jones & 
Pfaus, 2014). Moreover, in the absence of the opportunity to copulate, sensitization also occurs 
using 2µg EB, a dose that had previously been reported to be subthreshold at inducing sexual 
behavior without subsequent priming with progesterone (Jones & Pfaus, 2014). We are currently 
investigating the mechanisms that underlie this effect, using the dose that induced the most 
robust sensitization (10µg). In the present study we examined whether two housing factors might 
interfere with the effect. 
 Recently our animal care facility considered implementing corncob bedding in home 
cages. The primary advantage of this bedding is greater absorbency, which reduces bacterial 
growth and ammonia levels (Burn & Mason, 2005). The bedding is also beneficial to staff, since 
dust and allergens are reduced, and due to its increased absorbency, requires less frequent cage 
changes compared to wood chip bedding. However some groups have reported adverse effects of 
housing animals on corncob. Within two weeks, male and female (ovary-intact and OVX) rat 
sexual behavior was inhibited and ovarian cyclicity was disrupted (Mani, Reyna, Alejandro, 
Crowley, & Markaverich, 2005; Markaverich et al., 2007a; Markaverich, Alejandro, et al., 
2002a; Markaverich, Mani, et al., 2002b; Romero, Beltramino, & Carrer, 1990), effects that were 
reversed when returned to woodchip bedding or wire-mesh cages (Markaverich, Mani, et al., 
2002b). Although corncob is plant-based and may act as a phytoestrogen, the compound THF-
diols (tetradydrofuran diols), which appear to be the inhibitory agents in corncob bedding, do not 
compete for estrogen receptor (ER) binding sites in uterine tissue (Markaverich, Alejandro, et al., 
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2002a; Markaverich, Mani, et al., 2002b). However, Villalon Landeros et al. (2012) recently 
reported that male Californian mice housed on corncob exhibited differences in estrogen receptor 
alpha (ERα) signaling pathways in a number of brain regions associated with aggression, many 
of which are also implicated in rat sexual behavior. For example, they found fewer ERα-positive 
cells in the ventromedial hypothalamus (a region critical in the expression of lordosis, the 
concave arching of the back that permits penile intromission) and reduced numbers of 
phosphorylated ERK in the medial preoptic area and medial amygdala (regions that are 
implicated in sexually appetitive behaviors). Together these data suggest that compounds within 
corncob bedding do not act through ER, but merge and disrupt downstream ER signaling 
pathways.  This is problematic for studies investigating endocrine control of behavior. Given the 
implications this could have on the underlying mechanisms mediating the sensitization of sexual 
behaviors by chronic EB, we tested whether bedding type would alter this sensitization.  
 Olfactory cues from males might also affect the sensitization of female sexual behavior 
by repeated EB. Many rodent behaviors can be strongly influenced by olfactory cues, and 
enhanced in the presence of estradiol. For example the exposure of nulliparous and/or OVX 
female rats to pup odors can stimulate maternal behavior (Mayer & Rosenblatt, 1980), and the 
facilitation of maternal behaviors in OVX pregnancy-terminated (gestational day 15) dams is 
accelerated in the presence of estradiol (Stolzenberg et al., 2009). Olfactory stimuli from a 
sexually vigorous male may also be involved in mating-induced enhancement of sexual 
behaviors in estradiol-primed OVX rats repeatedly mated within an episode of heat (Rajendren et 
al., 1990). Moreover, female rats in estrus have an unconditioned preference for a sexually 
vigorous male (Agmo, 1999; Sakuma, 2008), an effect dependent on the presence of estradiol, 
and an intact medial preoptic nucleus (Sakuma, 2008; K. Xiao, Kondo, & Sakuma, 2005). Thus, 
if reducing exposure to cues (e.g., olfactory, auditory, visual) from the male (by housing the 
sexes in separate rooms), influences the development of the behavioral sensitization to EB, it 
may help pinpoint the underlying neural pathways involved.  
The current study examined whether housing females on corncob versus Sani-Chips 
bedding, or whether housing males and females in separate colony rooms, would alter sexual 
behavior in fully primed (EB+P) females, or the sensitization of sexual behaviors following 




Materials and Methods 
This experiment was conducted in accordance with the ethical standards established by 




Long-Evans female rats weighing approximately 150-200g were purchased from Charles 
River Laboratories (St-Constant, Quebec) where they were housed on Beta Chip® until weaning, 
then group housed in stainless steel cages with mesh bottoms. Upon arrival to our facilities, they 
were housed in pairs in clear Plexiglass chambers lined with either Sani-chips (category 7090A, 
Harlan, Montreal, Quebec) or corncob bedding (1/4” category 7097, Harlan, Montreal, Quebec) 
until the end of the experiment (total of 11 weeks). All colony rooms were maintained on a 12-
hour reversed light cycle (lights on at 8PM) at approximately 21ºC. Animals had ad lib access to 
standard laboratory chow (Charles River #5075) and tap water. They were given a week of 
acclimatization to the animal facilities and handled daily from days 4 to 7, when they were OVX.  
Sexually experienced Long-Evans males (housed 3-4/cage) obtained from the same 
supplier, were housed on Sani-chips bedding, and used as stimulus animals for training and test 
sessions. Each male was only used once on each training or test day, and assigned randomly to 
the female. Whereas females were strictly returned to their assigned colony room, males were 
returned at random (but never to a “female-only” room). Thus, they were always housed in a 
room that contained females. 
 
Ovariectomy 
 Ovariectomies (OVX) were performed following an i.p. injection (1mL/kg) of ketamine 
(50mg/mL; 50 mg/mL; Ketaset©, Wyeth Canada) and xylazine hydrochloride (4mg/mL; 
Rompum©, Bayer Healthcare) mixed at ratio of 4:3 respectively. When animals were no longer 
responsive to a foot pinch, the eyes were lubricated with drops (Natural Tears, Alcon), and ears 
were punched for identification purposes.  They were then bilaterally OVX via a single lumbar 
incision. Polysporin was applied to the incision site, and Flunixin Meglumine 2.5 mg/kg/mL 
(Banamine©) and 5 mg/kg/mL Enrofloxacin (Baytril©) were given by SC injection. Animals 





 Estradiol benzoate (10µg) was dissolved in 0.1mL of sesame oil, and injected SC 48 
hours prior to each training and test session. Progesterone (500µg) was dissolved in 0.1mL 
sesame oil and injected SC 4 hours prior to each training session. 
 
Treatment Conditions 
 One of the more practical advantages of using corncob bedding is it requires less frequent 
cage changes compared to woodchip beddings. One potential explanation for disrupted sexual 
behavior reported in animals housed on corncob bedding is the frequency of cage changes, and 
subsequently less frequent handling (Castelhano-Carlos & Baumans, 2009). For example, 
locomotor activity and grooming behaviors are increased on cage cleaning days (Saibaba, Sales, 
Stodulski, & Hau, 1996), and increased heart rate, blood pressure (Duke, Zammit, & Lawson, 
2001), and corticosterone (De Boer, Koopmans, Slangen, & Van der Gugten, 1990) are observed 
following handling procedures.  Good laboratory practices include handling of animals to 
minimize stress, by reducing the novelty of the experimental conditions. Novelty and stress 
disrupt sexual behavior in rodents (Pfaus & Wilkins, 1995; Yoon, Chung, Park, & Cho, 2004), 
and cage cleaning induces a stress response (Castelhano-Carlos & Baumans, 2009). Since 
corncob bedding requires less frequent cage changes, variations in handling and stress responses 
may account for these differences. Therefore, to control for the potential confound, cage change 
frequency was experimentally controlled. Sani-chips bedding was changed on a bi-weekly 
schedule, whereas corncob bedding was changed on a weekly schedule. However females 
housed on corncob also received a “sham-cage change”, such that they were simply lifted out of 
their cage, and placed back in, on days coinciding with the second cage change of Sani-chips 
animals. This ensured that handling was consistent between all groups. All cage changes were 
done in the afternoon (i.e., never prior to training or testing) to minimize the potential impact of 
cage changes on test days.  
To determine whether the presence of males housed in the same room as females would 
affect the sensitization of female sexual behavior, females on each bedding type were housed in 
either a female-only room or a room housing both males and females. Hence, this experiment 
consisted of a total of four groups according to housing condition: corncob in a room with males 
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(CC/M; n=8), corncob in a female-only room (CC/F; n=8), Sani-chips in a room with males 
(SC/M; n=9), or Sani-chips in a female-only room (SC/F; n=8).  
 
Apparatus and Sexual Behaviors 
 All training and test sessions took place in unilevel pacing chambers (46x39x37cm), 
bisected by a clear Plexiglas® divider with 4 square holes cut in the bottom (5x4cm), with the 
size adjusted such that the smaller female could pass but the larger male could not. The dustpan 
of the chamber contained Sani-chips, which lied below an elevated (1”) metal grid floor.  
Sexually appetitive behaviors included hops/darts, and full solicitations (a headwise 
orientation towards the male followed by a runaway) (Erskine, 1989; McClintock, 1984; Pfaus et 
al., 1999). Lordosis magnitudes were coded on a 3-point scale according to the intensity of 
dorsiflexion, and lordosis quotient (LQ) was calculated by taking the sum of lordosis postures 
divided by the sum of mounts, intromissions and ejaculations x 100 (Hardy & Debold, 1971b). 
Kicks and prone positions were coded as female defensive behaviors (Barnett, 1963). Male 
mounts, intromissions and ejaculations were also coded. 
 
Training and Testing Procedures 
 Following a one-week recovery period from surgery, females were put into heat with EB 
(10µg) and P (500µg) prior to each of 4 training sessions at 4-day intervals, followed by a 2-
week hormone washout period. Next, females were tested with 10µg EB-alone at 4-day intervals 
for 8 test sessions. Training and test sessions always began by placing a male in the 4-hole 
pacing chamber for a 5-minute period prior to introduction of the female. Females were placed 
on the empty side of the chamber and the pair was left to copulate for 30 minutes. All training 
and test sessions were video-recorded using a Sony Handycam Camcorder. Videos were 
uploaded to a personal computer, and behaviors were scored blindly using the Behavioral 
Observation Program (Cabilio, 1996), customized for rat sexual behavior. 
 
Statistical Analyses  
 A preliminary analysis first tested whether bedding type, or housing females in a room 
with or without males, would affect sexual behavior on the final training day when primed fully 
with 10µg EB + 500µg P, using a two-way ANOVA with bedding type and presence of males as 
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between subject factors. Next, to test the primary hypotheses, a 3-way mixed ANOVA was used 
by entering test as the within subject’s factor, and housing condition (bedding type, male housing 
condition) as between subject factors. Significant interactions were further analyzed with simple 
effect analyses using Sidak’s post-hoc test. A significant linear contrast using linear trend 
analysis was used to determine whether sensitization occurred (Jones et al., 2013; Keppel & 
Wickens, 2004). Eta squared (η2) and Cohen’s d are reported as measures of effect size. To 
overcome a statistical limitation on the analysis of LQ (given that no female in the CC/F group 
was consistently mounted across tests), a one-way ANOVA was conducted on each test day, to 
assess differences between groups. Chi-square analyses were used to test the proportion of 
females mounted on every test across groups, and Phi is presented as a measure of effect size. 
The level of significance for all analyses was set at p<0.05. All data are presented as mean 
(±SEM) unless otherwise indicated. 
  
Results 
Sexual Training with EB+P  
As shown in Table 1, housing females on Sani-chips in a room that only housed females 
(SC/F) induced more LM3 compared to females housed on corncob in a female-only room 
(CC/F; p<0.001, d=2.97) or on Sani-Chips in a room with males (SC/M; p=0.031, d=2.27) 
(significant bedding*male interaction, F(1,29)=5.74, p=0.023, η2=0.15). In addition, those 
females (SC/F) received more intromissions compared to those housed on Sani-Chips in a room 
that also housed males (SC/M; p=0.028, d=2.31) and tended to receive more than those housed 
on corncob in a room that only contained females (CC/F; p=0.06, d=1.95) (significant 
bedding*male interaction, F(1,29)=6.28, p=0.018, η2=0.18). Although the interaction between 
bedding and male condition on hops/darts approached statistical significance, the effect size was 
rather small, F(1,29)=4.15, p=0.051, η2=0.12, and simple effects analyses failed to detect any 
specific group differences (all p>0.09). No effects were detected on any other measure. 
 
Sensitization of sexual behaviors by EB-alone 
Lordosis. Some females were not mounted on every test limiting the statistical analyses 
on LQ (SC/F, n=6; SC/M, n=1; CC/F, n=0; CC/M, n=5). As shown in Figure 1A, fewer females 
were consistently mounted across tests in the CC/F group compared to the CC/M (𝛸𝛸2=7.28, 
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p=0.007 Phi=0.67) and SC/F (𝛸𝛸2=9.60, p=0.002, Phi=0.78), and fewer were consistently 
mounted in the SC/M compared to the CC/M (𝛸𝛸2=4.90, p=0.027, Phi=0.54) and SC/F groups 
(𝛸𝛸2=7.14, p=0.008, Phi=0.65) the lack of females consistently mounted in the CC/F group 
resulted in their exclusion from the repeated measures analyses, and as such the bedding*male 
and test*bedding*male interactions could not be properly assessed. Nevertheless, sensitization of 
LQ did occur in the remaining groups as depicted in Figure 1B (Flinear(1,9)=57.35, p<0.001, 
η2=0.84). Significantly higher LQ occurred on tests 5 (p=0.038, d=1.32), 6 (p=0.046, d=1.28), 
and 8 (p=0.033, d=1.34) compared to the first test (main effect of test, F(7,63)=12.77, p<0.001, 
η2=0.57). The main effects of bedding type, presence of males in the room, nor any of the 
interactions met statistical significance. 
 
Table 1 
Mean (±SEM) of sexual behaviors of Long-Evans female rats on training day 4 (primed 
fully with 10µg EB + 500µg P) and housed on either sanichip or corncob bedding in a 
room that housed females only, or males and females. 
 Sanichip   Corncob 
 Female-Only Male/Female   Female-Only Male/Female 
LQ 93.75±6.25 
(8) 
100±0.00 (7)   95.96±2.63 
(7) 
100±0.00 (8) 
LM1 2.62±1.24 1.67±0.99   5.75±2.16 3.12±1.01 
LM2 13.00±2.82 9.00±4.22   13.25±4.07 12±2.33 
LM3 26.88±7.02a,b 12.56±3.16a   7.62±3.89b 15.00±3.17 
Hops/Darts 71.50±11.20 43.78±10.53   45.12±10.94 64.12±13.13 
Solicitations 4.50±1.44 1.89±1.19   3.38±1.43 4.38±2.13 
Defenses 0.12±0.12 0.89±0.68   0.88±0.52 0.75±0.41 
Mounts 24.5±6.49 13.22±4.59   16.12±4.05 14.75±2.29 
Intromissions 15.75±3.34a 8.11±1.70a   9.12±2.12 13.38±2.15 
Ejaculations 2.38±0.38 1.89±0.39   1.88±0.44 2.00±0.42 








Figure 1. Females were housed either on Sani-Chips (SC) or corncob (CC) bedding in a room 
that only housed females (F) or also housed males (M). A. Percentage of females that were 
consistently mounted across the 8 estradiol sensitization tests following different housing 
conditions. Fewer CC/F (0/8) and SC/M (1/9) were mounted on every test compared to SC/F 
(6/8) and CC/M (5/8). B. Mean (SEM) LQ of females that were consistently mounted across all 
tests. C. Mean (SEM) LQ of females that were mounted on each given test day (see Table 2 for 
number of animals included on each test). aSignificantly greater than CC/F and SC/M groups. 
bDifference between CC/F and CC/M. cLower in CC/F compared to CC/M and SC/M.  





To partly overcome the statistical limitation of the mixed ANOVA caused by no female 
in the CC/F and only one female in the SC/M group being consistently mounted, a one-way 
ANOVA was conducted on each test day to assess differences between groups, which revealed 
that housing females on corncob in a female only room may have had a short-term inhibitory 
effect on the display of LQ. Figure 1C displays the average LQ of all females in each group that 
were mounted on a given test day. The pattern of LQ of the CC/F females was generally similar 
to that of the other groups on later tests, suggesting that sensitization did occur; however group 
differences were detected on early tests during the development of sensitization. There were no 
differences on test 1, but on Test 2 CC/F tended to have a lower LQ than SC/M (p=0.047, 
d=2.86) (trend toward a significant main effect of group, F(3,27)=2.92, p=0.052, η2=0.24). 
Group differences emerged on Test 3 such that CC/F had a lower LQ than CC/M (p=0.006, 
d=3.74) (main effect of group, F(3,24)=4.70, p=0.10, η2=0.370) and on Test 4 CC/F had a lower 
LQ than both groups housed with males (CC/M, p=0.001, d=4.38; SC/M, p=0.001, d=4.46) and 
tended to have a lower LQ than SC/F (p=0.066, d=2.73) (main effect of group, F(3,25)=8.52, 
p<0.001, η2=0.51). However despite these strong effects, the group differences disappeared by 
Test 5 and no further differences were detected on LQ throughout the remainder of the 
experiment.  
LM1 sensitized across tests as shown in Figure 2A (Flinear(1,29)=4.37, p=0.045, η2=0.12). 
Fewer LM1 were observed on test 4 compared to tests 6 (p=0.047, d=0.60) and 7 (p=0.034, 
d=0.62) (main effect of test, F(7,203)=3.00, p=0.005, η2=0.08). In addition, females that were 
housed in a room with males (i.e., SC/M and CC/M) displayed more LM1 on test 2 compared to 
test 4 (p=0.008, d=0.99), and displayed more LM1 on test 2 (p=0.031, d=2.27) and tended to 
display more on test 3 (p=0.051, d=2.03) compared to females that were housed in a female-only 
room (significant test*male presence interaction, F(7,203)=2.74, p=0.010, η2=0.08). 
LM2 also sensitized across tests as shown in Figure 2B, Flinear(1,29)=10.38, p=0.003, 
η2=0.26. Fewer LM2 were observed on Test 1 compared to all subsequent tests (all p<0.02 and 
d>0.65) except test 4 (main effect of test, F(7,203)=4.77, p<0.001, η2=0.13). No other effects 
were found. 
LM3 also sensitized across tests as shown in Figure 2C (Flinear(1,29)=42.99, p<0.001, 
η2=0.58). Fewer LM3 were observed on test 1 compared to all subsequent tests (all p<0.02, 
d>0.65), and fewer were seen on Test 2 compared to tests 4-8 (all p<0.05. d>0.60) (main effect 
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Figure 2. Lordosis magnitudes of females were housed either on Sani-Chips (SC) or corncob 
(CC) bedding in a room that only housed females (F) or also housed males (M). aSignificant 
linear trend. bDifferent from tests 6 and 7 c Different from test 4 in females housed with males 
(SC/M and CC/M groups). dDifference between male housing conditions. eDifferent from test 1. 





 of test F(7,203)=12.28, p<0.001, η2=0.28). However, housing females on corncob without the 
presence of males in the room appears to inhibit the display of LM3. CC/F females displayed 
fewer LM3 overall compared to CC/M (Mdiff=12.80±5.66, p=0.031, d=2.26), and SC/F 
(Mdiff=13.02±5.66, p=0.029, d=2.30) (significant bedding*male presence interaction, 
F(1,29)=6.04, p=0.20, η2=0.16). No other effects were detected. 
Appetitive Behaviors. Hops/darts sensitized across tests (Flinear(1,29)=47.82, p<0.001, 
η2=0.61) as shown in Figure 3A. Fewer hops/darts were displayed on test 1 compared to all 
subsequent tests (all p<0.03, d>0.63) and fewer occurred on test 2 compared to tests 5-8 (all 
p<0.007, d>0.73), and the most hops/darts occurred on test 7, such that it was significantly 
greater than tests 1-4 (all p<0.038, d>0.62) and test 6 (p=0.012, d=0.82) (main effect of test, 
F(1,29)=47.82, p<0.001, η2=0.34). Moreover, CC/F displayed significantly fewer hops/darts than 
CC/M, (Mdiff=20.31±8.64, p=0.026, d=2.35) and fewer than SC/F, (Mdiff=19.87±8.64, p=0.029, 
d=2.30) (significant bedding*male presence interaction, F(1,29)=4.21, p=0.049, η2=0.11). No 
other effects were detected. 
The number of full solicitations also sensitized across tests Flinear(1,29)=6.92, p=0.014, 
η2=0.18, as shown in Figure 3B. More solicitations were observed on test 3 compared to tests 1 
(p=0.034, d=0.62) and 4 (p=0.035, d=0.62), and more were observed on test 7 compared to tests 
1 (p=0.002, d=0.81), 4 (p=0.002, d=0.79), 6 (p=0.038, d=0.62) and 8 (p=0.048, d=0.60) (main 
effect of test, F(7,203)=7.64, p<0.001, η2=0.19). Moreover, females housed on corncob bedding 
tended to display fewer solicitations overall compared to those on Sani-Chips (trend toward a 
main effect of bedding: F(1,29)=4.09, p=0.053, η2=0.12). No other effects were detected. 
Female defenses. The number of defensive behaviors generally decreased across tests 
(Flinear(1,29)=17.05, p<0.001, η2=0.33) as displayed in Figure 3C. More defensive behaviors 
occurred on test 2 compared to tests 4 (p=0.031, d=0.63), 7 (p=0.022, d=0.65), and 8 (p=0.043, 
d=0.61) (main effect of test, (F(7,203)=5.02, p<0.001, η2=0.13). No other effects were detected. 
Male Behaviors. As shown in Figure 4A, the number of mounts received from males 
increased across tests (Flinear(1,29)=18.59, p<0.001, η2=0.39). Fewer mounts were received on 
test 1 compared to all subsequent tests (all p<0.03, d>0.63) except test 3 (main effect of test, 
F(7,203)=5.72, p<0.001, η2=0.16). In addition, CC/F received fewer mounts than CC/M 
(Mdiff=10.18±4.68, p=0.038, d=2.18) (significant interaction between bedding and male presence, 
F(1,29)=4.77, p=0.037, η2=0.14). No other effects were detected. 
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Figure 3. Appetitive and defensive behaviors displayed by females that were housed either on 
Sani-Chips (SC) or corncob (CC) bedding in a room that only housed females (F) or also housed 
males (M). aSignificant linear trend. bDifferent from test 1. cDifferent from tests 1 and 2. 
dDifferent from tests 1, 2 and 6. eDifferent from CC/F. fDifferent from test 1 and 4. gDifferent 
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Figure 4. Number of mounts, intromissions and ejaculations received by the male in females that 
were housed either on Sani-Chips (SC) or corncob (CC) bedding in a room that only housed 
females (F) or also housed males (M). aSignificant linear trend. bDifferent from test 1. cDifferent 






The number of intromissions (Figure 4B) received also increased across tests 
(Flinear(1,29)=30.04, p<0.001, η2=0.49). Fewer intromissions were received on test 1 compared to 
all subsequent tests (all p<0.001, d>0.85), and fewer were received on test 2 compared to test 7 
(p=0.017, d=0.67) (main effect of test, F(7,203)=11.17, p<0.001, η2=0.26). In addition, CC/F 
received fewer intromissions than CC/M (Mdiff=7.38±2.84, p=0.015, d=2.60) and SC/F 
(Mdiff=7.14±2.84, p=0.018, d=2.51) (significant interaction between bedding and male presence, 
F(1,29)=5.49, p=0.026, η2=0.14).  
The number of ejaculations (Figure 4C) received increased across tests 
(Flinear(1,29)=24.63, p<0.001, η2=0.43). Significantly fewer ejaculations were received on test 1 
compared to all subsequent tests (all p<0.003, d>0.78) (main effect of test, F(7,203)=7.37, 
p<0.001, η2=0.19). Although CC/F animals tended to receive fewer ejaculations than SC/F 
(Mdiff=0.80±0.35, p=0.031, d=2.29) and CC/M (Mdiff=0.68±0.35, p=0.06, d=1.94), the interaction 
between housing conditions only approached statistical significance with a relatively small effect 
size, F(1,29)=3.38, p=0.076, η2=0.09. 
 
Discussion 
The main goal of this study was to assess whether OVX Long-Evans rats would display 
behavioral sensitization of sexual behaviors following the repeated administration of EB while 
manipulations were made to their housing conditions, either by housing them on corncob 
bedding or in a room separate from males. Our main finding is that the sensitization of sexual 
behaviors by repeated administration of EB occurs regardless of housing conditions. However 
housing females on corncob bedding in a room separate from males inhibits sexual behavior 
when primed with EB alone, but this inhibition is overcome by exposure to male cues. The data 
also show that estradiol sensitization is a robust effect, since it occurs in a paradigm where 
sexual behavior is inhibited and the magnitude of the sensitization was robust (as reflected in the 
effect sizes). A secondary finding is that in females primed with EB+P, sexual behavior was not 
inhibited in any condition on the final training day. Thus, despite research suggesting that 
corncob bedding may disrupt estrous cyclicity and attenuate sexual behavior in male and female 
Sprague-Dawley rats, this study demonstrates that corncob bedding supplied from Harlan 
(Montreal, Canada) does not inhibit sexual behavior of OVX Long-Evans rats when primed with 
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EB+P, nor does it inhibit sexual behavior when females are primed with EB alone if those 
females are continuously exposed to male cues by housing them in the same room. As such, the 
disruption of endocrine-dependent behaviors by corncob bedding may interact with other 
housing conditions, and has the potential to be overcome. 
Sexual behavior was inhibited in females housed on corncob in a room separate from 
males when treated with EB alone. CC/F animals had a lower LQ on earlier tests, and displayed 
lower levels of the highest quality of lordosis (LM3), fewer H/D, and received fewer mounts and 
intromissions overall. They also tended to display fewer full solicitations and to receive fewer 
ejaculations from the male overall. The inhibitory effect on LM3 may be reproductively relevant, 
since the occurrence of at least one LM3 is more likely to induce the neuroendocrine changes 
associated with pregnancy/pseudopregnancy (Lehmann & Erskine, 2004). These results suggest 
that sexual behavior is inhibited in females housed on corncob bedding but only if they are 
housed in a room separate from males, and that the inhibitory effect on LQ can be overcome with 
repeated EB treatments. Moreover, cues from sexually vigorous males can buffer against any 
inhibitory effect of corncob bedding on female sexual behavior since no inhibitory effect was 
seen in females housed on corncob bedding if they were housed in a room that also housed males. 
Although from the current study it is not clear whether olfactory, auditory, or visual cues (or any 
combination of those cues) contribute to the effect, the data suggest that continuous exposure to 
male cues can facilitate the sensitization of sexual behaviors that occurs with repeated 
administration of estradiol. 
We found that corncob bedding was not inhibitory to sexual behavior on the final training 
day when females were primed with EB+ P, regardless of housing condition. This contrasts with 
other reports in the literature (Markaverich et al., 2007a; Markaverich, Alejandro, et al., 2002a; 
Markaverich, Mani, et al., 2002b; Romero et al., 1990). Although the details of housing 
conditions, such as bedding type and whether animals are housed in rooms that contain both 
sexes, are not frequently reported, informal discussions with colleagues revealed that a number 
of investigators use corncob bedding without any negative effects on sexual behavior. Our data 
suggest that since those groups also study sexual behavior, males and females may have shared 
housing rooms (as is customary in our lab) and therefore any inhibitory effect of corncob 
bedding was overcome. Whether sexes were housed in the same rooms in those studies that 
reported an inhibitory effect of corncob bedding (Mani et al., 2005; Markaverich et al., 2007a; 
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Markaverich, Alejandro, et al., 2002a; Markaverich, Mani, et al., 2002b; Romero et al., 1990; 
Villalon Landeros et al., 2012) is unclear.  
 One other possible explanation for lack of inhibition in our study (when females were 
primed with EB+P) compared to those of Markaverich’s group (2005; 2007a; 2002a; 2002b; 
1990) may be handling. We attempted to control for amount of handling associated with the 
differences in cage change frequency, and it is unclear whether this factor could account for the 
inhibitory effects found in the Markaverich studies. Animals housed on woodchip beddings 
(such as Beta Chip or Sani-Chips) compared to corncob bedding have their cage changed more 
frequently, since the increased absorbency of corncob bedding allows for less frequent changing 
(Burn & Mason, 2005). Cage changes are stressful for animals (Castelhano-Carlos & Baumans, 
2009; De Boer et al., 1990; Duke et al., 2001), and stress and handling are known to affect sexual 
behavior (Pfaus & Wilkins, 1995; Yoon et al., 2004). The increased frequency of cage changing 
with woodchips may allow the animal to learn more quickly that this procedure is not threatening, 
and subsequently lead to an attenuated stress response and normal levels of sexual behavior.  
Alternate explanations may also include strain and species effects, and differences in 
steroid hormone administration or sensitivity. The disruptive effects of corncob bedding on 
sexual behaviors and reproductive physiology of male and female rats were performed in the 
Sprague-Dawley strain (Mani et al., 2005; Markaverich et al., 2007a; Markaverich, Alejandro, et 
al., 2002a; Markaverich, Mani, et al., 2002b; Romero et al., 1990), and those females were 
treated with lower levels of steroid hormones (2µg EB + 100µg P). Numerous reports exist 
within the literature outlining strain effects on various physiological and behavioral measures 
(e.g., Brand & Slob, 1991; Maswood, Sarkar, & Uphouse, 2008; Miryala, Hiegel, & Uphouse, 
2013; Sachs, 1996; Sarkar, Hiegel, Maswood, & Uphouse, 2008; Uphouse et al., 2002). We have 
found that albino Wistar rats are behaviorally more sensitive to EB compared to the pigmented 
Long-Evans strain (Jones et al., 2013), whereas others have reported that 10µg EB administered 
alone failed to induce both lordosis and appetitive behaviors in albino Sprague-Dawley rats 
(Mani, Blaustein, Allen, Law, O’Malley, & Clark, 1994), suggesting strain differences in 
sensitivity to EB. Additionally, species differences regarding the effects of corncob bedding on 
neuroendocrine signaling may interact with differential sensitivities to steroid hormones. 
Impaired ERα signaling was reported in California mice (Villalon Landeros et al., 2012), and it 
is well known that ERα activation is important in the induction of female rat sexual behavior, 
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which suggests that ERα signaling was not disrupted in our rats when primed with EB+P or 
housed with males. This is consistent with reports showing that the active compound THF-diol in 
corncob bedding (which appears to be the compound involved in the inhibition of sexual 
behavior and cyclicity) does not compete for ER binding sites in the rat (Markaverich, Alejandro, 
et al., 2002a), which may reflect species differences in signaling pathways associated with 
corncob bedding. Relatedly, plasma levels of THF-diols were not increased in mice housed on 
corncob bedding when treated with the aromatase inhibitor fadrozole, as opposed to those treated 
with saline (Villalon Landeros et al., 2012); it was thus proposed that fadrozole may decrease 
fatty acid clearance, subsequently decreasing plasma levels of THF-diols (Villalon Landeros et 
al., 2012). Although speculative, strain and species differences in fatty acid metabolism may 
therefore explain differential responses to corncob bedding when primed with EB+P. 
It is also possible that some of the discrepancy in findings can be accounted for by 
variations in bedding composition (for example, variations in phytoestrogenic compounds from 
the variety of corn used, concentration of THF-diols, or other compounds, between lot numbers, 
or suppliers). In fact, the corncob bedding was produced by different suppliers throughout the 
research groups described here (Andersons, USA; Green Products company, USA; Harlan, 
Canada), and although THF-diols have been detected in corncob beddings by a variety of 
manufacturers (Markaverich, Mani, et al., 2002b), it is unclear whether beddings of Canadian 
manufacturers were assessed.  
Housing conditions between animal supplier facilities (i.e., during the perinatal period) 
may also account for differences in physiology and behavior. For example, the early perinatal 
environment, particularly by exposure to sex steroid hormones and endocrine disruptors, can 
have substantial effects on factors such as reproductive physiology and behaviors, brain 
morphology, and protein expression (Frye et al., 2012; Khurana, 2000; MacLusky, Bowlby, 
Brown, Peterson, & Hochberg, 1997; Patisaul & Polston, 2008; Pereira, Curvalho, & Cdos, 
1997; Phoenix, Goy, Gerall, & YOUNG, 1959). Aromatizable androgens during the perinatal 
period masculinize and defeminize sexually dimorphic brain areas and behaviors, and there is 
evidence that THF-diols present in corncob bedding may regulate aromatase activity 
(Markaverich, Crowley, Rodriquez, Shoulars, & Thompson, 2007b). As such, it would be 
important to determine whether THF-diols act as, or influence the synthesis or activity of, 
aromatizable androgens particularly in sexually dimorphic brain areas. If so, this would explain 
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why THF-diols do not bind ER (Markaverich, Alejandro, et al., 2002a; Markaverich, Mani, et al., 
2002b), but do affect downstream ERα signaling pathways (Villalon Landeros et al., 2012). If 
THF-diols increase aromatization of androgens to estrogens, then early perinatal exposure to 
corncob (and other critical periods, such as puberty) may disrupt activational effects of hormones. 
The animals in our study were housed on woodchip bedding during the perinatal period, and 
exposed to corncob only upon arrival to our facilities, whereas in the studies reported by 
Trainor’s group (2013; 2012), animals were continuously housed on corncob bedding. Trainor et 
al., (2013) recently suggested that housing on corncob bedding during development may 
masculinize brain circuits controlling behavioral responses to social defeat, since females housed 
on corncob (rather than Sani-Chips) behave more male-like.  Although perinatal exposure to 
aromatizable androgens on sexually differentiated behaviors are typically considered permanent, 
we have recently found that the decrease in sensitivity to the activational effects of sex steroid 
hormones in prenatally androgenized female rats can be overcome with sexual experience (Jones, 
S.L., Cordeaux, E., Germé, K., Pfaus, J.G., submitted), suggesting that any potential endocrine 
disrupting effects on sexual behavior by perinatal housing on corncob bedding may also be 
reversible. Importantly, Markaverich et al. (2002b) using a within-subjects design, were able to 
reverse the detrimental effects of corncob bedding by returning the animals to woodchips 
bedding or wire-mesh cages. Thus, although corncob bedding may be inhibitory to sexual 
behavior through alterations in steroid hormone signaling perinatally or in adulthood, there is 
evidence to suggest that that inhibition may be reversible. 
Housing females on Sani-chips separately from males (SC/F) facilitated sexual behaviors. 
During the training phase when those females were fully primed with EB+P, they displayed 
more high quality lordoses (LM3) and received more intromissions than females housed on Sani-
chips in a room with males. During the estradiol sensitization paradigm, SC/F animals were more 
likely to be consistently mounted across tests, but there were no beneficial effects of housing 
females alone on LM during the tests of estradiol sensitization. Together those results suggest 
that male sexual motivation was greater towards the “novel” SC/F females (novel since males 
were only ever exposed to them during test days) and that female sexual arousal was facilitated. 
Since a higher quality LM (LM3) was facilitated when SC/F females were primed with EB+P 
(but not when treated with EB alone), it is possible that progesterone signaling facilitates an 
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increase in female sexual arousal when those females are not given continuous exposure to male 
cues.  
The greater number of males mounting SC/F compared to SC/M animals is reminiscent 
of the Coolidge effect, a phenomenon whereby sexual behavior is reinstated in a sexually 
satiated male, or maintained for a longer period of sexual activity in sexually active males, by 
presentation of a novel female (Beach & Jordan, 1956). The data presented here suggest that the 
cues (e.g., estrous odors, or ultrasonic vocalizations) of a novel female (i.e., housed in a separate 
room) primed with EB can stimulate sexual activity in males when those females are housed on 
woodchips (i.e., Sani-chips). The cues associated with a novel female might trigger an increase 
in mesolimbic dopamine, stimulating the initiation of sexual behavior (Fiorino, Coury, & 
PHILLIPS, 1997), since neural firing increases in the nucleus accumbens, (a brain region 
implicated in appetitive sexual behaviors) in sexually-naïve males presented with estrous odors 
from a novel colony compared to females from a familiar colony (Wood, Kosobud, & Rebec, 
2004). The pathway mediating an increase in sexual motivation may be through the vomeronasal 
organ, whose activation is reduced (as measured by Fos-IR) in non-copulating males compared 
to sexually active males in response to estrous odors (Portillo & Paredes, 2004). Males are 
capable of attending to cues associated with a familiar female that predicts sexual reward (Ismail 
et al., 2009; 2011), and quickly learn to inhibit mounting sexually non-receptive females (Pfaus 
& PINEL, 1989). Thus, it is also possible that housing males and females in the same room 
might elicit a frustration phenomenon in males towards those females, such that all attempts to 
escape their cage and reach the sexual partner were unsuccessful. As such, when the animals are 
presented in the testing chambers, the motivation to mount the female may be reduced. A similar 
frustration phenomenon was proposed in female rats receiving clitoral stimulation in the 
presence of an inaccessible male restricted behind a screen (Parada et al., 2011). This inhibitory 
effect may have been overcome by housing the females on a “novel” bedding since CC/M 
females were also more likely to be mounted than SC/M and CC/F females, but it is unclear why 
this occurred.  
 
Conclusion 
Housing conditions are known to have an important influence of experimental outcomes, 
and as such it is important to consider how the conditions potentially impact study parameters. 
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Here we have shown that corncob bedding supplied in Canada from Harlan does not disrupt the 
sexual behavior of OVX Long-Evans rats treated with EB+P regardless of whether they are 
housed with males or not, nor does it disrupt the sensitization of female sexual behaviors by 
repeated treatment with EB-alone. However, if females were housed on corncob in a room 
separate from males, their sexual behavior was inhibited when treated with EB-alone. We have 
also shown that housing females on woodchip bedding (Sani-Chips) in a separate room from 
males may increase male sexual motivation towards those females and female sexual arousal 
when primed with EB-alone. In summary, the broad implications of these findings are that the 
beneficial effects of corncob bedding in animal husbandry can be applied to groups studying 
sexual behavior as long as males and females are housed in the same room (which is not an 
inconvenience since it is commonplace in the study of sexual behavior). Nevertheless, we 
recommend that quality control studies be conducted at individual institutions and research 
groups to assess any negative impact of corncob bedding on endocrine-dependent physiology 
and behavior.  
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4.2. Behavioral defeminization by prenatal androgen treatment in rats is overcome by 
sexual experience in adulthood  
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Exposure to testosterone during a critical period of prenatal development prevents the 
normal display of sexual behaviors in adult ovariectomized (OVX) rats treated with estradiol 
benzoate (EB) and progesterone (P). The organizational hypothesis posits that prenatally 
androgenized females (PNAFs) are desensitized to EB. We tested this hypothesis by first treating 
PNAFs with varying doses of EB (2.5, 5, 10, 20µg) and P (500µg), and second by subjecting 
females to an established estradiol sensitization paradigm where females are first given sexual 
experience with EB (10µg)+P prior to repeated testing with EB alone. Long-Evans females were 
androgenized in utero by a SC injection of 500µg testosterone propionate or the oil control to 
pregnant dams on gestational day 18. Female offspring were OVX on postnatal day 80 and tested 
one week later in the unilevel 4-hole pacing chamber. Genital tissue was defeminized in PNAFs, 
and the lordosis quotient (LQ) and partial (i.e., hops/darts) and full solicitations were 
significantly lower, while defensive behaviors were higher, in PNAF females, relative to non-
PNAF females regardless of acute EB priming. However, repeated testing with EB alone (10µg), 
or EB+P eliminated the differences between groups on LQ and hops/darts, indicating that the 
behavioral deficit can be overcome by sexual experience. These results suggest that PNAFs are 
not desensitized to EB, and despite morphological differences in genital development, the 
deficiency in sexual behavior in response to acute EB+P can be experientially overcome. 
However PNAFs appear to have a deficit in the expression of full solicitations. 
 





The hormonal environment during the perinatal period organizes reproductive and neural 
tissue in such a way that steroid hormone administration in adulthood differentially activates 
sexually dimorphic sexual behaviors (Janis L Dunlap, Gerall, & Carlton, 1978; Gerall & Ward, 
1966; Phoenix et al., 1959; Rhees, Kirk, Sephton, & Lephart, 1997). The presence of biologically 
active aromatizable androgens during the critical perinatal period in rodents induces 
masculinization and defeminization, whereas the absence of androgens, results in feminization.  
Behaviorally, perinatally androgenized rodents gonadectomized in adulthood display male-
typical sexual behaviors in response to androgens, whereas priming with estradiol benzoate (EB) 
and progesterone (P) fails to elicit female-typical sexual behaviors, regardless of chromosomal 
sex. If, on the other hand, androgens are not present during this critical period, animals fail to 
display male-typical sexual behaviors in response to androgens in adulthood, and instead will 
display female-typical sexual behaviors in response to EB and P. Similar effects of early 
hormone exposure are seen anatomically. For example, males and prenatally androgenized 
females (PNAF)s have a larger sexually dimorphic nucleus of the preoptic area (SDN-POA) 
compared to untreated females (Döhler et al., 1982; Gorski, Gordon, Shryne, & Southam, 1978; 
Gorski, Harlan, Jacobson, Shryne, & Southam, 1980), and genital morphology is masculinized 
by prenatal androgen treatment in females, resulting in a longer anogenital distance (Rhees et al., 
1997).  
Although it is commonly believed that the behavioral effects of perinatal hormonal 
disruption are permanent, earlier studies suggest that the deficits can be at least partially 
overcome by altering the hormonal priming conditions. Following gonadectomy in adulthood, 
both male and PNAF rats treated with estradiol and P display rates of lordosis similar to that 
observed in ovariectomized (OVX) rats in adulthood, provided estradiol is administered in a 
pulsed fashion (Olster & Blaustein, 1988; Södersten, Petterson, & Eneroth, 1983). In some cases, 
such males are also capable of displaying P-facilitated appetitive sexual behaviors such as ear-
wiggling (Södersten, 1976); but not more active forms such as hops and darts (Olster & 
Blaustein, 1988). Whether full solicitations (McClintock, 1984) can be restored in PNAF has 
never been examined. Thus, it is possible that the behavioral deficits can be restored in PNAF 
using higher hormonal priming EB doses given acutely in combination with P.  
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 Two critical hypothalamic regions that control female sexual behavior in a variety of 
species are the medial preoptic area (mPOA) and ventromedial hypothalamus (VMH). In adult 
female rats, estradiol binds to its receptors (ER) within the VMH to induce lordosis, as well as to 
promote P receptor synthesis in both these regions (MacLusky & McEwen, 1978). Progesterone 
binding to its receptor in the VMH potentiates lordosis, and binding within the mPOA induces 
sexually appetitive behaviors (such as hops/darts, solicitations, and ear wiggles) (Beyer et al., 
1997; Hoshina et al., 1994; Mani, Blaustein, Allen, Law, O’Malley, & Clark, 1994; Rubin & 
Barfield, 1983). Within these regions ER densities are sexually dimorphic in favor of females 
(Brown, MacLusky, Shanabrough, & Naftolin, 1990; Lauber, Mobbs, Muramatsu, & Pfaff, 
1991a; Lauber, Romano, & Pfaff, 1991b). This is mediated, at least in part, by aromatization of 
testosterone to estradiol during the perinatal period which organizes sexual differentiation of the 
brain and subsequent behavior (McCarthy, 2008; McCarthy, Schwarz, Wright, & Dean, 2008). 
Perinatal exposure to estradiol methylates the ERα promoter region, associated with a down-
regulation of ERα mRNA (DonCarlos, McAbee, Ramer-Quinn, & Stancik, 1995; Kurian, Olesen, 
& Auger, 2010). As such, early androgen exposure permanently reduces ERα expression, and it 
has been suggested that females are permanently desensitized to the activational effects of 
estrogens (MacLusky et al., 1997). In support of this, the expression of estradiol-induced P 
receptors is attenuated in PNAFs, suggesting that neurochemical events triggered by estradiol are 
disrupted (Foecking, Szabo, Schwartz, & Levine, 2005).  
 Although these data suggest a reduced responsivity of the androgenized female rat to 
estradiol, the degree of this insensitivity and whether it can be fully or partially rescued by 
subsequent hormonal treatment has not been fully explored. Thus in the first study described 
here we asked whether increasing the dose of EB when given acutely in combination with P, 
would facilitate sexual behavior. Next we tested whether prenatally TP-treated females would 
display behavioral sensitization to chronic EB. Although, acute administration of EB alone only 
partially activates female sexual behaviors repeated administration induces higher levels of 
sexual behaviors than the initial dose (Babcock et al., 1988; Beach & Orndoff, 1974; Blaustein et 
al., 1987; Clark & Roy, 1983; Gerall, Dunlap, & Hendricks, 1973; Jones et al., 2013; Kow & 
Pfaff, 1975; Parsons et al., 1979; Whalen & Nakayama, 1965). For example, we recently 
reported that when treated every four days, both OVX and OVX-adrenalectomized sexually-
experienced Long-Evans rats administered 5 and 10µg EB and given access to a sexually 
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vigorous male in a uni-level four-hole pacing chamber, display increasingly greater lordosis 
quotients (LQ) and sexually appetitive (hops/darts, full solicitations) behaviors with each 
injection, reaching a plateau by the fourth test (Jones et al., 2013). However EB doses below 3µg, 
when repeatedly administered alone, are insufficient to induce sexual behavior if the female has 
access to the male on every test (Jones et al., 2013; Jones & Pfaus, 2014; Kow & Pfaff, 1975; 
Micevych et al., 2008). Because PNAFs are less sensitive to the activational effects of EB on 
sexual behavior, in the second study described below, we investigated whether those females 
would express behavioral sensitization to repeated injections of EB, following sexual experience 
with EB and P. We hypothesized that if PNAFs were permanently desensitized to EB, as 
proposed by the organizational hypothesis, they would remain impaired to the activational 
effects of steroid hormone priming on the full array of sexual behaviors regardless of the EB 
dose administered, and fail to display behavioral sensitization to repeated EB treatments.  
  
Materials and Methods 
This experiment was conducted in accordance with the ethical standards established by 
the Canadian Council on Animal Care (CCAC), and approved by Concordia University’s Animal 
Care Committee. 
 
Animals, Mating, and Prenatal Treatment Procedures 
All animals in this study were housed in colony rooms maintained at approximately 21°C 
on a 12:12 light:dark schedule (lights off at 0800). Animals were given ad libitum access to food 
(Charles River, 5075) and tap water at all times, and environmental enrichment in the form of 
shredded paper was added to the homecage at each bi-weekly cage change. Home cages as well 
as the testing apparatus were lined with Betachip®. Adult males and females were housed in 
pairs in Plexiglass shoebox cages (48 X 25 X 20 cm) unless otherwise indicated.  
Dams. Twelve females of the Long-Evans strain were used. Sexual receptivity was 
verified daily by placing the female in a unilevel 4-hole pacing chamber with a sexually vigorous 
male. Copulation in these chambers allows the smaller female to pace the rate of copulation by 
entering the males’ side of the chamber, whereas the larger male is restrained to his side. Pacing 
the rate of sexual contact at her preferred interval is rewarding to the female, and increases the 
probability of impregnation (Erskine et al., 1989; Jenkins & Becker, 2003b; Paredes & Vazquez, 
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1999). Those displaying proceptive hopping, darting and solicitations as well as lordosis in 
response to a mount were left to copulate for one hour. The experimenter ensured that females 
received at least one ejaculation, and this day was considered GD0. 
Impregnation was successful in 7 of the 12 time-mated females, verified by an increase in 
body weight accompanied by abdominal distention in the weeks following copulation. Each 
female was randomly given a SC injection of either sesame oil (Oil, n=3) or 500µg of TP 
dissolved in 0.5mL of sesame oil (TP, n=4) on GD18, were housed individually, and provided 
with shredded paper for nest building. This TP dose disrupts genital morphology and the 
expression of female-typical sexual behaviors in adulthood (Rhees et al., 1997). As of GD20, 
twice a day (approximately 8AM and 5PM) a researcher verified whether the pregnant females 
had given birth. The day of birth was identified as postnatal day zero (PN0). Between PN21-23 
the pups were weaned, sexed and housed in same-sex groups of 3 or 4 until they required 
additional space (approximately 2 months of age), when they were finally housed in pairs until 
the end of the experiment. Since males were not experimental subjects in the study, those from 
oil-treated mothers were distributed as stimulus animals in other studies, whereas those from TP-
treated mothers were sacrificed under CO2 gas following weaning.  
Stimulus Males. A group of Long-Evans male rats (~6 months of age) that had previously 
been used in unrelated studies in our laboratory were used for mating, and behavioral training 
and tests.  They were sexually experienced in the unilevel 4-hole pacing chambers.  
Experimental Females. Females born from dams treated on GD18 were used as 
experimental animals. On GD80 females were OVX. On PN95 the anogenital region was 
photographed and anogenital distance was measured with a caliper.  
 
Ovariectomy 
Anesthesia was induced with a 4:3 mixture of ketamine hydrochloride (50 mg/mL; 
Ketaset®, Wyeth Canada) and xylazine hydrochloride (4 mg/mL; Rompum®, Bayer Healthcare) 
injected i.p (1mL/kg). An ocular ointment was applied (Natural Tears®, Alcon), and when 
unresponsive to a foot pinch, bilateral OVX was performed via a single lumbar incision. Animals 
were numbered by ear-punch and post-operative care was given with SC injections of Flunixin 
meglumine 2.5mg/kg (Banamine®, an anti-inflammatory, analgesic, and antipyretic) and 5mg/kg 
Enrofloxacin (Baytril®, an antibacterial), followed by 3mL of saline administered SC, and 
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polysporin was applied to the incision site. Animals were given one-week post-operative 
recovery prior to testing. 
 
Hormone treatments in adulthood 
17β-estradiol benzoate (2.5, 5, 10, or 20µg), and P (500µg) were dissolved in 0.1mL 
reagent grade sesame oil. EB was always injected SC 48 hours, and P 4 hours, prior to training or 
testing. Hormones and sesame oil were supplied by Steraloids (Newport, RI). 
 
Experimental procedures 
Experiment I. Increasing doses of EB given in combination with P on female sexual 
behavior. The week prior to OVX, females were acclimated to the 4-hole unilevel pacing 
chamber for 5 consecutive days, for 15 minutes each. One week following OVX females were 
primed with 2.5, 5, 10 or 20µg EB (n=6-7/group - see sample sizes in Table 1), followed by P.   
Table 1.  
Sample sizes of prenatally oil or testosterone 
propionate (TP) treated females used in Experiment 1. 
Females were treated with varying EB doses in 
combination with 500µg progesterone. 
  Prenatal Treatment 
  Oil TP (500µg) 
EB Dose    
2.5µg  6 7 
      5µg  6 9 
      10µg  6 6 
20µg  6 7 





Experiment 2a. Estradiol sensitization: Sexual training with EB+P. Rats treated with 2.5 
or 10µg EB in Experiment 1 were selected to assess behavioral sensitization to EB. Following a 
two-week hormone washout period, female rats were treated with 10µg EB and 500µg P every 4 
days and given four 30 minute sexual training sessions in the unilevel four-hole pacing chamber, 
followed by a second 2-week hormone washout period (as in Jones et al., 2013; Jones & Pfaus, 
2014).  
Experiment 2b. Estradiol sensitization: Repeated administration of 2.5µg or 10µg EB 
alone. Following training, half the females previously treated in Experiment 1 with 2.5µg EB 
were reassigned to receive 10µg EB, and half the females previously treated with 10µg EB were 
reassigned to receive 2.5µg EB, to balance prior EB-treatment history between groups. To test 
for behavioral sensitization to repeated EB over 6 test days, females were administered their 
respective EB dose, and tested 48 hours later in the unilevel 4-hole pacing chamber. After 
completion of all behavioral testing brains were collected from all rats in this study to assess the 
effect of prenatal androgen administration on the size of the sexual dimorphic nucleus using 
standard histological techniques.  
 
Behavioral Measures 
 Lordosis magnitude (LM) was coded on a 3-point scale as in Hardy and Debold (1971b),  
and lordosis quotient (LQ) was calculated as a ratio of the number of lordosis postures displayed 
to the total number of mounts, intromissions, and ejaculations received (x100). Hops/darts, and 
full solicitations (headwise orientation towards the male followed by a runaway) were analyzed 
both separately, and summed together as a general measure of appetitive sexual behaviors (as in 
Jones et al., 2013; Jones & Pfaus, 2014). Full solicitations are indicative of greater sexual 
motivation compared to hops and darts, since they are observed more frequently in fully EB+P 
primed females compared to those treated with EB alone (Pfaus et al., 1999). Kicks, sideways 
takedowns, boxing postures, and prone position were coded as defensive behaviors (Barnett, 
1963). Mounts, intromissions, and ejaculations from the male were also measured, as they 




Volume of SDN-POA 
 Two days following their last test day, rats in Experiment 2 were once again treated with 
their appropriate EB dose. Forty eight hours later rats were given an overdose of sodium 
pentobarbital (120mg/kg, ip), the descending aorta was clamped and animals were perfused 
intracardially with 250mL of ice-cold phosphate-buffer saline followed by 4% paraformaldehyde 
in 0.1M phosphate buffer. Brains were removed, postfixed in 4% paraformaldehyde for 4 hours 
and dehydrated in 30% sucrose solution overnight. The following day they were flash-frozen on 
dry ice and stored at -80C until anatomical staining with cresyl violet (<8 months). 
 Coronal sections (30µm) of the preoptic area were collected onto gel-coated slides, dried 
overnight, and stained with cresyl violet the following day. Slides were submerged sequentially 
in wheaton dishes containing dH2O, followed by 70%, 95% and 100% alcohol (3 mins in each). 
Next they were agitated in xylene for 2 mins, and rehydrated in 100%, 95%, 70% alcohol (3 
mins each) before rinsing in dH2O. Slices were then submerged for 5-7 mins in a 0.1% aqueous 
cresyl violet acetate solution (1% cresyl violet stock solution diluted in dH2O + 4 drops of 
glacial acetic acid per 100mL solution), and rinsed in dH2O. Next, slices were dehydrated in 70, 
95, and 100% ethyl alcohol (3 mins each) before rinsing in a 1% acid alcohol decolorizing 
solution (10% acetic acid dissolved in ethanol). Slices were then submerged for 3 mins each in 
100% alcohol, xylene:alcohol (mixed at 1:1), and finally xylene before coverslipping.  
 The sexually dimorphic nucleus of the preoptic area was located by first identifying the 
anterior commissure, suprachiasmatic nucleus and the optic chiasm. Serial pictures were taken 
with QCapture Pro 7 software (2010), with a 4x objective, between plates 33 and 44 of Paxinos 
and Watson (Paxinos & Watson, 2013) using the third ventricle, anterior commissure, and optic 
chiasm as landmarks. An investigator blind to the prenatal treatment independently selected the 
section containing the largest diameter (LD) of the SDN-POA for each brain, and calculated the 
area using ImageJ v.1.46 (Schneider, Rasband, & Eliceiri, 2012). Images were converted to 8-bit, 
brightness/contrast was automatically adjusted, the scale was set using a metric ruler and using 
the irregular tool the nucleus was carefully outlined. The average area of the left and right 




 Anogenital distance. Independent t-tests were used to compare anogenital distance, and 
area of the largest section of the SDN-POA between prenatal treatment groups. Cohen’s d is 
reported as a measure of effect size. 
 Experiment I. Increasing doses of EB given in combination with P on female sexual 
behavior. A 2 way between subjects ANOVA was used to assess the effects of prenatal treatment 
and EB dose on sexual behavior. Where appropriate t tests with Bonferroni adjustment were used 
to assess differences between EB groups.  
Experiment 2a. Estradiol sensitization: Sexual training with EB+P. The effect of prenatal 
treatment on sexual behavior displayed during training was assessed using a two way mixed 
ANOVA with prenatal treatment (TP vs oil) as the between groups factor and training day (Day1 
vs Day 4) as the within subjects factor.   
 Experiment 2b. Estradiol sensitization: Repeated administration of 2.5µg or 10µg EB 
alone. To evaluate any effects of prenatal treatment on the ability of repeated EB treatment to 
increase appetitive sexual behaviors a 3 way mixed ANOVA was used with prenatal treatment 
(TP vs oil) and EB treatment  (2.5 vs 10µg EB) as between group factors and test day (1-6) as the 
within subjects factor. Eta squared (η2) is reported as a measure of effect size. Simple main 
effect analyses were used to investigate interactions. Because the number of females receiving 
mounts varied across days, repeated measures ANOVA could not be used to assess differences in 
LQ. Thus, A 2 way ANOVA (prenatal treatment by EB dose) was used to assess differences in 
LQ on each test day. All alpha levels were set at p=0.05. Data are reported as mean ± SEM, 
unless otherwise noted. 
 
Results 
Subjective observations during ovariectomy 
 Although the morphology of ovaries and uterus appeared normal in oil-treated animals, 
the uterus of most prenatally TP-treated females was distended and filled with fluid, similar to 
that reported in Wolf (2002). Three prenatally TP-treated females died from surgical 





The anogenital distance was significantly longer in females treated prenatally with TP 
(M=2.18 cm, SD=0.23) than with Oil (M=1.76cm, SD=0.15), t(51)=7.55, p<0.001, d=2.08. 
Figure 1 illustrates representative photographs of the anogenital region of Oil (left) and  TP-
treated females (right) at 95 days of age. Few PNAFs had a vaginal opening at this time, 
although no systematic measurements were taken. 
 
Sexually dimorphic nucleus of the preoptic area 
  Figure 2 panels A and B depict representative images of the largest section (30µm thick) 
through the SDN-POA of prenatally Oil and TP treated females. Although the area of a section 
of the SDN-POA was larger in prenatally TP treated females (Figure 2 panel C), the independent 
t-test failed to meet statistical significance, but the large effect size suggests that the lack of 
significance may be due to low power, t(10)=1.67, p=0.126, d=0.96.  
 
Experiment I. Increasing doses of EB given in combination with P on female sexual behavior  
Lordosis. Fewer prenatally TP-treated females were mounted compared to controls, 
𝝌𝝌2=4.12, p=0.043, such that two females from the Oil group (2.5µg EB, n=1; 20µg EB, n=1) 
and nine in the TP group (2.5µg EB, n=4; 5µg EB, n=1; 10µg EB, n=2; 20µg EB, n=2) were 
excluded from the analysis of LQ. LQ was lower in females treated prenatally with TP (Figure 
3A) (main effect of prenatal treatment on LQ, F(1,34)=5.68, p=0.023, η2=0.14). Neither the main 
effect of EB dose, nor the interaction effect reached statistical significance. Similarly LM did not 
differ with either prenatal treatment, dose of estrogen or their interaction (data not shown). 
Appetitive and Defensive Behaviors. As shown in Figure 3, females treated prenatally 
with TP displayed fewer solicitations (panel B) and hops/darts (panel C) than Oil treated animals 
reflected in a significant main effect of prenatal treatment on both parameters (solicitations, 
F(1,45)=4.54, p=0.039, η2=0.09;  hops and darts, F(1,45)=35.10, p<0.001, η2=0.44). Neither the 
main effect of EB dose nor the interaction reached statistical significance. The same pattern was 
maintained when summed into a general measure of sexually appetitive behaviors, (main effect 
of prenatal treatment, F(1,45)=36.17, p<0.001, η2=0.45; data not shown). The main effect of EB 





Figure 1. Representative photographs of the anogenital region of Oil (Left) and TP-treated 
(Right) females. The anogenital distance was longer in prenatally TP-treated females, and most 




Figure 2. The section (30µm) with the largest diameter of the SDN-POA was selected for each 
rat, captured at 40x, and the average area of the left and right hemispheres were calculated. 
Prenatally oil treated females (A) generally had a smaller SDN-POA than TP treated females 





Figure 3. Varying doses of EB given in combination with 500µg P in prenatally Oil-treated or 
TP-treated females. Lordosis Quotient (A), Solicitations (B), and Hops/darts (C) were 
significantly attenuated, whereas Defensive behaviors (D) were significantly higher in prenatally 







Females treated prenatally with TP displayed more defensive behaviors than control 
animals (Figure 3D) (significant main effect of prenatal treatment F(1,45)=4.01, p=0.051, 
η2=0.08). Neither the main effect of EB nor the interaction was statistically significant. 
Male Behaviors. Number of mounts (Figure 4A) and intromissions (Figure 4B) received 
did not vary significantly as a function of prenatal treatment or dose of EB. A significant main 
effect of prenatal treatment was detected on ejaculations, (F(1,45)=15.93, p<0.001, η2=0.26, 
Figure 4C) which is probably attributable to the lack of vaginal openings in the TP treated group. 
Neither the main effect of EB nor the interaction met statistical significance.  
 
Experiment 2a. Estradiol sensitization: Sexual training with EB+P. 
Lordosis. LQ was higher on the final training day compared to the first (Figure 5A)  
(significant main effect of training day, F(1,15)=5.77, p=0.030, η2=0.28) but there was no effect 
of prenatal treatment on this parameter. LM neither changed across days nor differed between 
groups (data not shown). 
Appetitive and Defensive Behaviors. Significantly more full solicitations were observed 
overall in oil-treated animals than in TP-treated animals (Figure 5B; main effect of prenatal 
treatment, F(1,23)=10.43, p=0.004, η2=0.31). Neither the main effect of training day nor the 
interaction was significant. No differences were detected in the number of hops/darts (Figure 5C), 
on the combined measure of appetitive behaviors (data not shown but closely resembles 
hops/darts), or defensive behaviors (Figure 5D).  
Male Behaviors. Number of mounts did not differ significantly as a function of either 
prenatal treatment or training day (Figure 6A). However, prenatally-oil treated animals received 
more intromissions and ejaculations on the final training day compared to the first, as shown in 
Figure 6B and C respectively but this effect was not seen in androgen treated females, reflected 
in significant interactions: intromissions, F(1,23)=4.44, p=0.046, η2=0.16; ejaculations, 
F(1,23)=4.25, p=0.006, η2=0.28. Controls also received more intromissions (p=0.002, d=1.38) 
and ejaculations (p=0.002, d=1.40) on the final training day compared to prenatally TP-treated 









Figure 4. Varying doses of EB given in combination with 500µg P in prenatally Oil-treated or 
TP-treated females. The number of mounts (A) and intromissions (B) received were equal 
between prenatal treatment groups, but prenatally TP-treated females did not receive any 





Figure 5. A subset of females from Phase 1 were given a 2-week hormone washout, followed by 
4 sexual training sessions following EB (10µg) + P (500µg) priming. No prenatal treatment 
differences were found on LQ (A), hops/darts (C) or defenses (D), but fewer solicitations were 








Figure 6. A subset of females from Phase 1 were given a 2-week hormone washout, followed by 
4 sexual training sessions following EB (10µg) + P (500µg) priming. No prenatal treatment 
differences were found on the number of mounts received (A), but control females received 
significantly more intromissions (B) and ejaculations (C) on training day 4 compared to day 1, 
and on training day 4 they received significantly more intromissions and ejaculations than 






Experiment 2b. Estradiol sensitization: Repeated administration of 2.5µg or 10µg EB alone. 
Lordosis. Number of rats mounted on a given test day is shown in Table 2. As shown in 
Figure 7A, LQ was significantly higher in females treated with 10µg EB compared to those 
treated with 2.5µg EB, with significant main effects of EB at test 2 (F(1,12)=21.20, p=0.001, 
η2=0.64), test 3, (F(1,13)=4.59, p=0.05, η2=0.26), test 4, (F(1,8)=7.98, p=0.022, η2=0.50), and  
test 6, (F(1,10)=9.78, p=0.011, η2=0.49). On Test 5 LQ was significantly higher in oil than in TP 
treated females (p=0.039, d=5.60) but only at the 10µg dose of EB (significant dose x prenatal 
treatment interaction (F(1,9)=5.14, p=0.050, η2=0.36).  
Prenatally TP treated females displayed more LM1 (1.33±0.314) compared to oil treated 
females (0.367±0.302) (main effect of prenatal treatment, F(1,21)=4.92, p=0.038, η2=0.005), yet 
the small effect size suggests that this difference is not an important one. Although a main effect 
of test was detected, F(5,105)=2.40, p=0.042, η2= 0.08, the effect was small and Bonferroni post-
hoc failed to detect any specific test differences. The interaction was not significant. 
The frequency of LM2 generally increased across tests (main effect of test, 
F(5,105)=6.44, p<0.001, η2=0.19). Specifically, more LM2 occurred on Tests 2 and 3 compared 
to Test 1 (p=0.022, p=0.003, respectively), and more LM2 were observed overall in females 
treated with 10µg EB (4.47±0.52) compared to 2.5µg EB (0.53±0.50) (main effect of EB 
treatment, F(1,21)=29.70, p<0.001, η2=0.56). As shown in Figure 7B, females treated with 10µg 
EB displayed fewer LM2 on test 1 compared to all subsequent tests, and displayed more LM2 
compared to females treated with 2.5µg EB on all but the first test (significant EB treatment by 
test interaction, F(5,105)=4.53, p=0.001, η2=0.14). No effects of prenatal treatment were 
detected. 
Significantly more LM3 were displayed by females treated with 10µg EB (1.93±0.34) 
compared to 2.5µg EB (0.21±0.32) (main effect of EB treatment, F(1,21)=13.59, p=0.001, 
η2=0.35). The main effect of prenatal treatment, test, and the interaction effects were not 
statistically significant. 
Appetitive and Defensive Behaviors. As shown in Figure 7C, prenatally oil-treated 
animals displayed significantly more solicitations compared to TP-treated females (main effect 
of prenatal treatment, F(1,21)=4.55, p=0.045, η2=0.12), and more solicitations occurred with  
Table 2.  
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Number of prenatally androgenized (TP) or control female rats (Oil) that were 
mounted on a given test day during the test phase of the estradiol sensitization 
paradigm, and included in the 2 way ANOVA analyses on LQ.  
 Oil  TP 








LQ_1 3 5  3 2 
LQ_2 3 5  2 6 
LQ_3 3 6  2 6 
LQ_4 3 2  3 4 
LQ_5 3 4  4 2 
LQ_6 3 4  1 6 
Note. EB: estradiol benzoate. TP: testosterone propionate. Numbers represent 






Figure 7. Sexually experienced OVX females treated prenatally with oil or TP were repeatedly 
treated with 2.5µg or 10µg EB every 4 days, 48hrs prior to each of six sexual behavior tests. 
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aMain effect of prenatal treatment, greater in oil treated than TP treated. bMain effect of EB 
treatment, greater in 10µg EB than 2.5µg EB. cGreater in prenatally oil treated compared to TP 
when treated with 10µg EB. dSignificantly greater in 10µg EB compared to 2.5µg EB. eLess than 
tests 2-6 in females prenatally treated with TP and repeatedly tested with 10µg EB. fOverall, 
fewer hops/darts occurred on Test 1 compared to all subsequent tests. gFemales treated with 
10µg EB displayed fewer hops/darts on Test 1 compared to all subsequent tests. fMore defensive 




10µg EB compared to 2.5µg EB (main effect of EB treatment, F(1,21)=7.09, p=0.015, η2=0.19). 
For females treated with 10µg EB, fewer solicitations were observed in those prenatally treated 
with TP (p=0.008, d=1.15), and in those females prenatally treated with oil, more solicitations 
were elicited by 10µg EB than by 2.5µg EB (p=0.003, d=1.36) (significant EB treatment x 
prenatal treatment interaction, F(1,21)=4.44, p=0.047, η2=0.12). 
Significantly fewer hops and darts were observed on test 1 compared to all subsequent 
tests as shown in Figure 7D (main effect of test, F(5,105)=4.42, p=0.001, η2=0.14), and more 
hops and darts were induced by 10µg EB (9.33±1.04) than 2.5µg EB (1.37±1.00) (main effect of 
EB treatment, F(1,21)=30.13, p<0.001, η2=0.58). For females treated with 10µg EB, fewer 
hops/darts occurred on Test 1 compared to all subsequent tests, and significantly more hops and 
darts were induced by 10µg EB on tests 2-6 compared to 2.5µg EB (significant interaction 
between test and EB treatment, F(5,105)=3.49, p=0.006, η2=0.11). There was no significant 
effect of prenatal treatment, and no other interaction effects were observed.  
When hops/darts and solicitations were combined into a general measure of sexually 
appetitive behaviors, fewer appetitive behaviors were observed on test 1 compared to all 
subsequent tests (significant main effect of test, F(5,105)=4.34, p=0.001, η2=0.14). Significantly 
more appetitive behaviors were seen in females treated with 10µg EB compared to 2.5µg EB 
(main effect of EB treatment, F(1,21)=32.32, p<0.001, η2=0.59). Regardless of prenatal 
treatment, females treated with 10µg EB displayed significantly more appetitive behaviors on 
tests 2-6 compared to females treated with 2.5µg EB, and in females treated with 10µg EB, 
significantly more appetitive behaviors were displayed on Tests 2-6 compared to test 1 
(significant interaction between Test and EB-treatment, F(5,105)=3.45, p=0.006, η2=0.11). There 
was no significant effect of prenatal treatment, and no other interaction effects were observed. 
(Data not shown, but closely resembles that of hops/darts). 
Females treated with 10µg EB were significantly more defensive if they were prenatally 
treated with TP (4.31±0.97) compared to Oil (1.61±0.40) (p=0.016, d=1.51), and prenatally TP 
treated females were more defensive when treated with 10µg EB compared to 2.5µg EB 
(p=0.048, d=2.10) (significant interaction between EB treatment and prenatal treatment, 
F(1,21)=4.32, p=0.050, η2=0.15). 
Male Behaviors. More mounts were observed on test 3 compared to test 1 (main effect of 
test, F(5,105)=3.47, p=0.006, η2=0.13) as shown in Figure 8A, and more mounts and  
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A            B     	  
    	  
 
Figure 8. Average number of mounts (A) and intromissions (B) received from males in sexually 
experienced OVX females treated prenatally with oil or TP and repeatedly treated with 2.5µg or 
10µg EB every 4 days, 48hrs prior to each of six sexual behavior tests. aMain effect of EB 





intromissions (Figure 8B) were received by females treated with 10µg EB compared to 2.5µg EB 
(main effect of EB, mounts: F(1,21)=15.64, p=0.001, η2=0.41; intromissions: F(1,21)=12.46, 
p=0.002, η2=0.36). More ejaculations were received by prenatally oil-treated females 
(0.097±0.027) compared to prenatally TP-treated females (0.00±0.026) (main effect of prenatal 
treatment, F(1,21)=6.51, p=0.019, η2=0.16), and those treated with 10µg EB (0.097±0.027) 
received significantly more ejaculations than those treated with 2.5µg EB (0.00±0.026) (main 
effect of EB treatment, F(1,21)=6.51, p=0.019, η2=0.16). No other effects were detected 
 
Discussion 
 The goal of this study was to test whether PNAF rats were desensitized to the activational 
effects of EB on lordosis and appetitive sexual behaviors in adulthood. This was tested in two 
ways, first using varying doses of EB administered in combination with P, and second by 
subjecting the animals to an established estradiol-sensitization paradigm in which females are 
first given sexual training followed by a hormone washout period before being repeatedly treated 
with EB alone (Jones et al., 2013; Jones & Pfaus, 2014). The greater anogenital distance and size 
of the SDN-POA suggest that the prenatal TP manipulation was effective. However, the results 
of the behavioral analyses indicated that prenatal androgen treatment did not permanently 
desensitize females to the activational effects of EB. Although sexually naïve females were 
initially desensitized to the acute effects of EB+P within the varying EB doses administered 
(Experiment 1), this difference was largely overcome experientially by repeated testing with 
EB+P (training phase of Experiment 2). Moreover, sexually experienced females treated 
repeatedly with 10µg EB every four days experienced sensitization to the effects of EB on sexual 
behavior, whereas females treated with the 2.5µg dose of EB did not, regardless of prenatal 
treatment. Interestingly, PNAF displayed a consistent deficit in the display of full sexual 
solicitations. Together these data illustrate that prenatal androgen treatment does not permanently 
desensitize females to the activational effects of EB, and suggest that the decreased sensitivity 
can in part be overcome by repeated hormone exposure and sexual experience.  
The current data are in accord with prior reports that the behavioral deficits induced by 
prenatal androgen treatment can be overcome by modifying the estradiol priming conditions. 
Prior studies have shown that both PNAF and males gonadectomized in adulthood display 
normal levels of lordosis if estradiol is administered in a pulsed manner (Södersten et al., 1983; 
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Olster & Blaustein, 1988). The present studies demonstrate that the repeated administration of 
EB (alone or in combination with P) at four-day intervals (as occurs during the rat’s natural 
ovarian cycle) is capable of overcoming the initial deficit on lordosis measures as well as some 
appetitive measures observed in PNAFs. The recovery of hops/darts seen in our study parrallel’s 
the report by Södersten (1976) on ear wiggling in PNAF and males, yet is in contrast to the lack 
of hops/darts seen in males reported by Olster and Blaustein (1988). The magnitude of the 
androgenization, hormone priming regimen, strain differences, or the testing apparatus may all 
contribute to that discrepancy. We have extend the effect of prenatal androgen treatments on the 
recovery of appetitive measures of sexual behavior by showing that PNAF appear to have a 
chronic deficit in the ability to display full solicitations. In the current study animals were tested 
in the uni-level four-hole pacing chamber, and although the female has the ability to display full 
solicitations in this type of chamber (e.g., Jones & Pfaus, 2014), they are more readily observed 
in the bi-level pacing chamber (e.g., Pfaus et al., 1999). Very little is known about the underlying 
neural mechanisms that control varying forms of solicitations; therefore, it would be interesting 
to test whether this behavioral deficit is also observed in the bi-level pacing chamber, and if so, 
this may provide a useful paradigm to study those underlying mechanisms. We recently found 
that AMPA receptor activation within the vlVMH attenuates the sensitization of appetitive 
sexual behaviors by repeated EB treatments, mimicking the effect of repeated vaginocervical 
stimulation during copulation  (Jones, S.L., Farisello, L., Mayer-Heft, N., Pfaus, J.G., submitted). 
As such, it is possible that prenatal TP administration results in higher glutamatergic signaling in 
the vlVMH, which is inhibitory to sexual behavior (Georgescu et al., 2009; 2012; 2014; 
Georgescu & Pfaus, 2006a; 2006b; Kow et al., 1985). However, we cannot rule out the 
possibility that full solicitations would be restored to normal levels had the training phase been 
extended, or with the administration of EB alone (i.e., without access to a male) which 
potentiates the sensitization of hops/darts and solicitations (Jones & Pfaus, 2014). Nonetheless, 
here we have shown that a moderate disruption to normal female sexual differentiation (by a 
single TP injection on PN18, as opposed to for example, longer androgen treatment or the use of 
males), led to a chronic disruption in the female to display full solicitations. 
The retained sensitivity of PNAFs to EB and P on most measures of sexual behavior 
following repeated testing may be due to the presence of the ovaries throughout the early post-
natal period, as well as puberty, which is another well-recognized critical period. Gerall et al., 
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(1973) showed that females that were OVX early in life (within 10 days of birth) were 
behaviorally less sensitive in adulthood to the activational effects of EB+P compared to those 
OVX later (at 35 or 60 days after birth), suggesting that retention of the ovaries throughout 
development enhances the behavioral sensitivity to EB in rats. Although this suggests that had 
we OVX our females prior to puberty the behavioral deficits may not have been overcome with 
repeated testing under EB+P priming, the data by Gerall et al. (1973) also show that the 
differences in sensitivity were only apparent on the first three tests, and were eliminated as of the 
fourth test, up until the final test day (day 7, with tests occurring at 8-10 day intervals). Our 
EB+P training data are consistent with Gerall et al.’s data, and further suggest that the behavioral 
deficits can be overcome by repeated testing with EB+P.  
Sexually appetitive behaviors are activated, at least in part, by activation of P receptors in 
hypothalamic regions. Estradiol induces P receptors in sex-relevant brain areas such as the 
mPOA and VMH (MacLusky & McEwen, 1978; Mani, Blaustein, Allen, Law, O’Malley, & 
Clark, 1994), such that P can subsequently bind its receptors in these regions to potentiate 
lordosis and activate sexually appetitive behaviors (Etgen & Barfield, 1986; Mani, Blaustein, 
Allen, Law, O’Malley, & Clark, 1994; Rubin & Barfield, 1983). Females fully primed with 
EB+P display high levels of both hops/darts and solicitations, whereas very few of those 
behaviors are induced by acute administration of EB alone. Hops and darts occur in close 
proximity to the male, enticing him to mount, and solicitations occur more distally (as they 
include a runaway) and entice the male to chase her, and as such the size of the testing 
environment influences the expression of these behaviors (Erskine, 1989). When tested in a 
context that allows the expression of both solicitations and hops/darts, for example the unilevel 
4-hole pacing chamber or the bilevel chamber, hops/darts are often referred to as partial 
solicitations and full solicitations are interpreted as indicative of greater sexual motivation 
(McClintock, 1984; Pfaus et al., 1999).  However the neural mechanisms underlying the different 
components of appetitive sexual behaviors are not well-understood, although it is clear they can 
be selectively activated or inhibited by different pharmacological or behavioral manipulations 
(e.g., Gelez et al., 2013; Jones & Pfaus, 2014). The present data also suggest differential 
mechanisms underlying subcomponents of sexually appetitive behaviors, and one likely 
candidate could include differential activation of P receptors. 
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Estradiol not only induces the synthesis of P receptors, but also the production of 
neuroprogesterone within hypothalamic astrocytes (Sinchak et al., 2003), and the administration 
of a P receptor blocker RU486, or neuroprogesterone synthesis inhibitors on the fourth test 
attenuates sexually appetitive behaviors (hops/darts and ear wiggles) in adrenalectomized-OVX 
females when using a similar sensitization paradigm (Micevych et al., 2008). We have also 
found that chronic administration of RU486 disrupts the maintenance of sensitized sexual 
behaviors by repeated EB in OVX females (Jones, S.L., Gardner-Gregory, J., Pfaus, J.G., 
submitted). Estradiol-induced P receptors are attenuated in PNAFs (Foecking et al., 2005), which 
together with the present findings suggest that estrogen-induced P receptors are involved in the 
induction of appetitive behaviors by repeated EB. Estrogen-positive feedback, which is sexually 
dimorphic, appears to involve the production of neuroprogesterone synthesis in hypothalamic 
astrocytes by the activation of a membrane-initiated signaling mechanism by estradiol (Kuo & 
Micevych, 2012). Kuo and Micevych (2012), using the four-core genotype model in mice (see 
Arnold & Chen, 2009), found that regardless of chromosomal sex, estrogen positive feedback 
does not occur in phenotypic males (those that develop testes), and proposed that estrogen-
induced neuroprogesterone synthesis is sexually-dimorphic and dependent on the perinatal 
steroid hormone environment. If this mechanism occurs on a continuum, then variations in the 
ability of EB to induce neuroprogesterone, perhaps in combination with reduced P receptor 
synthesis (Foecking et al., 2005), could explain why overall, fewer solicitational behaviors were 
induced in PNAFs treated with EB-alone in the current study.  
It has also been proposed that sexual dimorphisms can be the result of chromatin 
remodeling occurring during the critical perinatal period (Gagnidze et al., 2010). The 
aromatization of testicular testosterone to estradiol in the brain, and its subsequent signaling 
through ER is critical for sexual differentiation of neural structures (Gagnidze et al., 2010; 
McCarthy, 2008; McCarthy et al., 2008; Patchev, Götz, & Rohde, 2004). ERs recruit 
coregulators, before binding estrogen-response elements on DNA, which alter the rate of 
transcription. Nuclear receptor coregulators can induce chromatin remodeling by acetylating, 
deacetylating, or methylating histone proteins (Gagnidze et al., 2010). Histone acetylation and 
deacetylation are typically associated with gene transcription and repression, respectively. 
Histone methylation can either activate or silence gene transcription, and long-term gene 
silencing can be induced by lysine methylation of histones (Gagnidze et al., 2010). Many nuclear 
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ER coregulators have been identified, and are expressed in a sexually dimorphic manner (Auger 
et al., 2002; Jessen, Kolodkin, Bychowski, Auger, & Auger, 2010; Misiti, Koibuchi, Bei, Farsetti, 
& Chin, 1999). As such, it was proposed that testicular steroid hormone secretion leading to ER 
activation can affect chromatin remodeling, leading to the activation of genes relevant to male 
sexual behavior, and the silencing of those involved in female sexual behavior (Gagnidze et al., 
2010). This proposed mechanism could potentially explain the long-lasting effect of inhibited 
sexual solicitations in PNAFs. It will be interesting to test whether ER mediated chromatin 
remodeling is sensitive to sexual experience in adulthood, which would not be surprising given 
the epigenetic literature, and could explain the restoration of sexual behaviors by EB+P in 
PNAFs. In fact, perinatal exposure to estradiol as well as maternal grooming during the early 
post-natal period methylates the ERα promoter region, associated with a down-regulation of ERα 
mRNA (Champagne et al., 2006; Kurian et al., 2010), which shows that somatosensory 
experiences can epigenetically modify genes coding ER.  It has also recently been shown that 
estradiol administration induces chromatin remodeling in the mPOA and VMH (Gagnidze, Weil, 
Faustino, Schaafsma, & Pfaff, 2013). Additionally, some sex differences are inherent in the sex 
chromosomes (Arnold, 2009), as they appear prior to the differentiation of the gonads, or the 
secretion of testicular hormones (Burgoyne, 1993; Burgoyne et al., 1995; Dewing et al., 2006; 
Thornhill & Burgoyne, 1993). As such, it will be important for future studies to assess sexual 
dimorphisms induced by differential gene expression between chromosomal sexes, and/or the 
interaction between sex steroid hormones and the sex chromosomes which can be examined 
using the four core genotype model (see Arnold & Chen, 2009). 
 
Conclusions 
 Although PNAFs that are OVX in adulthood are initially less sensitive to the activational 
effects of EB+P on female sexual behavior, this can be overcome experientially by repeated 
mating following priming with EB+P. Moreover, the PNAF brain remains relatively sensitive to 
EB in adulthood, since behavioral differences on LQ and hops/darts dissipated following 
repeated hormone priming in combination with mating. Nevertheless, prenatal androgen 
treatment appears to interfere with the normal expression of full sexual solicitations. Although 
the underlying mechanisms of the sensitization of sexual behaviors by repeated administration of 
EB are unknown at this time, EB induction of neuroprogesterone and/or P receptors, sexual 
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dimorphisms in chromatin remodeling, and the interaction between steroid hormones and gene 
function due to chromosomal sex differences are interesting possibilities.   
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CHAPTER 5: GENERAL DISCUSSION 
 This thesis established that the administration of EB to the OVX rat every four days, in a 
pattern that mimics the natural ovarian cycle of the rat, generates a behavioral sensitization such 
that sexual behavior is potentiated with its repeated administration. The first set of experiments 
(Chapter 2) characterized the dosing regimens required to induce and counteract sensitization of 
sexual behaviors by EB, and assessed the role of two primary candidates: P (and its receptor) and 
copulatory stimulation. It was established that a dosing regimen of 5µg EB every eight days 
counteracts the sensitization while inducing a relatively stable baseline that can be used to assess 
facilitative effects of compounds on female sexual behavior (Chapter 2.1, Experiment 1). To date, 
the methodology has been applied in at least one preclinical model which showed the facilitative 
role of the pharmacological agent flibanserin on female sexual desire (Gelez et al., 2010). It was 
also established that estradiol sensitization was robustly induced by 10µg EB administered at 4-
day intervals, and that it occurs in OVX rats in the absence of the adrenals, suggesting that 
neither ovarian nor adrenal P play a role in the sensitization (Chapter 2.1, Experiment 2). 
However, when PR were repeatedly blocked on the day of testing, using RU486 from the onset 
of the sensitization paradigm, lordosis and appetitive behaviors were facilitated on earlier tests, 
but were later inhibited, suggesting that PR activation may be involved in the maintenance of the 
sensitized response (Chapter 2.2). It was also determined that if the female is given the 
opportunity to copulate on every test session, the sensitization of sexually appetitive behaviors is 
attenuated compared to females that are not given that opportunity (Chapter 2.3).  
The primary aim of Chapter 3 was to more thoroughly assess the behavioral and neural 
mechanisms associated with copulation that contribute to the attenuation of estradiol 
sensitization of appetitive sexual behaviors. First it was found that repeated administration of 
10µg EB in the absence of other manipulations (ACF group) had the strongest effect on 
behavioral sensitization, and that effect was attenuated by VCS received either from the male or 
artificially from the experimenter on intermediate tests, suggesting that VCS activates 
mechanisms that are inhibitory to those that induce estradiol sensitization (Chapter 3.1). Given 
that VCS is also inhibitory to the duration of estrus, and that part of that inhibitory mechanism 
occurs via glutamate transmission in the VMH, the next set of experiments assessed whether 
mechanisms of estrous termination are also involved in the attenuation of estradiol sensitization 
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(Chapter 3.2). First it was found that repeated AMPA receptor activation within the VMH (in 
place of VCS) attenuates the sensitization of appetitive sexual behaviors by repeated 
administration of EB (Chapter 3.2, Experiment 1). Next it was discovered that females treated 
with EB alone (i.e., those that display a stronger sensitization), also have a quicker onset of 
estrous termination, particularly following VCS (Chapter 3.2 Experiment 2). This finding is 
particularly interesting as it suggests that their brains are not only more sensitive to the 
activational effects of EB on sexual behaviors, but are also more sensitive to the termination of 
those behaviors. As such, it appears that repeated administration of EB in the absence of 
copulation sensitizes circuits required not only for the induction of sexual behavior, but also the 
termination of that behavior, and the effect is potentiated in response to reproductively relevant 
stimuli.   
Sensitization is most robust if EB is repeatedly administered in the absence of the 
opportunity to copulate. Surprisingly, a low dose of EB (2µg EB) - that had repeatedly been 
shown to be suboptimal for inducing female sexual behavior in Long-Evans rats in the absence 
of subsequent P administration - resulted in the sensitization of sexually appetitive behaviors if 
the female was not given access to a sexually vigorous male on each episode of heat (Chapter 
2.3). That finding was replicated and extended when a similar effect was observed in females 
repeatedly treated with 10µg EB but left undisturbed in their home cage (ACF) on intermediate 
tests (Chapter 3.1). Those females displayed the greatest increase in the number of sexually 
appetitive behaviors on the final test day. Together those findings illustrate that the repeated 
administration of EB in the absence of sexual somatosensory stimulation from the male is 
sufficient to sensitize female sexual behaviors once the female is given access to a male. These 
findings are particularly relevant to studies examining the neurophysiological effects of EB, 
especially those using doses that were previously believed to be behaviorally “subthreshold”. 
Moreover, given that repeated administration of EB alters an overt behavioral response, any 
neurophysiological responses to acute EB treatment are surely different from those following 
repeated treatments. 
In Chapter 4, the estradiol sensitization paradigm was used as a diagnostic tool to test EB 
sensitivity in two paradigms of female sexual inhibition. In the first study, whether the sexual 
behavior deficits reported by the use of corncob bedding in the animal’s housing chambers could 
be overcome by repeated administration of EB was assessed (Chapter 4.1). However, corncob 
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bedding did not disrupt the display of sexual behaviors when females were treated with EB+P, 
much to the delight of the researchers who use our animal care facility. In contrast, although 
housing animals on corncob bedding did not prevent estradiol sensitization, if those females were 
housed in a room separate from males (CC/F) their sexual behavior was inhibited. This finding is 
important as it may help explain why only some research groups report sexual inhibition by 
corncob bedding, and moreover it suggests that continuous exposure to male cues can overcome 
inhibitory effects of corncob bedding. In the next study, whether prenatally androgenized 
females would display estradiol sensitization was assessed (Chapter 4.2). Despite a behavioral 
deficit following an acute treatment of EB+P, when tested in the estradiol sensitization paradigm 
their sexual behavior was nearly identical to prenatally oil-treated controls. This finding is 
important as it challenges the notion that early androgen exposure in females permanently 
impairs all female sexual behavior, by illustrating that the deficits observed following acute EB 
can be overcome with repeated administration. Thus, prenatally androgenized females retain 
their sensitivity to EB.  
Overall, the primary findings of this thesis illustrate that sexual behaviors in the female 
rat sensitize to the repeated administration of EB, that the effect is robust as it occurs with 
varying doses at varying dosing intervals, and that the magnitude of the sensitization interacts 
with sexual experience and exposure to male cues. Sexual behavior in the female rat is dependent 
on E2 signaling in sex-relevant brain regions, and in particular the vlVMH. The data in this 
thesis show that estradiol sensitization is attenuated both by VCS (which alters neural activity in 
those same brain regions) as well as by pharmacological manipulations (i.e., AMPA receptor 
activation) within the VMH. Taken together, these findings illustrate that the female brain 
becomes increasingly sensitive to the activational effects of EB on sexual behavior with its 
repeated administration, and extend the hypothesis that glutamate signaling within the VMH is 
inhibitory to sexual behavior. Moreover, the data illustrate the flexibility in female rat sexual 
strategies as a function of prior sexual experience.  
 
Role of the VMH in competing motivated behaviors 
 One of the primary findings in this thesis is that the receipt of VCS on prior successive 
episodes of heat attenuates the sensitization of appetitive sexual behaviors induced by the 
repeated administration EB, and that the effect is mimicked by repeated AMPA receptor 
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activation within the vlVMH. There are clearly other factors involved in the attenuation, since 
females repeatedly administered 2µg EB and placed with a sexually vigorous male fail to display 
behavioral sensitization, an effect that cannot be dependent on VCS since they do not receive 
intromissions (see Chapter 2.1, Figure 3e). Nonetheless, the finding that AMPA receptor 
activation attenuated the sensitization extends our hypothesis that glutamate signaling in the 
VMH is inhibitory to sexual behaviors. Moreover, when considered in the context of feeding 
behaviors, the data suggest that glutamate signaling within the VMH can act as a switch between 
these competing motivated behaviors.   
It is becoming increasingly clear that the VMH has both excitatory and inhibitory 
pathways with respect to sexual behavior, as first proposed by Kow et al., (1985). It also plays a 
very important role in feeding and energy homeostasis by integrating peripheral signals of 
nutrient status and adiposity (Routh, 2010). Moreover E2 modulates the activity of glucose 
responsive neurons within this region (Kow & Pfaff, 1985) The VMH can therefore act as a 
switch between the execution of sexual behavior and feeding depending on the hormonal state of 
the animal. It is well recognized that OVX, which abolishes the expression of sexual behavior, 
results in a dramatic increase in food intake and weight gain compared to ovary-intact control 
animals, whereas administration of E2 reverses those effects (Asarian & Geary, 2002; 2006; 
Butera, Wojcik, & Clough, 2010; Geary & Asarian, 1999; Wade, 1972). Some of those effects 
are driven by E2 actions within the VMH and the nearby ARC (Frank, Brown, & Clegg, 2014). 
EB infusions to the VMH inhibit feeding (Nunez, Gray, & Wade, 1980), and disrupting ERα 
expression in the vlVMH disrupts the ability of E2 to reduce body weight, leads to a decrease in 
energy expenditure and an increase in visceral adiposity, and abolishes sexual behavior (Musatov, 
Chen, Pfaff, Kaplitt, & Ogawa, 2006; Musatov et al., 2007). Moreover, leptin, an anorexigenic 
hormone released from fat cells that leads to the inhibition of feeding, stimulates lordosis 
(Garcia-Juárez, Beyer, & Gómora-Arrati, 2013; Wade, Lempicki, Panicker, Frisbee, & Blaustein, 
1997), but only if the animals are fed ad-lib, since in food deprived animals not only is the 
facilitation by leptin abolished, it actually amplifies sexual inhibition (Wade et al., 1997). 
Part of the mechanism through which E2 regulates food intake and energy balance is by 
altering the brain’s sensitivity to orexigenic and anorexigenic hormones, which stimulate and 
inhibit feeding respectively. For example, E2 administration attenuates the orexigenic effects of 
melanin concentrating hormone (Messina, Boersma, Overton, & Eckel, 2006) and neuropeptide 
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Y (Jessica Santollo, 2008). Estradiol also enhances the anorexigenic effects of centrally 
administered leptin and insulin in gonadectomized animals (Clegg, Brown, Woods, & Benoit, 
2006; Clegg, Riedy, Smith, Benoit, & Woods, 2003), at least in part via classic ERα as well as 
mER signaling in a subset of neurons located within the ARC, which project to the VMH (Frank 
et al., 2014; Sinchak & Wagner, 2012).  
Glutamate transmission within the VMH appears to be a key switch for the onset of 
feeding and the control of energy homeostasis, and the inhibition of sexual behavior. For 
example, blocking the ability of VMH cells to release glutamate by selectively knocking out 
VGLUT2 (vesicular glutamate transporter type 2, necessary for the packaging and consequently 
the release of glutamate into the synapse) prevents the activation of systems that counter 
hypoglycemia (e.g., the release of glucagon), suggesting that glutamate transmission in the VMH 
is involved the activation of systems that stimulate food intake (Tong, Ye, McCrimmon, Dhillon, 
& Choi, 2007). Similarly, glutamate release is increased in the nearby mediobasal hypothalamus 
(particularly the ARC, though a weaker response was also seen in the VMH of animals with 
incorrect placements) within 1-2 seconds of oral contact with a food pellet, and the increase is 
further potentiated in response to a palatable high-fat food pellet, whereas this increase was not 
observed in response to water ingestion (Guyenet, Matsen, Morton, Kaiyala, & Schwartz, 2013). 
Glutamate release within the VMH appears to be under inhibitory control of GABA, since 
bicuculline, a GABA-A receptor antagonist, increases glutamate transmission, indicating that 
glutamate is released by a mechanism of disinhibition (Booth et al., 2010).  
In summary, the VMH is a hypothalamic integrator of peripheral and central signaling, 
that orchestrates behavioral outputs associated with at least two competing motivated behaviors: 
sex and feeding. As just reviewed in this section, one important and likely mechanism that could 
regulate these behavioral systems is glutamate signaling, which may act on discrete neuronal 
populations of estrogen sensitive neurons within the VMH (Akesson et al., 1994).  
 
Other potential mechanisms of behavioral sensitization to estradiol 
 Across the lifespan of the female rat, sexual behavior is predominantly in a state of sexual 
inhibition. Sexual behavior only appears once the ovarian cycle has been initiated in puberty, and 
then only occurs for a small window of time (approximately 12-20 hours) throughout her 4-5 day 
ovarian cycle. If the female has the opportunity to copulate, sexual behavior will be inhibited 
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during a two to six week period of pseudopregnancy or pregnancy, respectively. Sexual behavior 
again declines with age, as ovarian cyclicity becomes disrupted (beginning around 10 months of 
age). As such, a mechanism whereby sexual behavior becomes sensitized must involve a process 
of disinhibition particularly within the VMH, and potentially through increased GABA-ergic 
signaling to reduce glutamate transmission in this region. This is a possibility since it has been 
shown that glutamate release occurs through a process of disinhibition by GABA acting at 
GABA-A receptors in the VMH (Booth et al., 2010).  
This thesis has provided indirect evidence of this by demonstrating that behavioral 
sensitization to EB is attenuated by repeated infusions of the ionotropic glutamate receptor 
agonist, AMPA, infused into the VMH; this suggests that glutamate transmission is attenuated by 
repeated EB treatments, potentially by sensitizing GABAergic transmission on glutamate 
neurons, as previously proposed (Georgescu et al., 2014). GABA-A receptors exist on VMH 
glutamate neurons, and the percentage of glutamate neurons expressing GABA-A receptors is 
approximately doubled by EB or EB+P treatments (Georgescu, Del Corpo, & Pfaus, in 
preparation). As such, repeated treatment with E2 may sensitize GABAergic transmission onto 
those glutamate neurons within the VMH, thereby acting to disinhibit sexual behavior. In 
addition, the administration of E2 also triggers the upregulation of a number of systems within 
the hypothalamus and limbic regions (Micevych & Sinchak, 2007; Pfaff, 1999), including PR, 
nP, dopamine, enkephalins, and opioid receptors; thus, a number of converging systems may be 
involved in the behavioral sensitization. Some of the primary candidates include mER, opioids, 
nP, dopamine, as well as estrogen-induced epigenetic changes. 
Membrane estrogen receptor signaling. Although E2 administration is necessary for 
the display of female sexual behavior, lordosis only begins to occur approximately 24 hours later, 
which led early investigators to believe that E2’s actions on sexual behavior occur through 
genomic (i.e., long, taking hours or days) mechanisms. However it is now clear that the induction 
of sexual behavior following E2 treatment also involves rapid actions through mER signaling.   
Estradiol has rapid membrane actions within the VMH to promote sexual behavior (Kow 
& Pfaff, 2004). Priming with a membrane impermeable form of E2 (E2 bound to bovine serum 
albumin, BSA), followed by a behaviorally ineffective dose of EB was as effective at inducing 
lordosis as two injections of free E2, and this membrane potentiation of lordosis likely occurs 
through activation of protein kinases A and C (PKA, PKC) (Kow & Pfaff, 2004). Similarly, 
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GPR-30 (G-protein coupled receptor 30, also known as GPER1, or G-protein coupled ER1) 
which has a high binding affinity for E2, has been shown to be sufficient in the activation of 
lordosis behavior in EB+P treated OVX mice (Anchan et al., 2014). Thus, repeated EB treatment 
might also sensitize mER signaling to potentiate sexual behaviors. 
One interesting possibility of how E2 can induce long-term changes in cell signaling through 
membrane receptors and ultimately lead to a potentiation of sexual behaviors was proposed by 
Caldwell (Caldwell, 2002). In this model membrane steroid receptor complexes interact with G-
protein coupled receptors (such as oxytocin receptors) to alter the affinity of the steroid hormone 
ligand-binding sites. More specifically, Caldwell proposed that the membrane receptor complex 
has multiple binding sites for different steroid hormones, in particular E2 and P. Based on the 
initial observations by Frye, Mermelstein, DeBold (1992) that sexual behavior in the hamster 
could be altered by infusing membrane impermeable P-BSA in the ventral tegmental area, 
Caldwell and Moe (1999) later reported that E-BSA given in combination with oxytocin 
enhanced LQ and the quality of the lordosis posture. Together those findings suggest that steroid 
hormones have the ability to activate membrane receptors, and that membrane receptors can 
interact with oxytocin receptors to facilitate sexual behavior. Moreover, E-BSA and P-BSA can 
act on the same receptors at times, something that is unique to membrane bound receptors, (since 
E2 and P intracellular receptors are separate proteins) (Caldwell, Walker, Rivkina, Pedersen, & 
Mason, 1999), providing a unique way to alter subsequent binding ability. For example, the 
priming dose of E2 may bind to an allosteric site, opening new sites for subsequent E2 or P 
binding (Caldwell, 2002). Uncoupling the binding sites from the G-protein using G-protein 
antagonists increased high-affinity P-BSA binding and decreased high-affinity E-BSA binding 
(Caldwell, 2002; Caldwell & Moe, 1999). Thus, membrane bound receptor complexes with 
multiple steroid hormone binding sites and their ability to interact with G-proteins to open new 
binding sites might explain the priming effect of E2, whereby subsequent injections of E2 induce 
higher levels of receptivity.  
Membrane estrogen-receptor signaling also occurs in the ARC by forming a complex with 
mGluR, and activation and deactivation of this complex is involved in the inhibition and 
facilitation of sexual behavior (lordosis) through opioid receptor signaling (recently reviewed in 
Micevych & Sinchak, 2013), and is important in the timing of sexual behavior. In fact, opioid 
receptors are also primary candidates in the underlying mechanism. 
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Opioids. E2-induced opioid receptor signaling in the mPOA and VMH is one likely 
potential candidate in the sensitization of sexual behaviors. There are four known opioid 
receptors: delta (δ), kappa (κ), mu (µ), and opioid receptor-like receptor 1 (ORL-1). In general, 
activation of δ receptors in the VMH (Micevych & Sinchak, 2007; Pfaus & Pfaff, 1992) and 
ORL-1 (Sanathara, Moraes, Kanjiya, & Sinchak, 2011) facilitate sexual behavior, whereas µ 
receptor activation inhibits sexual behavior (Pfaus & Pfaff, 1992), particularly within the mPOA 
(Sinchak, Shahedi, Dewing, & Micevych, 2005). Ovarian hormones increase ORL-1 expression 
in the mPOA and increases mRNA expression of its endogenous agonist OFQ/N (orphanin-
FQ/nociceptin) in the VMH (Sinchak, Romeo, & Micevych, 2006). Infusions of OFQ/N to the 
mPOA (Dewing et al., 2007; Micevych & Sinchak, 2007; Sinchak & Micevych, 2003; Sinchak, 
Dewing, Cook, & Micevych, 2007) or VMH (Micevych et al., 1996; Micevych & Sinchak, 2007; 
Sinchak et al., 2007; Sinchak, Hendricks, Baroudi, & Micevych, 1997) facilitate lordosis in 
females treated with physiological doses of E2.  
 Initially, E2 actually inhibits female sexual behavior during the first 20-24 hours of 
administration, through actions in the ARC which result in µ-opioid receptor activation within 
the mPOA. The ARC, in addition to its role in feeding, plays an important role in the inhibition 
and disinhibition of female sexual behavior by E2. Estradiol induces rapid membrane-initiated 
signaling within the ARC, which sends projections to the mPOA, and a subset of µ-opioid 
receptor containing neurons in the mPOA project to the VMH (Sinchak & Wagner, 2012) (see 
Figure 1.1). Within the ARC, mER form a complex with mGluR, such that E2 binding signals 
the release of beta-endorphins within the mPOA, causing µ-opioid receptor activation and 
internalization, to inhibit lordosis (Micevych, Kuo, & Christensen, 2009). This µ-opioid receptor 
activation is maintained for at least 48 hours in OVX females treated with EB alone (Sanathara et 
al., 2011; Sinchak & Micevych, 2001; Sinchak & Wagner, 2012). The circuit is deactivated by 
subsequent administration of P, a high dose of E2, or the administration of the opioid receptor 
antagonist naloxone (Acosta-Martinez & Etgen, 2002; Eckersell, Popper, & Micevych, 1998; 
Sinchak & Micevych, 2001). Thus, repeated EB treatments may sensitize the deactivation of this 
inhibitory system. 
µ-opioid receptor activation also fluctuates with the natural ovarian cycle in the rat, such 
that it is active during periods of sexual inhibition (diestrus and estrus) and deactivated on the 
evening of proestrus when sexual behavior emerges (Sinchak & Micevych, 2003). Sinchak and 
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Wagner (2012) proposed that a bolus dose of E2 administered 24-48 hours following the priming 
dose down-regulates the mER-mGluR1 complex within the ARC, through a down-regulation of 
ERα. This hypothesis is supported by a preliminary report that ERα antagonists administered 44 
hours after a priming dose of E2 reduces mER-mGluR1 activation, coincident with an increase in 
lordosis (as cited in Sinchak & Wagner, 2012). Since E2 downregulates its own receptor (Lauber 
et al., 1991a; Lauber, Romano, Mobbs, Howells, & Pfaff, 1990), this hypothesis may also hold 
true for EB induced sensitization. Frequent EB priming may down-regulate mERα within the 
ARC, thus reducing mERα-mGluR1 signaling, thereby reducing µ-opioid receptor signaling in 
the mPOA, and reducing this inhibitory mechanism (thereby facilitating lordosis). In females 
maximally primed with EB+P, µ-opioid receptor agonists infused within the mPOA or VMH 
inhibits lordosis (Acosta-Martinez & Etgen, 2002; Pfaus & Pfaff, 1992; Sinchak & Micevych, 
2001) consistent with the idea that opioid release induces a state of satiety, and the inhibition of 
sexual behavior.  
In addition, it has been proposed that the µ-opioid receptor signaling in the mPOA circuit 
is important in the timing of sexual behavior, involved in both its onset and offset (Micevych & 
Sinchak, 2007; Sinchak & Wagner, 2012). Such a mechanism may help explain the quicker onset 
of estrous termination in EB/Alone females that received VCS. Estrous termination was more 
readily apparent in EB/Alone females following VCS compared to those that copulated (Chapter 
3.2), suggesting that the offset of sexual behavior was accelerated in those females, further 
indicating a potential role for this circuit in the underlying mechanism. It would be interesting to 
test µ-opioid receptor activation in the mPOA is modulated by afferent signals from the pdMeA 
for example, following VCS, which could be one other way in which VCS might modulate the 
expression of female sexual behavior. Thus, opioid signaling within the mPOA and VMH, 
initiated at least in part via E2’s actions within the ARC may be involved in both the induction 
and inhibition of the behavioral sensitization to EB.  
 Mechanisms of estradiol sensitization may also occur via changes in δ opioid receptor 
signaling. Delta opioid agonists infused in the lateral ventricles or the VMH facilitate lordosis 
(Acosta-Martinez, González-Flores, & Etgen, 2006; Pfaus & Pfaff, 1992) and sexually appetitive 
behaviors such as hops, darts and present postures (Pfaus & Pfaff, 1992). Since E2 upregulates 
pro-enkephalin in the VMH (Lauber et al., 1990; Romano, Mobbs, Lauber, Howells, & Pfaff, 
1990), an endogenous opioid which binds δ-opioid receptors, repeated treatment with E2 may 
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sensitize the release of pro-enkephalin signaling through δ-opioid receptors in the VMH, 
contributing to the behavioral sensitization of sexual behaviors. Similarly, repeated EB 
administration may sensitize ORL-1 signaling within the VMH, since ORL-1 activation by 
OFQ/N in the VMH is necessary for the facilitation of lordosis in females treated with E2-alone 
(in an E2 facilitation paradigm) (Sanathara et al., 2011). 
Neuroprogesterone. Neuroprogesterone may be particularly relevant in the sensitization of 
appetitive sexual behaviors. Micevych et al. (2003) and Sinchak (2003) reported that nP is 
induced by E2 and is involved in the initiation of the LH surge, which occurs around the time 
that sexual behavior is displayed. Given that sexual behaviors are reliably reinstated by the co-
administration of EB+P, tested whether E2-induced nP is also involved in the increased 
behavioral sensitivity experienced in female rats treated repeatedly with E2 (in an E2-facilitated 
paradigm) was examined (Micevych et al., 2008). OVX/ADX rats were administered 10µg EB 
every 4 days and tested for sexual behavior 52 hours later. On the fourth test they received an 
injection of unconjugated E2 (50µg), which led to maximal LQ and a significant increase in 
appetitive behaviors (hops, darts, ear wiggles). Pre-treating the animals with RU486 (a PR 
antagonist), AGT (aminoglutethimide, a P450 side chain cleavage inhibitor), or trilostane (3-β-
hydroxysteroid dehydrogenase inhibitor, which blocks the synthesis of P from pregnenolone) 
failed to prevent the facilitation of LQ by repeated exposure to EB on the 4th test. However, 
appetitive behaviors were significantly attenuated, illustrating that the facilitation of proceptive 
behaviors are PR dependent, and furthermore that this facilitation is dependent on E2-induced 
synthesis of nP (Micevych et al., 2008). Although that study used an E2-facilitated paradigm, nP 
may also play a role in our paradigm when EB is administered every four days. Repeated E2 
treatment may lead to a progressive increase in nP signaling, (e.g., by increasing the efficacy of 
nP synthesis, or increasing PR density), leading to a potentiation of sexual behavior with 
repeated EB administration. If this does occur, it would explain why the competitive PR 
antagonist RU486 only inhibited female sexual behavior on later tests (Chapter 2.2), once there 
was enough nP to compete with.  
Dopamine. Dopamine (DA) is also a primary candidate in the sensitization of sexual 
behaviors, particularly within the mPOA, striatum, nucleus accumbens (NAcc) and pdMeA. 
Dopaminergic systems are key players in sexual excitation once steroid hormones have set the 
stage by controlling attention and behavioral responses towards incentive stimuli and outflow of 
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the autonomic nervous system that controls sympathetic nervous system activation, for example 
by increasing heart rate and parasympathetic activation to increase blood flow to the genitals 
(Hull et al., 1999; Pfaus, 2009).  
Dopamine within the mPOA plays an important role in female sexual behavior, 
particularly the induction of appetitive sexual behaviors (Graham & Pfaus, 2010; 2012; 2013), 
and its effects are sensitive to hormonal status of the female. Within the mPOA, extracellular 
DOPAC, a DA metabolite, fluctuates across the estrous cycle, rising in late proestrus, coinciding 
with the expression of female sexual behavior (Luine, 1993). Similarly, extracellular DA levels 
increase in the mPOA in OVX rats primed with EB+P, although not with acute EB administered 
alone (Matuszewich et al., 2000), and that DA increase occurs approximately 3.5 hrs after the P 
injection (the time when P activated sexual behavior is induced), and a further increase occurs 
following presentation of male (Matuszewich et al., 2000). The ability of DA receptor agonists 
infused in the mPOA to facilitate female sexual behavior is also dependent on the hormonal 
status of the female through varying effects on its receptor subtypes. D2 receptor activation 
facilitates sexual behavior in OVX rats primed with EB-alone (Graham & Pfaus, 2010) whereas 
blocking D2 receptors or activating D1 receptors is facilitative in females treated with EB+P 
(Graham & Pfaus, 2012). As such, it has been proposed that differences in the activation of DA 
receptor subtypes are subject to the hormonal status of the female, such that when the female’s 
hormonal state is one of sexual excitation (e.g., fully primed with EB+P) D1 receptor activation 
is favored (Graham & Pfaus, 2012). Thus, it would be interesting to test whether chronic E2 
treatment shifts the DA receptor ratio activity within the mPOA in favor of the state induced by 
fully priming with EB+P (for example from D2 to D1). Dopamine also has the ability to activate 
PR in a ligand-independent manner and to facilitate P-dependent (i.e., appetitive) sexual 
behaviors (Mani et al., 1996; Mani, Allen, Clark, Blaustein, & O'Malley, 1994a; Mani, Reyna, 
Chen, Mulac-Jericevic, & Conneely, 2006; Mani & Portillo, 2010; Power, Mani, Codina, 
Conneely, & O'Malley, 1991), and may play a role in the enhancement of lordosis behavior in a 
mating-induced enhancement paradigm (Auger et al., 1997).   
Dopamine is also well-recognized as one of the mechanisms involved in the locomotor 
sensitization to psychomotor stimulants and stress (and the cross-sensitization between the two) 
(Kalivas & Stewart, 1991). Females, through estradiol-dependent mechanisms, are more 
sensitive to the sensitization effects of psychomotor stimulants (e.g., Hu & Becker, 2003; Zhao 
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& Becker, 2010; Zhen, Goswami, Abdali, Frankfurt, & Friedman, 2006) and vulnerability to that 
behavioral sensitization may be partly programmed by the early perinatal environment by 
altering DAergic systems (Meaney, Brake, & Gratton, 2002). Estradiol enhances behavioral 
sensitization to psychomotor stimulants in adult female rats (Hu & Becker, 2003), and similarly, 
an increase in locomotor activity is required in sexual behavior, for instance to engage the animal 
in motivational approach behaviors, as well as with respect to active solicitations which require 
an orientation towards the sexual incentive (the male) followed by a runaway. Dopamine release 
within the nucleus accumbens (NAc) helps orient the female towards a sexually active male in 
anticipation of sexual reward (Jenkins & Becker, 2003a), and increases with the presentation of a 
sexually vigorous male, and a further increase occurs during copulation (Pfaus, Damsma, 
Wenkstern, & Fibiger, 1995). Estradiol also stimulates the release of DA in the striatum and NAc 
during mating (Becker, Rudick, & Jenkins, 2001; Jenkins & Becker, 2003a; Mermelstein & 
Becker, 1995; Pfaus et al., 1995), and this increase is more pronounced if the copulatory 
stimulation is received at her preferred interval (such as in a paced mating chamber) (Jenkins & 
Becker, 2003a; Mermelstein & Becker, 1995). Moreover, paced mating behavior is disrupted by 
lesions to the NAc (Guarraci, Megroz, & Clark, 2002; Jenkins & Becker, 2001) and striatum 
(Jenkins & Becker, 2001), at least in part through direct actions of E2 on these regions (L. Xiao 
& Becker, 1997). Thus, repeated E2 may sensitize the mesolimbic DAergic system to facilitate 
sexual behavior, or alter the female’s reproductive strategies (since paced mating behavior was 
disrupted in EB sensitized animals, Chapter 2.3). 
Dopamine transmission within the pdMeA is also implicated in the facilitation of sexual 
behavior. Ovarian hormones increase tyrosine-hydroxylase (the rate-limiting enzyme in DA 
synthesis) in the pdMeA (Holder et al., 2010), and it has recently been reported that DA within 
the pdMeA enhances PR signaling (Holder, Veichweg, & Mong, 2015), which is associated with 
the increase in sexually appetitive behaviors following the administration of methamphetamine 
(Holder et al., 2010; 2015; Holder & Mong, 2010). Infusions of D1 receptor agonists to the 
pdMeA facilitate sexually appetitive behaviors (hops, darts, ear wiggles) (Holder et al., 2015; 
Mascó & Carrer, 1984), whereas D1 receptor blockade prevents the facilitation by 
methamphetamine (Holder et al., 2015). The facilitation may occur through MeA efferents 
terminating in the VMH, since destruction of the connections from the MeA to the VMH impairs 
lordosis (Mascó & Carrer, 1984), yet lesioning the MeA does not impair sexual behavior (Mascó 
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& Carrer, 1984). In addition, OVX rats that had previously been treated with amphetamine (at 
doses that induce locomotor sensitization) display greater levels of appetitive sexual behaviors 
such as hops and darts, solicitations, and female-male mounting, the latter of which is considered 
a super-solicitational behavior (Afonso, Mueller, Stewart, & Pfaus, 2009b). Moreover, this 
super-solicitational behavior was associated with greater Fos-IR in the MeA, as well as the 
mPOA and VMH (Afonso, Lehmann, Tse, Woehrling, & Pfaus, 2009a). Taken together, these 
findings suggest that increased DA signaling within the MeA may be associated with the 
sensitization of appetitive sexual behaviors following repeated administration of EB. 
Epigenetic modifications. Acting as a transcription factor through classic genomic 
mechanisms, E2 binds its receptors, dimerizes, and activates estrogen-response elements on 
DNA to initiate transcription, upregulating a number of systems some of which are themselves 
transcription factors (e.g., PR). An important regulatory step in transcription by hormone 
receptors involves the interaction with cofactors, including histone acetyltransferase (HATs), 
histone methyltransferase (HMT) and histone deacetylases (Gagnidze et al., 2013), which are 
involved in chromatin remodeling, and  can activate (e.g., HAT and HMT) or suppress (e.g., 
histone deacetylation) gene transcription. It has recently been shown that E2 administration 
upregulates cofactors associated with the synthesis of PR in the mPOA and VMH in adult female 
mice (Gagnidze et al., 2013). As such, repeated administration of EB may, through its effects on 
epigenetic mechanisms, amplify transcription of systems that are facilitative to both appetitive 
and consummatory aspects of sexual behavior. 
It has also been proposed that neurons retain their perinatal ability to switch on or off 
gene silencing mechanisms (Wilson & Westberry, 2009). ERα and ERβ are highly expressed in 
the rodent cerebral cortex early in postnatal life but they decline as the animal approaches 
puberty, but middle cerebral artery occlusion increases ERα mRNA. As such, it has been 
proposed that E2 can be neuroprotective by returning to an earlier stage of developmental 
programming ERα gene expression, potentially through changes in DNA methylation, which can 
reversibly silence genes (Wilson & Westberry, 2009; Wilson, Westberry, & Prewitt, 2008). If 
this mechanism is in fact conserved, then repeated administration of E2 may facilitate such a 
process within the hypothalamus, to silence genes involved with sexual inhibition, while 




Is behavioral sensitization adaptive or maladaptive? 
 Behavioral sensitization broadly refers to an enhanced level of behavioral responding 
(e.g., locomotor activity) after repeated exposure to a stimulus (e.g., psychomotor stimulant, 
hormones, shock) (Kalivas & Stewart, 1991; Steketee & Kalivas, 2011), and can be adaptive or 
maladaptive. For example, pain sensitization can be adaptive to prevent further injury by 
generating a withdrawal reflex and a more complex behavioral response to escape future 
encounters with the stimuli (Latremoliere & Woolf, 2009). Moreover, repeated exposure to the 
painful stimuli lowers the pain threshold and amplifies the response, which increases the 
protective function of this system on the organism (Latremoliere & Woolf, 2009). However, pain 
sensitization can become maladaptive in some clinical syndromes (Latremoliere & Woolf, 2009).  
Estradiol’s ability to sensitize central nervous system functioning with respect to 
psychomotor stimulants can also be maladaptive or adaptive. For example, in OVX rats, E2 
administration (5µg/day for two days) lowered the threshold for intracranial self-stimulation, and 
the threshold was even lower if cocaine was co-administered (5mg/kg for 5 days), indicating that 
E2 sensitized the reward system (which can be adaptive in some instances) but also amplified the 
rewarding effects of cocaine (Galankin, Shekunova, & Zvartau, 2010). Females also display a 
stronger behavioral sensitization of psychomotor behaviors in response to psychomotor 
stimulants such as cocaine and amphetamine, which may be due in part to a facilitative role of 
E2 (Forgie & Stewart, 1993; 1994; Peris, Decambre, Coleman-Hardee, & Simpkins, 1991), 
which increases striatal DA release (Becker, 1999). In humans, chronic amphetamine use 
induces a sensitized covert behavioral response such that paranoid behaviors progressively 
increase to the point of psychosis (Robinson & Becker, 1986). Interestingly, E2 appears to 
protect against psychotic (positive) symptoms (Kulkarni et al., 2014). In a behavioral model of 
schizophrenia, where OVX rats are first sensitized to AMPH, the antipsychotic effects of 
haloperidol (represented by a decrease in locomotor sensitization) following the administration 
of E2 at a dose meant to mimic that of proestrus, enhanced the effects of haloperidol (i.e., 
resulted in a further reduction in locomotor activity following an AMPH challenge) (Madularu, 
Shams, & Brake, 2014). It was proposed that this ameliorating effect of E2 may be in part via a 
blunted release of NAc DA in response to haloperidol treatment, or changes in striatal DA 
receptor subtype binding and/or affinity states (Madularu et al., 2014).  
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It was proposed that heightened sensitivity to E2 or reduced sensitivity to the inhibitory 
effects of VCS may serve as an adaptive mechanism to keep ovary intact cycling females in heat 
for a longer period of time, if they have not mated for a long period of time or have recently been 
pseudopregnant (Pfaus et al., 2000). There is evidence that behavioral sensitization to EB occurs 
with aging, suggesting that females that have been through more ovarian cycles are more 
sensitive to E2. Cooper (1977) showed that aged (25 months) females (both sexually-naïve and 
retired breeders) are more sensitive to EB than their younger (3 months) counterparts following 
OVX. Females were OVX then administered repeated daily injections of E2 (0.5µg/kg or 
1µg/kg). The older females displayed lordosis a day sooner (31 hrs after EB treatment) than the 
younger females, accompanied by a progressive increase in LQ, reaching max five days later, 
which was maintained until the end of the experiment (three additional days), and was 
significantly higher than the younger females during that period. Moreover, once EB treatment 
had ceased, the older females continued to display significantly higher LQ compared to the 
younger animals, and continued to display lordosis for at least one day longer than their younger 
counterparts. This important study suggested that the aged female brain is more sensitive to the 
activational effects of EB, translating into higher and more prolonged expression of sexual 
behavior.  
 Thus, a mechanism of estradiol sensitization of sexual behaviors may be adaptive for 
species survival. But if that is true, what then would be the purpose of pseudopregnancy in a 
naturally cycling female? Why would the brain be set up to cease sexual behavior for an 
extended period of time (equivalent to 3-4 ovulatory cycles) and prepare the body for pregnancy, 
in the absence of fertilization? One answer may be that the rat brain contains mechanisms to 
optimize its potential for reproduction. Pseudopregnancy is a common phenomenon in other 
animals such as mice and dogs (Gobello, La Sota, & Goya, 2001), and even occurs to some 
extent in humans (Tarín, Hermenegildo, García-Pérez, & Cano, 2013) (although the underlying 
mechanisms in humans are likely more complex), yet its evolutionary purpose is not known. 
However, pseudopregnancy appears to sensitize the latency to onset of maternal behavior, when 
examined after its natural termination (Steuer, Thompson, Doerr, Youakim, & Kristal, 1987), 
which may be further evidence of an adaptive behavioral response for species survival. Taken 
together, it appears more and more obvious that the female rat brain is set up to optimize 
reproductive success, potentially through a series of “failsafe” mechanisms, one of which is 
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estradiol sensitization of sexual behaviors by enhancing excitatory neural mechanisms to activate, 
and reducing inhibition of systems that inhibit sexual behavior, as initially proposed by Pfaus et 
al. (2000), while also sensitizing the onset of estrous termination and presumably 
pseudopregnancy, particularly upon receipt of reproductively relevant stimulation (i.e., VCS). 
 
Estradiol sets the stage for transition to the next phase  
 Although E2 sets up a state of sexual excitation such that the animal can respond 
appropriately to olfactory, auditory and somatosensory sexual stimulation, it also acts by 
reducing inhibitory neural processes. Powers and Valenstein (1972) were the first to show that 
one of the actions of E2 is to reduce neural inhibition that prevents the display of lordosis. They 
found that OVX females with lesions to the mPOA were more sensitive to the activational 
effects of EB on lordosis, and that those females stayed receptive for a longer period of time, 
showing that for lordosis to occur, EB must be removing inhibition within the mPOA in the 
intact animal. Similar disinhibitory effects of E2 have also been reported more recently in the 
VMH, whereby E2 reduces neural processes that are inhibitory to sexual behavior, by reducing 
glutamate transmission (Georgescu et al., 2009; 2014).  
The ability of E2 to reduce the activation of systems that are inhibitory to sexual behavior 
may allow females to receive sufficient amounts of VCS required for the activation of the 
neuroendocrine events necessary to promote fertilization and sustain pregnancy (Georgescu et al., 
2009; 2012; 2014; Pfaus et al., 2000). Without such a mechanism she might enter estrous 
termination too soon, since a requisite amount of stimulation is necessary for sperm transport 
(Adler & Toner, 1986; Adler, 1969; Matthews & Adler, 1978; Toner, Attas, & Adler, 1987) and 
the twice daily prolactin surges required for maintaining pregnancy (Adler & Toner, 1986). This 
thesis extends that idea by illustrating that the ability of E2 to activate excitatory systems and 
inhibit inhibitory systems interacts with the receipt of VCS during previous episodes of heat.  
It was proposed previously that heightened E2 sensitivity or a lower sensitivity to the 
inhibitory effects of VCS may enhance reproductive success in ovary intact cycling females that 
have not mated for long periods of time, perhaps by extending the time they are in behavioral 
estrus at least long enough to receive a requisite number of intromissions and VCSs (Pfaus et al., 
2000). However the present data suggest an alternate, though compatible, mechanism. Increasing 
doses of EB extend the amount of time that females will display lordosis (Quadagno, 
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McCullough, & Langan, 1972), yet females that received repeated EB treatments but were not 
given the opportunity to mate for six consecutive tests were at a later stage of estrous termination 
and were more sensitive to the inhibitory effects of VCS (Chapter 3.2). Thus, although E2 may 
extend the period of behavioral estrus (Albert et al., 1991), its repeated administration sensitizes 
systems that lead to its quicker termination, particularly following receipt of VCS, thereby 
shortening the period of behavioral estrus. Thus, E2 not only primes the circuits necessary for 
the activation of sexual behavior given the appropriate sexual stimuli and inhibits systems that 
act in opposition to those of sexual behavior (e.g., feeding, or on a neurochemical level 
glutamate transmission in the vlVMH), it also sensitizes the activation of systems required to 
shift the animal into the next phase (i.e., the termination of estrus, and presumably a return to 
behaviors that are incompatible with sexual behavior, such as feeding, nest building, and 
sleeping). Moreover, its sensitizing effects interact with prior sexual experience, particularly 
VCS. In addition, it appears that in EB treated females, repeatedly stimulating a mechanism that 
has been shown to be inhibitory to sexual behavior (AMPA receptor activation in the vlVMH), 
alters the female’s sexual behavior pattern, by reducing appetitive aspects of sexual behavior 
while facilitating the expression of LM3 (Chapter 3.2 Experiment 1), a behavior that potentiates 
the onset of pseudopregnancy. This finding highlights the plasticity and reproductive adaptability 
of the female brain to the interaction between E2 and sexual experience.  
The present data in combination with evidence in the field allows the generation of a rate-
limiting rule of E2’s enhancement and termination of sexual behavior: repeated cyclic exposure 
to E2 sensitizes the activation sexual behaviors in the OVX rat, which is a function of the dose 
and administration interval, while the rate of sensitization and duration of its expression, is 
limited by the sexual stimulation received (Figure 5.1). What is the applicability of the rule, and 
how does it translate into different scenarios? The neuroendocrine and experiential effects of 
behavioral estrus set the stage for the subsequent phase, beginning with estrous termination. For 
example, with the receipt of VCS sexual behavior becomes inhibited, while promoting 
physiological actions (such as prolactin release) that lead to a change in behavior (such as nest 
building and feeding) to prepare the animal to enter the next phase: pregnancy. Metabolic 
changes associated with pregnancy are a necessary adaptation to prepare the body for massive 




Figure 5.1 Rate-limiting rule of the ability of estradiol to sensitize mechanisms that facilitate as 
well as terminate sexual behavior. The rate of sensitization of female sexual behavior by 
estradiol is a function of dose (increasing color intensities represent increasing EB doses, e.g., 2, 
5, 10µg), administration frequency (not shown), and sexual experience. Relative rates of 
sensitization are depicted as the upward arm of each line, whereas descending arms represent 
offset of the behavior in a given episode of heat in EB sensitized animals. As the dose increases 
the rate of sensitization increases, yet the rate is limited by the receipt of sexual stimulation. The 
repeated administration of EB without the opportunity to copulate (dashed lines) induces a robust 
sensitization, yet sexual behavior terminates quicker relative to females given the opportunity to 




food intake, reduced energy expenditure, and more efficient nutrient absorption (Grattan & Le 
Tissier, 2014). Initially two daily surges of prolactin release from the pituitary maintains the P 
secreting corpora luteum, for approximately 12 days (Levine, 2014), after which the placenta in a 
fertilized female would take over. In the case of pseudopregnancy, the absence of the placenta 
results in luteolysis, a drop in P levels, and the resumption of the ovarian cycle. In a fertilized 
female, P production transitions to the placenta, and complex neuroendocrine events initially 
inhibit the expulsion of the fetus followed by a release of that inhibition to deliver the offspring 
(Kota et al., 2013). Just prior to parturition there is a dramatic reduction in P, and an increase in 
E2 and prolactin, and this state in turn alters the females’ physiology and metabolism that must 
occur in the next state: lactation. The metabolic changes associated with lactation have recently 
been extensively reviewed (Woodside, Budin, Wellman, & Abizaid, 2012).  
In summary, the neural consequence of repeated E2 administration interacts with sexual 
stimulation received to prepare the animal for the next phase. Since the phase that follows 
behavioral estrus requires the disinhibition of feeding, which presumably occurs at least in part 
through glutamatergic signaling in the VMH, it would be interesting to test differences in feeding 
behaviors in E2 sensitized animals following varying stimulations (e.g., EB/Alone vs EB/Male), 
or following the receipt of VCS in a pattern that is sufficient to induce pseudopregnancy. In the 
former case we might expect feeding behaviors to be greater (or a quicker onset) in those females 
that copulate with every episode of heat (compared to those that do not) since the receipt of VCS 
on each copulatory session activates mechanisms that are inhibitory to sexual behavior. In 
contrast, in the latter case it would be expected that feeding behaviors would be greater in 
females repeatedly treated with EB without an opportunity to copulate (e.g., after eight 
injections) particularly following VCS, since estrous termination was accelerated in that group. If 
these findings were supported, they would provide evidence that an increased behavioral 
sensitivity induced by E2 in one phase (i.e., sexual behavior) translates into increased behavioral 
responses in a subsequent, competing phase (i.e., feeding).  
 
Additional applications of the phenomenon of estradiol sensitization  
In Chapter 4 the estradiol sensitization paradigm was applied to two scenarios of sexual 
inhibition; yet another circumstance where sexual behavior is inhibited is with aging. As the 
female rat ages, ovarian steroid hormone secretion is disrupted (Borchardt, Lehman, & 
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Hendricks, 1980; Chambers & Phoenix, 1986; Cooper & Linnoila, 1977; Gerall, Dunlap, & 
Sonntag, 1980; Huang, Steger, & Bruni, 1978), resulting in abnormal patterns of sexual behavior. 
Although lordosis remains relatively intact in aged females that have transitioned into a period 
known as constant estrus, or in aged OVX rats treated with EB+P, the expression of appetitive 
sexual behaviors remains impaired compared to their younger counterparts (Borchardt et al., 
1980; Chambers & Phoenix, 1986; Cooper & Linnoila, 1977; Gerall et al., 1980). We reported a 
similar impairment in female sexual behavior in aged ovary-intact Wistar rats tested in bi-level 
chambers, such that their behavior resembled that of younger OVX rats in estrous termination 
(Jones & Pfaus, 2007). Whether older female rats would sensitize to repeated treatment of EB is 
not known, although there is some evidence that chronically high levels of E2 is in fact 
inhibitory to female sexual behavior in aged females (Jones, Ismail, King, & Pfaus, 2012; Jones, 
2009), suggesting that the ability of the brain to sensitize to E2 is disrupted with aging (perhaps 
due to an already heightened sensitivity to E2 (Cooper, 1977), as previously discussed, which 
may shunt them into an inhibitory state). Continuous treatment with testosterone propionate (an 
aromatizable androgen) via a subcutaneously implanted capsule can significantly increase the 
expression of lordosis and appetitive sexual behaviors, although the effect is short-lasting (Jones 
et al., 2012). Maintaining that facilitation may instead require periodic hormone treatments (e.g., 
every 4 days to mimic younger ovarian release), as previously proposed (Jones et al., 2012). 
Testing whether aged OVX females would sensitize to the repeated administration of EB, would 
allow a more thorough investigation of E2 sensitivity in the aged female brain. In fact, there may 
also be a sensitive window of opportunity to conserve the facilitative effects of E2 on rat sexual 
behavior with aging, as has been reported with E2’s role in the conservation of cognitive 
function as women transition into menopause (e.g., Sherwin, 2005). 
 
Further implications of the phenomenon of estradiol sensitization 
Veterinary medicine. Our paradigm of estradiol sensitization may be particularly 
relevant to those in veterinary medicine, as it can be used as a diagnostic tool to test decreased 
sensitivity to E2, and potentially as a means to enhance reproductive behaviors and success. 
However, it would first be important to test whether in ovary-intact females repeated episodes of 
heat in the absence of mating would also enhance subsequent sexual behavior, and second 
whether that manipulation would improve fertility. One way this can be tested is using normally-
	  	  
218 
cycling ovary-intact females that are first mated (with vasectomized males, preventing 
impregnation), then tested for sexual behavior after varying numbers of complete cycles have 
passed. If repeated episodes of heat in the absence of mating potentiates sexual behaviors in 
naturally-cycling animals, then one would expect that the display of sexual behaviors would 
increase within group from the initial test to the final test, and that those females that complete 
more ovarian cycles prior to the second sexual behavior test would display higher levels of 
sexual behavior as the number of cycles increased (e.g., 1, 2, 4) compared to the other groups. If 
that were indeed the case, then it would be interesting to test whether those females that show 
higher levels of sexual behavior would be more likely to become impregnated once given access 
to a sexually vigorous (gonad-intact) male. If that were the case, and if it generalized to other 
species, it may be one way in which reproductive success could be enhanced in endangered 
species. 
Sexual response cycles. Human data also reflect variability and flexibility in female sexual 
responses. This variability was first described in a linear sexual response model proposed by 
Masters and Johnson’s (1966) and later revised by Kaplan (1974) which begins with sexual 
desire, followed by excitement, plateau, orgasm, and a resolution phase. In this model, sexual 
responses can differ between women or within the same woman at different times. The linear 
model has been generally replaced by circular models (Basson, 2005) which incorporate more 
cognitive factors, such as the desire for intimacy, pleasure and satisfaction, all of which must be 
considered in the context of the individual’s relationship (Basson, 2005). Moreover, they 
emphasize the interaction between women’s sexual desire and physiological arousal.  
In women there exists discordance between subjective (self-report) and objective (e.g., 
vaginal blood flow) measures of arousal, in contrast to men who have a high concordance. A 
woman’s physiological arousal occurs not only to images of their preferred sex, for example to 
heterosexual porn in heterosexual women, but also to homosexual porn (of men or women) as 
well as to nonhuman stimuli, despite discordance with their self-reports (Chivers & Bailey, 2005; 
Chivers, Rieger, Latty, & Bailey, 2004). Interestingly, the discordance between increased vaginal 
blood flow and measures of sexual desire in women has also been analogously shown in female 
rats. Whereas compounds that increase genital blood flow and sensitivity also increase sexual 
motivation in male rats (Chu et al., 2008), compounds that increase genital blood flow in female 
rats can in fact alter female sexual behavior (by increasing the contact-return latency following 
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ejaculation, suggesting heightened genital sensitivity to intense VCS) without affecting 
motivational components (such as hops/darts, or partner preference). This illustrates that 
increased physiological genital arousal does not necessarily translate into an increase in 
appetitive sexual motivation (Clark, Meerts, & Guarraci, 2009; Guarraci, 2010), analogous to the 
dissociation that is reported in women. Comparisons between human and rat sexual behavior 
(Pfaus, 1996) and the use of rodents in preclinical models of sexual function and dysfunction 
(Giuliano & Pfaus, 2006; Giuliano et al., 2010) have been thoroughly discussed. 
The difference in appetitive behaviors found between females that copulate on every test 
(EB/Male) compared to those that are not given that opportunity (EB/Alone or ACF) may reflect 
differences in spontaneous and reactive sexual desire, as proposed in Basson’s model (Basson, 
2005). Basson’s model stipulates that initially, sexual desire is typically absent and becomes 
active through a complex set of internal and external factors including a desire for emotional 
intimacy, and a need to increase a woman’s sense of well-being and self-image (e.g., feeling 
attractive and loved) which can be partly dependent on the hormonal and physiological state of 
the woman (Basson, 2005). As such, in this model it is proposed that female sexual desire is 
responsive to the context, and only in some women is sexual desire spontaneous. It is 
spontaneous desire that may be related to hormonal status and pharmacological manipulations, 
and subject to increase with a new relationship (Basson, 2005; Klusmann, 2002). Is it possible 
then that the difference in appetitive measures of sexual behavior between animals that 
repeatedly copulate and those that do not reflect different aspects of sexual desire?  Perhaps the 
greater display of appetitive behaviors displayed by animals not given the opportunity to 
copulate reflects an aspect of spontaneous desire.  
Sand and Fisher (Sand & Fisher, 2007) found that Basson’s model appears to best explain 
sexual responses of women with sexual dysfunction. Women were asked to identity themselves 
with one of three sexual response models (Masters and Johnson, Kaplan, or Basson’s models); 
the distributions were equal among the three, and importantly 10% of women felt that none of 
the available categories best fit their sexual response. This report is particularly interesting as it 
demonstrates the variability in sexual responses between women; however it also reflects a major 
hindrance in our current understanding of female sexual responses given that we really have no 
good model in women. Nonetheless, an animal model of variations in different aspects of sexual 
desire, as we currently understand them, may help identify endocrine and physiological 
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underpinnings of differences in sexual responses between women, and how variability in those 
responses are altered by prior sexual experience. In closing, although patterns of sexual 
stimulation have been shown to improve fertility in rodent research as discussed in this thesis 
(e.g., distributed clitoral stimulation, paced VCS) limited evidence suggests that fertility is 
dependent on any aspect of human sexual response cycles or sexual stimulation (e.g., Levin, 
2002; 2011). However, this may reflect our limited understanding of the parameters underlying 
the variability in women’s sexual responses and sexual function, and only with the progression 
of sexual research can we truly address this question.  
 
Conclusions 
This thesis has established that repeated administration of E2 in combination with sexual 
experience converge within brain regions relevant to the expression of sexual behavior resulting 
in different sensitivities and behavioral baselines. The expression of those behaviors changes not 
only within an episode of heat (e.g., Bennett, Blasberg, & Blaustein, 2002; Blaustein et al., 2009), 
but the data in the present thesis show that sexual experience across multiple episodes of heat 
also changes the expression of sexual behaviors on subsequent sexual encounters. The 
differential sensitivities and behavioral outcomes that occur with repeated E2 and sexual 
experience may to be set up to increase the probability of reproductive success. In addition the 
data in the current thesis have shown that the repeated administration of EB, even at doses that 
have previously been shown to be subthreshold, sensitizes an estrogen-dependent behavior. This 
suggests that E2 has differential actions on neural physiology and behavior depending on the 
dose, and whether it is administered acutely or chronically, and that those effects interact with 
experience. Thus, these findings have important implications for all studies examining the role of 
E2 on neural physiology and behavior. 
Finally, the findings of the current thesis have broad implications. On a proximal level 
the phenomenon of estradiol sensitization has implications for the design of preclinical models of 
female sexual function, and all studies examining the effects of E2 on neural function and 
resulting behavior in female rats. On a more distal level, the work has implications for 
understanding neural mechanisms of sensitization, and potentially as a way to enhance 
reproductive function (which may be pertinent to other species) and increase our understanding 
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